Yaya tsawon lokacin da waɗannan alamun ke ci gaba?
Kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ma a shekarunka.
Kuma ban da zazzabi,
Hakanan za'a gwada yawan cholesterol naka.
Kuma yanzu kina da zazzabi?
Kuma yanzu kuna jin wannan ciwon kirji?
Kuma, kuna da wahalar numfashi?
Za ka iya gaya mini wasu alamun da kake da su ban da wannan?
Kuma yadda zafin jiki ya yi maka zafi.
Ina kuma da tari.
Ina fama da sanyi da tari.
Ina fama da ciwon kirji sosai yau.
Kuma wannan shine lokacin da ya dace don zafin hay.
Kuma ciwon kirji yana faruwa.
Kuma ina tsammanin ina da zazzabi kaɗan.
Kuma ina son ka bayyana inda kake jin ciwon kirji.
Suna kuma fama da zazzabi.
Kuma da tarihin ciwon sukari.
Kuma kamar yadda ka sani, ina jin kamar kirji na zai fashe.
Kuma, ka sani, mutane suna tari a kaina a koyaushe.
Kuma kuna jin ciwon kirji.
Kuma na ce wannan matsi ne a kirjinka.
Kowa a cikin iyalin yana da ciwon zuciya, ciwon zuciya, bugun zuciya, yawan cholesterol, ko hawan jini.
Shin akwai wasu alamomi ko matsaloli da kuka lura da su ban da ciwon tsoka?
Akwai wasu mutane a gidan da suke da alamun da kake da su?
Kana jin wasu cututtuka?
Kana jin numfashi a cikin iska?
Har yanzu kuna jin ciwon kirji?
Domin wannan shine lokacin mura.
Amma kuma bai kamata mu manta da ciwon kirji ba wanda ke haifar da cututtukan zuciya.
Amma matsalar da ta fi muhimmanci yanzu ita ce wannan ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa suna tari a kaina.
Amma muna bukatar mu ɗauki kowace ciwon kirji da muhimmanci.
Amma yanzu tana numfashi daidai, ko ba haka ba?
Na manta da shi gaba daya saboda wannan ciwon kirji.
Kana jin kamar wani yana matsa maka a kirji?
Har yanzu kana jin kamar kana numfashi a cikin iska?
Suna da irin wannan ciwon?
Kuna da wata cuta mai tsanani kamar hawan jini ko wani abu makamancin haka?
Kuna da wasu cututtuka, ko kuma matsaloli na rashin lafiya kamar ciwon sukari?
Kuna jin wani numfashi mai wuya tare da wannan ciwon kirji?
Kana da hawan jini?
Kuna jin wani numfashi mai wuya duk da haka?
Ka san irin cututtukan da take ji?
Ka ga hoton?
Ya sha ruwa da yawa yau.
Duk da haka, ana gwada su don ciwon sukari.
Duk da haka, tana da alamun da suka yi kama da nawa.
Yaya zazzabinka yake?
Yaya hawan jini naka yake?
Idan zazzabinka ya ci gaba da tashi,
Idan zazzabi ya kai 102 ko sama da haka,
Idan kana ganin alamun cututtukanka ko kuma wasu matsaloli na bukatar a yi maka gwaji sosai
Na yi zazzabi a jiya.
Ni ma na kamu da zazzabi.
Na yi zazzabi a jiya.
Ina da ciwo mai tsanani a cikin kirji.
Ina kuma fama da wahalar numfashi.
Zan aiko maka da hoto.
Ina fama da ciwon kirji a yau.
Ina fama da ciwon kai da zazzabi ne kawai yau.
A ganina, yana da mura.
A ganina, kawai mura ce.
Kana ganin kamar wani mai nauyi yana zaune a kan kirjinka?
Wannan duka ya fara ne da ciwon kai da zazzabi a lokaci guda.
Akwai ciwo a tsakiyar kirji na.
Wannan matsi ne kamar ciwon kirji.
Yana cikin ƙirjina.
Yana tsakiyar kirji na.
Yana tsakiyar kirji.
Na ji ciwo a kirji.
Wannan ciwon kirji yana damuna sosai.
Ina so ka bayyana mini wannan ciwon kirji.
Kamar hawan jini ko ciwon sukari.
Kamar dai a tsakiyar kirji ne.
Yanzu za ku iya shan tachipirina don zazzabi.
Yanzu Mary, kwana nawa ne ka sha wahala daga waɗannan alamun?
Ka ce yanzu kana da ciwon kirji.
Ina fama da ciwon kirji a wasu lokatai.
To, kuna da wasu alamun bayyanar cututtuka banda wannan, banda ciwo?
Ko kuwa kana jin kamar wani yana zaune a kan kirjinka?
Yana kama da zazzabi da ciwon kai da ke haifar da tari da ciwon tsoka.
A tsakiyar ƙirjina.
Ka nuna mini inda nake jin zafi a wannan hoton.
Tun lokacin da ka kamu da zazzabi.
To, kana ganin wasu daga cikin waɗannan alamun na iya zama na ciki?
Shin yaranku ma suna da irin wannan alamun?
Ka gaya mini game da ciwon kirjinka.
Zazzabi yakan ƙaru da dare.
Zazzabin da na yi a cikin kwanaki biyu da suka gabata.
Ta fara zazzabi a daren jiya.
Wannan shi ne Dr. Porter a cikin gaggawa a cikin Cibiyar Kula da Cutar.
To, za ka iya gaya mini game da ciwon kirjinka?
Na ji ciwo a gaba na, a cikin kirji.
Na ji ciwo mai tsanani a kirji.
To, lokacin da na ji wannan ciwon a kirji na,
Wane irin ciwo ne ke damunki a kirji?
Yaushe wannan ciwon kirji ya fara?
A ina ne ciwon yake a kirjinka?
A ina kake jin wannan ciwon kirji?
Kana da ƙuntataccen ji a cikin kirjinka.
Ka san ina da ciwon sukari da wasu abubuwa.
Ka ce kana da wannan ciwon kirji.
Yawan kamuwa da cutar korona (Covid-19) a cikin EU/EEA da UK, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a cikin EU/EEA da UK, wanda ke nuna cewa duk da cewa matakin ya bambanta dangane da ƙasa, annobar COVID-19 tana ƙaruwa cikin sauri a cikin ƙasashe.
Bisa ga kwarewar Italiya, ya kamata ƙasashe, asibitoci da kuma cibiyoyin kula da marasa lafiya su ƙara shiri don ƙara yawan marasa lafiya na COVID-19 waɗanda za su buƙaci kula da lafiya, musamman na ICU.
A ranar 31 ga Disamba, 2019, an bayar da rahoton tarin cututtukan huhu na rashin sanannun cututtuka a birnin Wuhan, lardin Hubei, a kasar Sin.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ce, sabon kwayar cutar coronavirus da ake kira SARS-CoV-2 ya haifar da cutar.
Tun daga wannan lokacin, cutar da SARS-CoV-2 ke haifarwa an kira ta cutar coronavirus (COVID-19).
Bayani har zuwa yanzu shine kusan kashi 80 cikin ɗari na mutanen da ke da COVID-19 suna da rashin lafiya mai sauƙi, wato suna da kamuwa da cutar numfashi tare da alamomi ko babu alamomi, kuma yawancin waɗannan suna murmurewa.
A cikin kusan kashi 14 cikin ɗari, kamuwa da COVID-19 ya kara muni zuwa rashin lafiya mai tsanani da ke buƙatar asibiti yayin da sauran kashi 6 cikin ɗari ke fama da mummunan cuta da ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kusan kashi 4 cikin ɗari.
A cikin wannan binciken, an kimanta yanayin ƙididdigar COVID-19 a kowace ƙasa a cikin EU/EEA da UK kuma an kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da COVID-19 a EU/EEA da UK da adadin da aka samu a Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Cutar COVID-19 a cikin EU/AEA da United Kingdom
Bayan abin da ya faru a China, COVID-19 ya bazu sosai a duniya kuma yana bin sahun sauran ƙasashe a duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar EuroSurveillance na 5 ga Maris, 2020, Spiteri da sauransu sun ba da rahoton farkon tabbacin cutar COVID-19 ta Turai bisa ga ma'anar WHO.
A cikin EU/AEA, an ba da rahoton farkon lokuta uku da Faransa ta tabbatar a ranar 24 ga Janairu, 2020 ga mutanen da suka dawo daga Wuhan, lardin Hubei, China.
Tun daga ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU / EEA 30 da Ingila (UK), inda tsakanin 31 ga Disamba, 2019 zuwa wannan ranar, an ba da rahoton shari'o'i 39,768 da mutuwar 1,727, tare da shari'o'i 17,750 da mutuwar 1,441 a Italiya kadai.
Samun ƙididdigar yawan adadin masu kamuwa da COVID-19
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana sabunta adadin masu cutar COVID-19 da aka ruwaito a kowace ƙasa a duniya, wanda aka samo daga kafofin hukuma kawai kamar ma'aikatar lafiya ta ƙasar, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana da ƙarfe 8:00.
An yi amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU/AEA da United Kingdom da kuma kwatanta su da na Italiya.
A matsayin ma'auni na yaduwar cututtukan COVID-19, mun lissafa yawan adadin cututtukan COVID-19 a cikin kwanaki 14, sannan kuma mun yi la'akari da yanayin COVID-19, a duk ƙasashen EU/AEA da Ingila, tsakanin Janairu 1 da Maris 15, 2020.
Mun kuma ba da adadin adadin cututtukan da aka ruwaito daga kowace ƙasa daga 15 ga Maris, 2020 da ƙarfe 8:00 na safe, idan aka kwatanta da adadin a Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/AEA da UK
Hanyoyin da aka samu na yawan masu kamuwa da cutar COVID-19 a cikin kwanaki 14 a cikin EU/EEA da UK sun bi na lardin Hubei (China) (Figure 1).
Ga EU/AEA da UK gabaɗaya, yawan adadin COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu, sannan ya ƙaru sosai a kusan 28 ga Fabrairu, 2020 (Mataki na gaba).
Wannan ya fi yawaita ne saboda saurin karuwar adadin masu kamuwa da cutar da aka ruwaito daga Italiya, amma duk ƙasashen EU/AEA da Ingila sun nuna irin wannan karuwar adadin COVID-19 (ƙarin bayani).
Hoto na 2 ya nuna adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Ingila idan aka kwatanta da Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa tun daga ranar 15 ga Maris da ƙarfe 8:00 na safe, wasu ƙasashe 15 na EU / EEA da Burtaniya sun ba da rahoton jimlar adadin shari'o'in da suka riga sun yi daidai da na Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa adadin masu kamuwa da COVID-19 da aka ruwaito suna ƙaruwa cikin sauri a EU/AEA da UK.
Hanyoyin da ake gani a cikin adadin COVID-19 sun nuna cewa annobar tana ƙaruwa da sauri a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, duk da bambancin amsoshin lafiyar jama'a na ƙasa, yiwuwar bambancin ma'anar yanayin a cikin ƙasashe da kuma ladabi daban-daban don zaɓar marasa lafiya da za a gwada su don tabbatar da cutar COVID-19, gami da gwajin biye.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kusan kashi 10 cikin 100 na marasa lafiyar COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da raka'a kulawa mai tsanani a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
A halin yanzu akwai bayanai game da asibitoci da/ko cibiyoyin kulawa na musamman na COVID-19 a cikin EU/AEA don kashi 6% da 1% na shari'o'in bi da bi (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara su ta hanyar da ta dace don haɓaka bayanan sa ido na yanzu wanda ke mai da hankali kan yawan adadin rahotanni da yawan mutuwar.
Wani bincike da aka yi a shekara ta 2010-11 ya nuna cewa akwai bambanci sosai a wuraren kula da marasa lafiya a Turai, daga wurare 29.2 a Jamus zuwa wurare 4.2 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da albarkatun Italiya (gadoje 12.5 na kulawa mai tsanani da kulawa ta matsakaici ga mutane 100,000 a 201011).
Ana samun yanayin samfurin da ya danganci wadatar kiwon lafiya, tare da kimantawa ga kowace ƙasa ta EU/EEA da UK na yaduwar COVID-19 da aka kwantar da su a asibiti da ke da alaƙa da haɗarin &gt; 90% na wucewar ƙarfin gadaje na ICU, a cikin sabuntawa na shida na ƙimar haɗarin gaggawa na COVID-19 na CTE.
Tun da yake har yanzu an tattara lokuta a yankuna na EU / EEA da UK, asibitoci da cibiyoyin kulawa da hankali suna ba da sabis ga takamaiman al'ummomin yanki, ana son samar da bayanai game da lokuta da gadaje masu kulawa a matakin SUN 2 (NTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ƙaruwa cikin sauri a cikin EU/AEA da United Kingdom.
Don haka, dole ne ƙasashe, asibitoci da cibiyoyin kulawa da keɓaɓɓu su shirya kansu don yanayin ci gaba na SARS-CoV-2 da kuma ƙaruwar yawan marasa lafiyar COVID-19 da ke buƙatar kulawa ta kiwon lafiya, musamman kulawa mai tsanani, kamar wannan da ke faruwa a yankunan da cutar ta shafa a Italiya.
Kamar yadda aka nuna a cikin ƙididdigar haɗarin gaggawa na CDC, tsarin gabaɗaya mai saurin gaba yana da mahimmanci don jinkirta yaduwar SARS-CoV-2 yayin da ake canzawa daga hanyar hanawa zuwa ragewa, saboda ƙididdigar ƙaruwa cikin sauri na ƙwayoyin cuta na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita amsar su idan ba a aiwatar da su ba a gaba.
Ƙididdigar haɗarin gaggawa ta kuma lissafa matakan kiwon lafiya na jama'a don rage tasirin annobar.
Akwai iyakantaccen damar da ƙasashe za su iya ƙara ƙarfin sarrafawa don rage yaduwar SARS-CoV-2 da rage matsin lamba kan kiwon lafiya.
Idan hakan bai yi nasara ba, tsarin kiwon lafiya a sauran ƙasashen EU/EEA na iya fuskantar ƙaruwar yawan marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19), wacce cutar coronavirus ta 2 (SARS-CoV-2) ke haifarwa, ta kashe mutane sama da 3,000 kuma ta kamu da mutane sama da 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'in jin kai.
Kwayar SARS-CoV-2, kamar kwayar cutar ta SARS-CoV, wacce ta kamu da dubban mutane da cutar SARS a 2003, kuma tana iya yaduwa daga jemage kuma yana haifar da irin wannan alamun ta hanyar irin wannan tsari.
Ko da yake, COVID-19 yana da ƙananan haɗari da mutuwar fiye da SARS amma yana da ƙarin kamuwa da cuta tsakanin tsofaffi fiye da matasa da maza fiye da mata.
Domin yawan littattafan da ake wallafawa game da wannan cuta, wannan talifin yana ba da cikakken bayani a kan wannan batun bincike.
Za mu tattauna abubuwa na asali game da cutar, da sanadin cutar, da ilimin kwayoyin cuta, da ganewar asali, da magani, da kuma tsinkaya da kuma rigakafin cutar.
Ko da yake har yanzu akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan bita zai taimaka wajen fahimtar cutar da ke barazana da kuma kawar da ita.
Bikin bazara na ranar 25 ga watan Janairun 2020 ya zama abin tunawa ga duk Sinawa da aka umurce su da su zauna a gidajensu a lokacin hutu da kuma makonni bayan haka saboda barkewar cutar.
Kwayar cutar ta yi kama da kwayar cutar Corona (COV) wacce ta haifar da barkewar cutar cututtukan numfashi mai tsanani (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta kira shi SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma an kira cutar da ke da alaƙa da cutar COVID-19.
An fara annobar ne a birnin Wuhan na kasar Sin, kuma nan take ta yadu zuwa dukan ƙasar, da kuma wasu ƙasashe kusan 50 a faɗin duniya.
Ya zuwa ranar 2 ga Maris, 2020, cutar ta haifar da mutane 80,000 da suka kamu da cutar COVID-19, tare da fitar da marasa lafiya sama da 40,000 daga asibitoci da mutuwar sama da 3,000.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 shine "Abokin gaba na jama'a" kuma yana iya zama mafi ƙarfi fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga bincike sama da 200 game da COVID-19 wanda ya haɗa da ilimin ƙwayoyin cuta na cutar, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Wannan bita yana nufin taƙaita ci gaban bincike a cikin sabon batun da ke ci gaba da sauri.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da SARS da kuma wata cuta da ke haifar da COPD, wato cutar murhun Gabas ta Tsakiya (MERS, wata annoba da ta faru a shekarar 2012).
Za mu kuma tattauna abin da muka sani har yanzu game da rigakafin cutar da kuma tsinkayar yadda za ta kasance da kuma wasu tambayoyi masu muhimmanci da har yanzu ba a amsa ba.
Ana yawan daukar coronaviruses a matsayin masu haifar da cututtuka marasa mutuwa a cikin mutane, kuma suna haifar da kusan kashi 15 cikin ɗari na cututtukan mura na 4.
Duk da haka, a wannan karni mun fuskanci coronaviruses guda biyu da ke haifar da mummunan cututtuka a cikin mutane, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar a China a 2003 da Saudi Arabia a 2012, bi da bi, kuma cutar ta bazu cikin sauri zuwa wasu ƙasashe da yawa tare da yawan yaduwa da mutuwa.
Saboda haka, COVID-19 na yanzu shine barkewar cutar coronavirus ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a cikin Figure Figure 1.1, an fara ba da rahoton rukunin mutane da cutar huhu da ba a sani ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai, an saki jerin kwayoyin cutar korona.
A ranar 15 ga Janairun 2020, Wuhan ta ba da rahoton mutuwar mutum na farko.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga Janairu, an samu rahoton kamuwa da cutar tsakanin masu ba da kiwon lafiya, wanda ke nuna yiwuwar yaduwar cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an rufe birnin Wuhan tare da dakatar da duk hanyoyin sufuri.
A ranar 24 ga Janairu, binciken asibiti na farko game da cutar ya ba da rahoton cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, marasa lafiya 21 ne kawai ke da alaƙa kai tsaye da kasuwar abincin teku ta Wuhan, wanda aka ɗauka cewa wurin da kamuwa da cutar ta fara daga asalin dabba da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin da aka buga wannan rahoton, cutar ta riga ta bazu ko'ina cikin China da wasu ƙasashe kusan 50 a duniya (Hoto (Hoto 2) 2).
Yayin da lamarin ke ci gaba da sauri, har yanzu ba a tantance iyakar yaduwar cutar da kuma tsananin ta ba.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi da yawa da aka gudanar akan marasa lafiya 8,866, gami da marasa lafiya 4,021 da aka tabbatar da cutar COVID-19 sun ba da ƙarin bayani game da cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a duk shekaru, amma ya fi kamuwa da masu shekaru tsakanin 30 zuwa 65.
Kusan rabin wadanda suka kamu da cutar (47.7%) sun wuce shekaru 50, kuma kaɗan ne a ƙarƙashin shekaru 20, kuma 14 ne kawai ke ƙarƙashin shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu tsakanin al'ummomi a cikin da kewayen Hubei.
Cutar COVID-19 ta ɗauki kwanaki 5 (2-9) a matsakaita daga lokacin kamuwa da cutar zuwa lokacin ganewar asali.
Matsakaicin lokacin haifuwa ya kai kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin kamuwa da cutar daga farawa zuwa mutuwa ya kai kwanaki 9.5 (4.8-13).
Ƙididdigar ƙididdigar ƙididdiga ta kasance 3.77 (yanayin amincewa 95%: 3.51-4.05), kuma ƙididdigar ƙididdigar ƙididdiga ta kasance 2.23-4.82.
Yawan masu kamuwa da cutar ya karu sosai kafin ranar 23 ga Janairu, 2020, daidai da yawan tafiye-tafiye kafin bikin bazara na kasar Sin.
Yawan mutuwar tsakanin marasa lafiya da aka tabbatar ya kasance 1.44% (yanayin amincewa 95%: 1.10-1.86%) kuma yawan mutuwar da aka gyara ga dukkan marasa lafiya ya kai 3.06% (yanayin amincewa 95%: 2.02-4.59%).
Abubuwa uku masu haɗari na COVID-19 sune jinsi (namiji), shekaru (≥60), da kuma ciwon huhu mai tsanani.
Coronaviruses wani babban nau'in kwayar cuta ne mai ɗauke da kwayoyin halittar RNA mai ɗauke da madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaida
Ana iya raba su zuwa jinsuna huɗu, wato alpha, beta, gamma, da delta, kuma an san cewa coronaviruses na jinsi alpha da beta suna cutar da mutane.
S-furfuren sukari yana haɗuwa da masu karɓar salula, wato, Angiotensin-converting enzyme 2 (ACE2) da Sars-Cove da MERS-Cove di-peptidyl peptidase 4 (DBP4), kuma an haɗa su cikin membrane.
Ana sakin kwayoyin halittar RNA zuwa cikin kwayar halitta; bayan kwayar halitta ta kwayar halitta ta kwayar halitta, kwayoyin halittar RNA tare da sunadarai masu dauke da sinadarin sukari da kuma sinadarin sinadarin nucleated sun zama kwayar halitta mai dauke da virons, wanda ya haɗu da membrane na plasma don sake sakin kwayar cutar.
An ba da rahoton farkon tsarin halittar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 an gano cewa sabon nau'in beta-CoV ne tare da asalin kwayoyin halitta wanda ya wuce kashi 99.98 cikin ɗari tsakanin samfuran 10 da aka tattara daga asalin cutar, kasuwar abincin teku ta Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar binciken microscopy na watsawa, an gano cewa SARS-CoV-2 yana cikin ƙananan sassan iska na ɗan adam.
An gano cewa enzyme mai canzawa na mutum na Angiotensin 2 mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure da enzyme mai canzawa na mutum na angiotensin 2 a cikin haɗin gwiwa mai rauni fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙarancin kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da wani ɗan ƙaramin furotin mai ɓoyewa wanda aka ɓoye ta hanyar orf3b da furotin mai ɓoyewa wanda aka ɓoye ta hanyar orf8.
Orf3b a cikin SARS-CoV-2 na iya taka rawa a cikin cutar kwayar cutar da kuma hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani zangon ko tsari wanda ke da aikin da aka sani.
A ranar 18 ga Fabrairun 2020, Chu da sauransu sun ba da rahoton cikakken tsarin enzyme na mutum wanda aka canza zuwa angiotensin 2 a ƙarƙashin microscope mai sanyaya mai sanyaya a cikin ƙayyadaddun 2.9 Å a cikin mahadi tare da mai jigilar amino acid B0AT1.
Sun gano cewa mahaɗin, wanda ke da tsarin buɗewa da rufewa, ya haɗu don samar da dimer kuma cewa ACE2-B0AT1 na iya ɗaure furotin S, yana ba da wata alama don gano coronavirus da kamuwa da cuta.
Mai ɗaukar amino acid mai tsaka tsaki mai amfani da sodium zai iya zama maƙasudin magani don gwajin magunguna don hana kamuwa da SARS-CoV-2.
Mai watsa shiri na asali da mai watsa shiri na tsakiya
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga ƙuda kuma an kawo su ga mutane ta hanyar cats da kuma camels, bi da bi.
Ta hanyar kwatanta ci gaban SARS-CoV-2 da sauran coronaviruses, an dauki jemage a matsayin asalin mai karɓar SARS-CoV-2, inda sabon kwayar cutar ta kasance daidai da kashi 96% tare da SARS-like coronaviruses daga jemage kuma ana kiransu bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san wanda ya taimaka wa kwayar cutar ta shiga cikin mutane ba, kuma ba a san hanyar da za ta iya yaduwa ba.
Jay da sauransu sun ba da shawarar maciji a matsayin mai ɗaukar kwayar cutar daga jemage zuwa mutane wanda ya ƙunshi sake haɗuwa da simintin a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa tururuwan da ke cin abinci da ƙwari - dabbobi masu harshe mai tsayi da ke cin ƙwari da ake amfani da su a maganin gargajiya na kasar Sin - sune masu karɓar SARS-CoV-2 bisa ga kamannin kwayoyin halitta na kashi 99% a cikin coronavirus da aka gano a cikin tururuwan da ke cin abinci da kuma SARS-CoV-2.
Duk da haka, bambancin kashi 1 cikin dari a cikin kwayoyin halittar mutum biyu har yanzu babban bambanci ne; saboda haka, muna jiran sakamako mai ƙarfi tare da tabbataccen shaida (Figure 33).
Har yanzu ba a san ainihin yanayin Sars-Kov-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin dakin gwaje-gwaje har tsawon awanni 48 a cikin yanayin bushewa har zuwa kwanaki 5 a cikin zafin jiki a ƙarƙashin digiri 20 da zafi tsakanin kashi 40 zuwa 50%.
SARS-CoV-2 na iya samun irin wannan halayen.
An ce SARS-CoV-2 yana da ƙarancin haske da zafin jiki a 56 ° C na tsawon minti 30; ether, ethanol a cikin maida hankali na 75%, chlorine disinfectants, peroxy acetic acid, chloroform, da sauran masu narkewar mai, amma ba chlorhexidine ba, na iya hana kwayar cutar sosai.
A yawancin lokaci, mutane ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, ba a yi wani bincike mai zurfi game da amsar garkuwar jiki ga SARS-CoV-2.
Don haka, zamu iya komawa ga binciken da aka yi a baya game da wasu coronaviruses, musamman SARS-CoV, da MERS-CoV (hoto (hoto 4) 4.
Gabaɗaya, bayan kamuwa da kwayar cuta ta mamaye mai masaukin, tsarin garkuwar jiki na al'ada yana gane shi ta hanyar masu karɓar karɓar ƙirar (PRRS) gami da masu karɓar nau'in C-like, mai karɓar mai kama da Toll (TLR), mai karɓar mai kama da yanki na haɗin nucleotide (NLR), da mai karɓar mai kama da furotin RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtukan ƙonewa, haɓakar ƙwayoyin cuta, da kuma samar da nau'in I (IFN) wanda ke iyakance yaduwar kwayar cutar da kuma saurin ƙwayoyin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta.
Duk da haka, furotin N a cikin SARS-CoV na iya taimaka wa kwayar cutar ta tsere daga amsawar rigakafi.
Nan da nan, tsarin garkuwar jiki ya shiga cikin gwagwarmayar da ake yi da kwayar.
Kwayoyin T, ciki har da CD4+ da CD8+ suna da muhimmiyar rawa wajen kāriya.
Kwayoyin CD4+ T suna motsa ƙwayoyin B don samar da ƙwayoyin cuta na musamman ga kwayar cutar, kuma CD8+ T suna kashe ƙwayoyin da ke da cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu saurin kumburi don taimakawa kwayoyin kariya.
Duk da haka, kwayar cutar korona tana iya rage aikin ƙwayoyin T ta hanyar sa su mutu.
Tsarin rigakafi na al'ada, gami da cikakkun sunadarai kamar C3a da C5a da ƙwayoyin cuta, suna da mahimmanci don yaƙar kamuwa da ƙwayoyin cuta.
Alal misali, na kawar da ƙwayoyin cuta da aka ware daga wani mai ciwon Mers-Cove.
A wani ɓangare kuma, yawan amsawar tsarin garkuwar jiki yana haifar da ƙwayoyin cuta da yawa a cikin gida waɗanda za su iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayin, rashin aiki na gabobin jiki da mutuwa.
SARS-CoV-2 wanda ya fara bayyana a cikin rukuni, ya fi dacewa ya kamu da tsofaffi da ke fama da cututtuka da yawa da kuma mata masu ciki.
Mutane da ke fama da ƙwayoyin cuta da yawa ko kuma waɗanda suke da lahani a cikin tsarin garkuwar jiki suna da damar kamuwa da cutar fiye da wasu.
Matsakaicin lokacin haifuwa na SARS-CoV-2 ya kai kwanaki 1-14 ko kuma daga kwanaki 3 zuwa 7 a mafi yawan lokuta, bisa ga binciken da aka yi kan mutane 425 da suka kamu da cutar a Wuhan.
Duk da haka, binciken da aka yi a kan mutane 1,099 ya nuna cewa tsawon lokacin haifuwa ya kai kwanaki 3 a matsakaita kuma ya kasance tsakanin 0 zuwa 24 days.
Wani sabon bincike, kamar yadda aka nuna a sama, ya nuna cewa tsawon lokacin ɗaukar ciki ya kai kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866.
Yana da matukar muhimmanci hukumomin kiwon lafiya su daidaita lokacin keɓewar da ya dace bisa ga lokacin da ya fi dacewa don hana mutane da ke da cutar amma ba su da alamun cutar daga yada cutar ga wasu.
A matsayin al'ada, ana buƙatar mutanen da ke da cutar ko waɗanda ke da cutar su keɓe kansu na kwanaki 14.
Shin ya kamata a ƙara wa'adin keɓewa zuwa kwanaki 24?
Sau da yawa zazzabi ne babban bayyanar COVID-19 kuma yana iya kasancewa ba tare da alamomi ba ko kuma tare da wasu alamomi, kamar bushewar tari, numfashi mai wuya, ciwon tsoka, zafin rai, ciwon kai, kumburi, ɓacin rai, ciwon kirji, tashin zuciya, da amai.
Wasu marasa lafiya sun sha wahala daga numfashi da / ko rashin iskar oxygen a cikin jini mako guda bayan cutar ta fara.
A cikin mawuyacin hali, marasa lafiya suna saurin kamuwa da cututtukan numfashi, ciwon daji, ƙwayoyin cuta, da kuma rashin lafiya.
Ya kamata a bincika marasa lafiya da zazzabi ko kuma alamun numfashi da zazzabi mai tsanani, har ma ba tare da yin hoton da zai nuna cutar huhu ba, don neman kwayar cutar don ganewa da wuri.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98 cikin ɗari na alamun cutar zazzabi ne, kashi 76 cikin ɗari na tari mai bushe, kashi 55 cikin ɗari na numfashi, kashi 3 cikin ɗari na zawo; kuma kashi 8 cikin ɗari na marasa lafiya suna buƙatar tallafin numfashi.
An bayar da rahoton irin wannan sakamakon a cikin binciken biyu na kwanan nan na ƙungiyar iyali da ƙungiyar da aka ɗauka daga wani wanda ba shi da alamun cutar.
A wani bincike da aka yi a shekara ta 2012, an gano cewa marasa lafiya da ke fama da cutar MERS-CoV suna fama da zazzabi (98%), tari (47%), da kuma numfashi mai wuya (55%) a matsayin manyan alamun cutar.
Duk da haka, kashi 80 cikin ɗari na waɗannan sun buƙaci tallafin numfashi fiye da marasa lafiya na COVID-19 kuma sun dace da mafi girman mutuwar MERS daga COVID-19.
An kuma lura da zawo (26%), da cututtukan makogwaro (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiyar SARS, zazzabi (99-100%), tari mai bushe (29%-75%), wahalar numfashi (40%-42%), zawo (20-25%) da kumburi (13-25%) sune alamun mafi mahimmanci, kuma kusan kashi 14-20% na marasa lafiya suna buƙatar tallafin numfashi.
A ranar 14 ga watan Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin ɗari yayin da aka tabbatar da mutane 66,576 a duniya.
Idan aka kwatanta, yawan mutuwar SARS a watan Nuwamba 2002 ya kai kashi 10 cikin 100 na mutane 8,096 da suka kamu da cutar.
Ga MERS, yawan mutuwar ya kai kashi 37 cikin ɗari na mutane 2,494 da aka tabbatar, bisa ga binciken alƙaluma da aka gudanar a watan Yunin 2012.
Wani binciken da ya gabata ya ba da rahoton cewa ƙimar Sars-CoV-2 ta kasance har zuwa 6.47 a cikin ƙarfin amintaccen CI 95% na 5.71 zuwa 7.23, yayin da ƙimar Sars-CoV ta kasance tsakanin 2 da 4 kawai.
Kwatanta SARS-CoV-2, MERS-CoV da SARS-CoV dangane da alamun su, yawan mutuwar su, da kuma yawan haifuwa da aka nuna a cikin teburin tebur 1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da haɗari kamar na biyun.
Saboda haka, cutar SARS-CoV-2 ta fi wahalar shawo kanta fiye da cutar MERS-CoV da SARS-CoV.
Sau da yawa, cutar tana faruwa ne a cikin iyali ɗaya ko kuma a cikin wani gari ko kuma a cikin wani jirgin ruwa.
Sau da yawa marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da cutar ta shafa, ko kuma hulɗa da mutane ko marasa lafiya a cikin makonni biyu kafin cutar ta fara.
Koyaya, an bayyana cewa mutane na iya ɗaukar kwayar cutar ba tare da nuna alamomi ba har tsawon makonni biyu, kuma marasa lafiya da suka dawo daga asibitoci na iya ɗaukar kwayar cutar kuma, wanda ke aika faɗakarwa don ƙara lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin jini ko ƙarancin ƙwayoyin jini (musamman ƙwayoyin lymphocytes) a farkon matakin.
Alal misali, an gano ƙarancin ƙwayoyin lymphocytes da ƙididdigar ƙwayoyin farin jini 4 x 109/litra ciki har da ƙididdigar ƙwayoyin lymphocytes 1 x 109/litra, da kuma matakan amine aspartate da jini a cikin marasa lafiya 1,099 da ke da COVID-19.
Wasu marasa lafiya suna da ƙwayoyin enzyme na hanta, tsoka, da muoglobin a cikin jinin su, kuma yawancin marasa lafiya suna da ƙwayoyin C-reactive da ƙwayoyin red cell.
A cikin marasa lafiya masu fama da cutar, dimer D ya ƙaru, wanda ke haifar da lalacewar fibrin a cikin jini, kuma ƙwayoyin lymphocytes sun ragu a hankali.
Rashin daidaituwa a cikin radiography yana faruwa a yawancin marasa lafiya na COVID-19 kuma ana nuna su da inuwa biyu ko kuma duhu mai haske a cikin huhu.
A wasu lokatai, marasa lafiya suna fama da ciwon huhu, da ciwon huhu, da kuma ciwon numfashi mai tsanani.
Sa'ad da ciwon ciwon numfashi mai tsanani ya faru, ƙonewa da ruwa da kuma ciwon ƙwayoyin cuta suna shafar musayar gas.
Rashin aiki na ƙwayoyin huhu na nau'in 1 da na 2 yana rage matakin mai karɓar jini kuma yana ƙara damuwa, don haka, yana rage ƙarfin huhu da kuma ƙara haɗarin rushewar huhu.
Saboda haka, sakamakon da ya fi muni a cikin sashin kirji sau da yawa yana kwatanta da yadda cutar take da tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna ƙwayoyin cutar huhu, samuwar ƙwayar cuta, ƙwayoyin lymphatic lymphatic, da ƙwayoyin ƙwayoyin cuta a cikin huhu na mai haƙuri wanda ya mutu saboda cutar, daidai da cututtukan cututtukan ƙwayar cuta da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
An yi amfani da gano SARS-CoV-2 RNA ta hanyar RT-PCR a matsayin babban ma'auni don gano COVID-19.
Koyaya, saboda yawan sakamakon ba daidai ba, wanda zai iya hanzarta cutar, an fara amfani da bayyanar asibiti don ganewa (wanda ba ya dogara da RT-PCR a cikin mutum) a China a ranar 13 ga Fabrairu, 2020.
Haka ma yake da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwaje na dakin gwaje-gwaje, da binciken radiography, yana da muhimmanci kuma yana da mahimmanci don yin ganewar asali mai tasiri.
A ranar 14 ga Fabrairun 2020, ƙungiyar Feng Chang ta bayyana wata yarjejeniya don amfani da fasahar CRISPR-based Sherlock don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 a cikin 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafi ga kowane microliter na shigarwar) ta amfani da nutsewa a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu mahimmanci ba.
Muna fatan cewa sabuwar fasahar za ta iya inganta ƙwarewa da dacewa sosai idan aka tabbatar da ita a cikin samfuran asibiti.
Saboda rashin ƙwarewar sabon coronavirus, likitoci na iya ba da kulawa ta tallafi ga marasa lafiya na COVID-19, yayin da suke gwada magunguna iri-iri waɗanda aka yi amfani da su ko aka ba da shawarar su don magance sauran coronaviruses, kamar SARS-CoV da MERS-CoV, da sauran cututtukan ƙwayoyin cuta (Table (Table 2).2).
Wadannan magunguna sun hada da magungunan da ake da su yanzu da kuma masu yuwuwa, magungunan rigakafin cutar, masu hana rigakafi, masu kara kuzari, jini daga marasa lafiya da suka warke, maganin kasar Sin, da kuma tallafin tunani.
Har ma an ba da shawarar amfani da jini daga marasa lafiya da suka warke.
Kamfanonin magunguna suna tsere don samar da ƙwayoyin cuta da alluran rigakafin cutar.
SARS-CoV-2 yana kai hari ga huhu da farko, kuma yana iya kai hari ga wasu gabobin da ke samar da enzyme mai canza angiotensin 2, kamar narkewa, hanji da kodan.
Duk da haka, rashin aiki na numfashi da rashin aiki shine mafi haɗarin haɗari ga marasa lafiya kuma babban dalilin mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci don rage alamun cututtuka da ceton rayuka, kuma ya haɗa da maganin oxygen gaba ɗaya, yawan iskar oxygen, na'urar numfashi da ba a sakawa, da na'urar numfashi ta wucin gadi bisa ga tsananin cutar.
Masu fama da ciwon numfashi mai tsanani dole ne a tallafa musu da ECMO, wata hanyar kula da zuciya da huhu da ake amfani da ita wajen magance ciwon zuciya ko kuma rashin numfashi mai barazana.
Bugu da ƙari, kiyaye daidaiton ruwa, hanawa da magance cututtukan na biyu da rauni na cututtuka, da kare ayyukan gabobin jiki, suma suna da mahimmanci ga marasa lafiya SARS-CoV-2.
An san cewa guguwar cytokine tana haifar da hawan jiki a cikin marasa lafiya SARS da MERS.
Cytokin Storm wani nau'i ne na halayen kumburi na yau da kullun wanda ke nuna ƙaddamar da jerin cytokines waɗanda suka haɗa da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan cytokines suna motsa ƙwayoyin garkuwar jiki su saki ƙwayoyin halitta masu yawa kuma sune babban dalilin ciwon numfashi mai tsanani da rashin aiki na gabobin jiki.
Maganin hana kamuwa da cuta yana da muhimmanci wajen magance cutar sankarar jijiyoyin jiki, musamman ma a cikin marasa lafiya masu tsanani.
An yi amfani da kwayoyin hormones, toselisumab, da kuma kwayar halitta guda daya da ke hana interleukin-6 don magance hadarin cytokine.
Sauran magungunan hana kamuwa da cutar cytokine sun hada da daidaita tsarin rigakafin da aka tsara ta hanyar T-cell; toshe IFN-γ, IL-1, da TNF; hana janus kinase; Blenatumumab; hana siginar cytokine 4; da masu hana histone decyclase.
An yi amfani da magungunan kashe ƙwayoyin cuta da magungunan hana kamuwa da cuta sosai wajen magance SARS don rage lalacewar kumburi.
Koyaya, masu haɓaka masu amfani da allurai masu yawa ba su da amfani tare da mummunan rauni na huhu a cikin marasa lafiya SARS da COVID-19.
Maimakon haka, yana iya haifar da mummunan sakamako, musamman ƙwayoyin cuta, wanda ke shafar tsinkayar cutar.
Koyaya, an ba da shawarar yin amfani da gajeren lokaci na haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar
A lokacin da aka rubuta wannan rahoton, babu wani magani da aka tabbatar yana da tasiri a kan cutar.
Duk da haka, an gano cewa ba da Remdesivir, wani kwayar halitta, ta hanyar jijiya ya yi tasiri a cikin wani mai cutar COVID-19 na Amurka.
Remdesivir wani sabon maganin rigakafin cutar ne wanda Gilead ta fara samarwa don magance cututtukan da cutar Ebola da Marburg ke haifarwa.
Daga baya, Remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta masu ɗauke da RNA mai ɗauke da keɓaɓɓen keɓaɓɓen RNA, ciki har da MERS da SARS.
Bisa ga waɗannan ƙwayoyin cuta, Gilead ta ba da wannan fili ga China don yin wasu gwaje-gwaje a kan mutanen da ke da cutar SARS-CoV-2, kuma ana jiran sakamakon da kyau.
Bugu da ƙari, an ba da shawarar parisetinib, interferon-alpha, lupinavir/ritonafir, da ribavirin, a matsayin yiwuwar jiyya ga marasa lafiya da ke fama da ciwon numfashi mai tsanani.
Za a iya samun zawo, tashin zuciya, amai, lalacewar hanta, da sauran halayen bayan maganin haɗin jini na Blobenavir/Ritonavir.
Ya kamata a lura da yadda waɗannan magunguna suke hulɗa da wasu magunguna da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya masu warkewa da samar da kwayoyin rigakafi.
Tattara jini daga marasa lafiya da suka warke daga wata cuta don magance wasu marasa lafiya da ke fama da wannan cuta ko kuma don hana mutane masu lafiya kamuwa da cutar yana da tarihi mai tsawo.
Hakika, marasa lafiya da suka warke suna da yawan ƙwayoyin cuta a cikin jinin su.
Antibodies ne immunoglobulin (AG) da kwayoyin B ke samarwa don yaƙi da cututtuka da sauran abubuwa. Suna gane kwayoyin da ke cikin cututtuka kuma suna kawar da su kai tsaye.
Bisa ga wannan, an tattara jini daga rukunin marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar cikin marasa lafiya 10 masu tsanani.
Alamun su sun inganta cikin sa'o'i 24, tare da rage kumburi da ƙwayoyin cuta da ingantaccen oxygenation cikin jini.
Duk da haka, ana bukatar tabbatarwa da kuma bayyanawa kafin a yi amfani da wannan hanyar sosai kafin a samu takamaiman magani.
Bugu da ƙari, saboda tasirin magani, dole ne a yi la'akari da wasu lahani da ke tattare da jini.
Alal misali, ƙwayoyin cuta suna iya sa jikinmu ya soma yin aiki da ƙarfi kuma hakan yana sa mu kamu da cutar da ake kira cytokine-release syndrome.
Yawan ƙwayoyin cuta a cikin jini yana da ƙarancin ƙwayoyin cuta, kuma ana buƙatar plasma don magance marasa lafiya masu tsanani.
Yana da wuya a samar da takamaiman rigakafi da kuma samar da su cikin sauri don magance annobar duniya.
Saboda haka, ware kwayoyin B daga marasa lafiya da suka warke da kuma gano lambobin kwayoyin da ke ƙunshe da ƙwayoyin cuta masu aiki, ko kuma bincika don gano ƙwayoyin cuta masu aiki da sunadarai masu mahimmanci na kwayar cutar, ya fi mahimmanci da aiki.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin cuta.
An yi amfani da maganin gargajiya na kasar Sin don magance cututtuka daban-daban a kasar Sin tsawon dubban shekaru.
Koyaya, tasirinsa ya dogara sosai da tarin abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali bisa ga ka'idodin maganin gargajiya na kasar Sin.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba a san su ba saboda yana da wuya a gano su kuma a tabbatar da waɗannan abubuwan da ke aiki ko kuma abubuwan da suka dace.
A halin yanzu, saboda rashin ingantacciyar magani ga COVID-19, maganin gargajiya na kasar Sin ya zama muhimmin magani na madadin marasa lafiya da ke da alamun rashin lafiya ko kuma waɗanda suka warke daga mawuyacin yanayi.
Alal misali, an gano cewa shan shan shan Shu Feng Ji Do da Lian Hua King Wen sun yi tasiri wajen magance COVID-19.
An lura da mafi yawan adadin warkewar marasa lafiya na COVID-19 a larduna da yawa a China waɗanda suka yi amfani da maganin gargajiya na kasar Sin a cikin kashi 87% na marasa lafiyarsu, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda kawai ya yi amfani da maganin gargajiya na kasar Sin tare da kusan 30% na marasa lafiyar COVID-19, yana da mafi ƙarancin adadin warkewa (13%).
Duk da haka, wannan kwatancen kusan ne, saboda dole ne a haɗa wasu abubuwan da ke shafar kamar yawan marasa lafiya da kuma tsananin cutar a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Polly Chang da abokan aikinsa sun buga wani bincike don kwatanta maganin maganin Yammacin Turai (WM) da kansa tare da maganin haɗin Yammacin Turai da na gargajiya na kasar Sin.
Sun gano cewa lokacin murmurewa daga zazzabi, rashin bayyanar cututtuka, da kuma asibiti ya fi guntu a cikin rukunin maganin Yammacin Turai da na gargajiya na kasar Sin fiye da rukunin maganin Yammacin Turai kawai.
Mafi ban sha'awa, yawan ciwon alamun cutar (wanda ya kasance daga mai sauƙi zuwa mai tsanani) ya kasance ƙasa da ƙasa a cikin ƙungiyar maganin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Y
Duk da haka, inganci da amincin maganin gargajiya na kasar Sin har yanzu suna jiran ƙarin gwaji da aka yi nazari sosai a kan manyan sikelin da kuma a wasu cibiyoyi.
Zai kuma zama da ban sha'awa a kwatanta yadda ake yin maganin kuma a bayyana abubuwan da ke cikin maganin gargajiya na kasar Sin ko kuma yadda ake hada su.
Marasa lafiya da ake zargi ko tabbata cewa suna da COVID-19 galibi suna jin tsoron kamuwa da cuta mai saurin yaduwa har ma da mutuwa, kuma mutanen da ke keɓewa suna jin gundura, kaɗaici, da fushi.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi, rashin iskar oxygen, tari da kuma sakamakon maganin, kamar rashin barci da ake samu daga maganin hormonal, suna iya sa mutum ya ƙara damuwa da kuma rashin lafiya.
A farkon lokacin barkewar SARS, an samu rahoton wasu cututtuka na ƙwaƙwalwa da suka haɗa da baƙin ciki, damuwa, firgita, tashin hankali, alamun hauka, hauka, har ma da tunanin kashe kansa.
Bibiya da keɓewa na tilas, a matsayin ɓangare na amsar lafiyar jama'a ga ɓarkewar COVID-19, na iya sa mutane su ƙara damuwa da jin laifi game da tasirin kamuwa da cuta, keɓewa, da ɓata sunan danginsu da abokansu.
Saboda haka, dole ne a samar da kulawar lafiyar kwakwalwa ga marasa lafiya na COVID-19, mutanen da ake zargi da cutar, mutanen da suka taɓa hulɗa da su, da kuma jama'ar da ke buƙatar ta.
Tallafin tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar hankali na ƙwarewa da yawa, wuraren sadarwa masu kyau tare da sabuntawa na yau da kullun game da barkewar SARS-CoV-2 da tsare-tsaren magani, da amfani da kayan aikin lantarki na musamman da aikace-aikace don guje wa tsoma baki kai tsaye.
Alluran rigakafi masu tasiri don yanke sarkar watsa kwayar cutar daga dabbobi da mutane masu kamuwa da cuta zuwa masu karɓar cutar suna da mahimmanci kuma galibi ana haɓaka maganin rigakafi don yaƙar cutar da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don haɓaka alluran rigakafi na S-protein don samar da ƙwayoyin cuta marasa ƙarfi, masu tasiri, masu ɗorewa da / ko rigakafin rigakafin SARS-CoV.
An gwada alluran rigakafin da ke rayuwa a cikin samfurin dabbobi don maganin SARS.
Koyaya, ba a tantance ingancin waɗannan alluran rigakafin a cikin tsofaffi ba, da kuma ƙalubalen haɗari da kariya daga kamuwa da cutar ta asalin dabba kafin a fara binciken asibiti.
Wataƙila saboda SARS ya ɓace shekaru 17 da suka gabata kuma ba a sami wani sabon labari ba tun daga lokacin.
Akasin haka, wasu lokuta da kuma kungiyoyin da ke fama da MERS suna ci gaba da bayyana a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna saboda ci gaba da samun tushen dabbobi a yankunan da cutar ta kamu.
An haɓaka dabarun rigakafin MERS ta amfani da kwayar cutar da ba ta aiki, da kuma ƙwayoyin cuta na RNA, masu ɗaukar hoto, da ƙwayoyin cuta, da ƙwayoyin cuta, da ƙwayoyin cuta, da ƙananan ƙwayoyin cuta, wasu kuma an kimanta su a cikin samfurin dabba.
Samar da ingantaccen allurar rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne mai gaggawa da mahimmanci don sarrafa cutar da ke ci gaba.
Koyaya, shawo kan wahalar yana da ƙalubale saboda tsawon lokacin (a matsakaita watanni 18) da ake buƙata don haɓaka allurar rigakafi da canje-canje masu ƙarfi na coronaviruses.
COVID-19, a matsayin sabuwar cuta, ta fara nuna cikakkiyar hanyar asibiti a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya murmurewa a hankali ba tare da wata matsala ba.
Koyaya, COVID-19, kamar SARS da MERS, suma suna da alaƙa da yawan yaduwar cutar da yawan mutuwar marasa lafiya masu tsanani.
Saboda haka, gina samfurin tsinkayen cutar yana da muhimmanci ga hukumomin kiwon lafiya don saita fifiko ga ayyukansu, musamman a yankunan da ba su da albarkatu.
Dangane da nazarin asibiti da aka ruwaito zuwa yanzu, abubuwan da ke gaba na iya tasiri ko alaƙa da tsinkayen cutar a cikin marasa lafiya na COVID-19 (Table (Table 33)):
Shekaru: Shekaru sune mafi mahimmancin abin da ke ƙayyade tsinkayen SARS, wanda kuma ya shafi COVID-19.
Mutanen da shekarunsu suka kai 30 zuwa 65 ne suka fi kamuwa da COVID-19, tare da kashi 47.7% na waɗannan marasa lafiya da suka wuce shekaru 50 a cikin binciken da aka yi akan mutane 8,866 kamar yadda aka nuna a sama.
Marasa lafiya da ke buƙatar kulawa mai mahimmanci sun fi saurin kamuwa da cututtuka da rikitarwa kuma sun fi waɗanda ba su buƙata ba tsufa (a matsakaicin shekaru 66 da 51, wanda ke nuna shekaru a matsayin mai tsinkaye na sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka nuna a sama.
Cutar da ke tattare da ita da kuma rikitarwa: Marasa lafiya da ke da cutar COVID-19 da ke bukatar kulawa mai tsanani suna da haɗarin kamuwa da cututtukan zuciya da kuma bugun zuciya.
Har ila yau, cututtukan zuciya sune manyan abubuwan da ke kashe mutane a cikin SARS.
An ce SARS-CoV-2 na iya ɗaure ƙwayoyin cuta na jini da ƙwayoyin cuta na angiotensin 2, wanda zai iya haifar da cututtukan hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da kuma ciwo suna da nasaba sosai kuma suna iya shafan juna.
Sakamakon gwaje-gwaje na al'ada: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko lalacewar nama, kuma an ba da shawarar cewa yana da alamun cutar, amsawa ga magani, da kuma dawowa.
An kuma ba da shawarar alaƙa tsakanin matakin C-reactive protein da tsananin cutar COVID-19 da kuma tsinkayen rayuwa.
Bugu da ƙari, ƙaruwa na LDH, AST, ALT, da CK na iya taimakawa wajen hango sakamakon.
Ana samun waɗannan enzymes a cikin gabobin jiki da yawa, musamman a zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, alamun alamun cututtuka ne na zuciya ko hanta.
Manyan alamun asibiti: Ana buƙatar yin la'akari da hoton kirji da ci gaban alamun asibiti tare da sauran matsaloli don hango sakamakon COVID-19 da rikitarwa.
Amfani da magungunan kashe ƙwayoyin cuta: Kamar yadda aka bayyana a sama, magungunan kashe ƙwayoyin cuta sune masu hana rigakafi da ake amfani da su a matsayin magani na taimako don cututtukan cututtuka don rage tsananin lalacewar kumburi.
Tun lokacin da aka yi amfani da allurai masu yawa na hormones masu motsa jiki a cikin marasa lafiya na SARS, yawancin waɗanda suka tsira daga cutar anemia sun sha wahala tare da nakasa na rayuwa da rashin ingancin rayuwa.
Saboda haka, ya kamata a yi amfani da magungunan ƙwayoyi masu ƙarancin magani na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19, idan ya cancanta.
Matsin lamba: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19, yawancin marasa lafiya sun sha wahala matsi mai tsanani; sau da yawa suna jimre wa tsawon lokacin keɓewa, rashin tabbas mai tsanani, kuma sun ga mutuwar danginsu da abokan aikin da ke fama da cutar.
Yana da muhimmanci a ba da shawara da kuma taimako na dogon lokaci don taimaka wa waɗannan marasa lafiya su warke daga damuwa kuma su koma rayuwa ta yau da kullum.
Bisa ga binciken alƙaluma da aka yi, COVID-19 ya bambanta da SARS.
Baya ga sake haifuwa a cikin ƙananan iska, SARS-CoV-2 na iya sake haifuwa cikin iska kuma yana haifar da alamun rashin lafiya ko rashin alamun cutar a farkon kamuwa da cuta, kamar sauran coronaviruses da ke haifar da sanyi.
Saboda haka, marasa lafiya da ke fama da cutar a farkon lokacin haihuwa ko lokacin haihuwa suna iya samar da kwayar cutar da yawa a yayin ayyukan yau da kullun, wanda ke sa ya zama da wahala a sarrafa cutar.
Koyaya, an ɗauka cewa watsa SARS-CoV yana faruwa ne lokacin da marasa lafiya ke cikin mummunan yanayin rashin lafiya, yayin da yawancin watsawar kwayar cutar ba ta faru a farkon matakin ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi SARS tsanani da kuma wahalar sarrafawa.
Ana yin ƙoƙari sosai a China, ciki har da rufe Wuhan da biranen da ke kewaye da shi da kuma keɓewar kusan dukkanin mazauna ƙasar don fatan hana yaduwar SARS-CoV-2.
Duk da cewa waɗannan matakan sun yi mummunan tasiri ga tattalin arziki da sauran sassan ƙasar, yawan sabbin masu cutar yana raguwa, wanda ke nuna cewa annobar ta ragu.
Hasashen da aka fi bayarwa shi ne cewa annobar za ta ƙare a watan Maris kuma za ta ci gaba da raguwa har tsawon watanni uku zuwa huɗu.
Duk da haka, wasu masana ba su da irin wannan kyakkyawan fata.
Paul Hunter da wasu sun kimanta cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare a shekarar 2020 ba.
Ira Longini da wasu sun kirkiro wani tsari don hango sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiya ta Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin binciken matsakaiciyar ƙuƙwalwa da makogwaro na marasa lafiya da suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama rikice-rikice kamar mura.
Duk da haka, akwai alamun da ke nuna cewa akwai ci gaba a China dangane da ƙarancin sabbin masu cutar, wanda ke nuna cewa dabarun da ake da su yanzu na iya yin aiki.
An yi hasashen cewa cutar Ebola za ta iya haddasa kamuwa da cutar har miliyan daya tare da mutuwar mutane miliyan rabin.
Duk da haka, an kawo ƙarshen cutar ta hanyar tsauraran matakan keɓewa da keɓewa.
Kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma daga ƙarshe ya ɓace ko kuma ya zama ƙarancin cutar da ke rayuwa tare da mutane.
An kwatanta cutar COVID-19 da SARS da MERS a ƙasa (Figure 55).
SARS-CoV-2 yana yaduwa sosai ta hanyar tari ko hancin mutum, kuma ana iya yaduwa ta hanyar tuntuɓar abubuwa da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin bargo, wanda ke haifar da sabon yiwuwar yaduwa daga bargo zuwa baki.
Wani bincike da aka yi kwanan nan a kan mutane 138 ya nuna cewa kashi 41 cikin ɗari na waɗannan cututtukan suna iya kasancewa ne daga kamuwa da cuta a asibiti, har da 17 da ke da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ana bukatar a ɗauki matakan kariya don kare mutane, musamman ma masu kula da lafiya, masu ba da agaji, dangi, abokan aiki, har ma da masu wucewa da suka taɓa saduwa da marasa lafiya ko waɗanda ke da cutar.
Sanye da abin rufe fuska shine layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta; amfani da masks na tiyata da masks na numfashi na N95 (jerin 1860s) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana ruwa daga wani mai cutar daga wucewa ta iska ko mannewa da kayan aiki, inda za a iya watsa su ga wasu.
Koyaya, kawai masks na N95 (jerin 1860s) na iya karewa daga shan ƙananan ferrions a tsakanin 10 zuwa 80 nm, tare da kashi 5% na ferrions suna iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma kowannensu yana da girma kusan 85 nm.
Saboda barbashi na iya shiga cikin masks na tiyata guda biyar a haɗe, masu ba da kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa masks na N95 (jerin 1860s) amma ba masks na tiyata ba.
Baya ga abin rufe fuska, masu kula da lafiya dole ne su sa rigunan da suka dace don rage haɗuwa da cutar.
Ƙari ga haka, ƙwayoyin cuta suna iya kamuwa da mutum ta idanunsa.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta idanunsa masu kumburi.
Saboda haka, masu kula da lafiya su sa rigakafin fuska ko tabarau yayin aiki da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma za a iya kamuwa da ita, ana ba da shawarar sosai cewa kowa ya wanke hannayensa da sabulu da sabulu fiye da yadda ya saba, kuma ya yi ƙoƙarin kasancewa a gida don keɓe kansa da rage hulɗa da mutanen da cutar ta shafa.
Tsawon kafa uku ya dace don nisantar da mutane daga mai ciwo.
Waɗannan matakan hanyoyi ne masu tasiri na rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo duniyar mutane a matsayin sabon kwayar cuta, kamanninsa da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 zai haifar da tsananin faɗakarwa a China bisa ga ƙwaƙwalwar ajiyar cutar SARS a 2003.
Koyaya, darektan CDC na Wuhan bai tabbatar wa jama'a ba har zuwa 19 ga Janairu 2020 yana cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakantaccen kwayar halittar mutum zuwa mutum kuma babu matsala wajen hanawa da kuma hana cutar.
Wannan sakon ya rage fargabar jama'a, musamman a lokacin da kasar ke shirin bikin bazara, lokacin da cutar ta kasance a Wuhan.
Hukumar rigakafin cututtuka ta kasar Sin za ta iya amfana daga wannan darasi mai wuya kuma ta yi wasu ci gaba masu muhimmanci a nan gaba.
Misali, waɗannan hukumomin dole ne (1) su kasance masu hankali yayin sakin bayanan jama'a saboda kowace kalma tana da mahimmanci ga 'yan ƙasa kuma tana iya canza halayensu da yanke shawara; (2) su zama masu saukin kai da amsawa ga bayanan da ba a saba gani ba daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci ko jami'ai; (3) su kasance masu ƙuntatawa don ƙuntata yiwuwar annobar a farkon matakin sa maimakon ƙoƙarin tabbatar da jama'a; (4) su ba da ƙarin horo mai ma'ana da tasiri don haɓaka kulawar jama'a game da cututtukan annoba da kuma inganta tsarin amsawar al'umma a kai a kai.
Cutar COVID-19 ta SARS-CoV-2 ta fara fitowa a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu a duk faɗin China da kuma wasu ƙasashe 50 a duniya a lokacin da nake rubuta wannan.
Saboda cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, cutar ta COVID-19 ta haifar da sake kamuwa da cutar SARS.
Koyaya, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana cutar da kula da marasa lafiya.
COVID-19 tana shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yawan cutar da mutuwa ya fi girma a cikin tsofaffi fiye da matasa.
SARS yana da yawan mace-mace fiye da COVID-19 (10.91% da 1.44%).
Marasa lafiya da COVID-19 suna watsa kwayar cutar ko da ba su da alamomi, yayin da marasa lafiya da SARS galibi suna yin hakan lokacin da suke rashin lafiya, wanda ke sa ya zama da wahala a hana yaduwar COVID-19 daga SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ya fi yaduwa da sauri fiye da SARS-CoV.
Gwajin SARS-CoV-2 na yau da kullun na iya zama mara kyau a wasu marasa lafiya na COVID-19.
A wani ɓangaren kuma, marasa lafiya da suka warke suna iya sake kamuwa da cutar.
Wannan sakamakon yana kara hadarin yaduwar cutar.
Tare da wannan ci gaba mai sauri a cikin binciken COVID-19, har yanzu akwai wasu tambayoyi masu mahimmanci da za a warware, kamar haka:
Daga ina ne SARS-CoV-2 ya fito?
Duk da gano kamanceceniya ta kwayoyin halitta da kashi 96 cikin dari tsakanin SARS-CoV-2 da SARS-CoV-2 a cikin jemage, har yanzu ba za mu iya cewa SARS-CoV-2 ya fito ne daga jemage ba.
Wane dabba ne ya kasance matsakaiciyar halitta da ke watsa kwayar cutar daga asalin mai shi, kamar su jemage, zuwa mutane?
Idan ba mu san amsoshin waɗannan tambayoyin ba, ba za mu iya hana yaduwar cutar ba, kuma za ta iya sake barkewa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da gwaje-gwaje na biochemical sun nuna cewa SARS-CoV-2 yana da alaƙa da enzyme mai canza angiotensin 2, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje masu gamsarwa?
Shin kwayar cutar tana da alaƙa da ƙwayoyin da ke samar da enzyme mai canza angiotensin 2 a wasu gabobin jiki?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya yin bincike mai sauri da kuma magani mai kyau ba.
Har yaushe wannan annoba za ta ci gaba?
Ta yaya kwayar cutar ke canzawa yayin da take yaduwa tsakanin mutane?
Shin zai zama annoba a duniya, ko kuma ya ɓace kamar SARS, ko kuma ya sake dawowa a cikin yanayi kamar mura?
Yana da muhimmanci amma zai ɗauki lokaci kafin a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Duk da haka, ko da menene farashin, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu yadda ta saba.
Asalin dabbobi na kwayar cutar coronavirus ta mutum
Juyin halitta da kuma daidaitawa sun haifar da juyin halitta tsakanin coronaviruses da masu karɓar su, ciki har da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa nau'i biyu na kwayar cutar korona na mutum suna haifar da rashin lafiya mai sauƙi, kamar mura.
Cutar SARS da MERS sun nuna wani bangare na cutar da ke nuna yadda kamuwa da cutar coronavirus na mutum zai iya zama mai tsanani da barazana ga rayuwa.
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya kawo sabon haske game da coronaviruses, kuma mun yi mamakin yadda ya bazu cikin sauri amma tare da damar haifar da cuta idan aka kwatanta da ɗan'uwansa SARS-CoV.
Kwayar cutar korona ta mutum cuta ce ta dabbobi, don haka fahimtar asalin dabbobi na kwayar cutar korona na mutum zai taimaka mana sosai.
Yawancin kwayar cutar korona ta mutum ta fito ne daga ƙuda inda ba ta haifar da cuta.
An kuma gano masu karɓar bakuncin wasu cututtukan coronavirus na ɗan adam.
Zaɓin dabbobi masu karɓar baƙi yana da tasiri kai tsaye wajen hana cututtukan mutane.
Binciken hulɗar da ke tsakanin coronavirus da mai masaukin baki a cikin dabbobi yana ba da mahimman bayanai game da asalin cutar coronavirus a cikin mutane.
A cikin wannan bita, mun ba da bayyani game da bayanan da ake da su game da coronaviruses guda bakwai na ɗan adam, tare da mai da hankali kan tarihin gano su da asalin dabbobi da kuma sauyawa tsakanin jinsuna.
Mafi mahimmanci, muna kwatanta da kuma nuna bambancin coronavirus na mutum daga yanayin juyin halitta na kwayar cutar da sake fasalin kwayoyin halitta.
A cikin wannan mahallin, ana tattauna cutar da cutar coronavirus ta 2019 (COVID-19) ke haifarwa.
Bugu da ƙari, ya kuma nuna yadda sauyawar mai watsa shiri ke da tasiri a kan cutar.
Kwayar cutar Corona (coronavirus) ta kasance cikin dangin coronaviruses, wanda ya ƙunshi tarin ƙwayoyin cuta masu ɗauke da madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaicin madaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaidaida
Waɗannan ƙwayoyin cuta suna da mafi girman kwayoyin halitta tsakanin ƙwayoyin cuta masu ƙwayoyin cuta na RNA, suna da kilo 26 zuwa 32 kuma ana kiran su "ƙwayoyin cuta na kambi" saboda tsarin su kamar kambi ne a ƙarƙashin na'urar bincike.
A cikin tsarin kwayoyin halitta, coronaviruses suna da kwayoyin halitta marasa rarrabuwa waɗanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan nau'ikan buɗe-karanta masu haɗuwa (ORF1a da ORF1b), waɗanda ke canzawa zuwa nau'ikan ƙwayoyin cuta masu yawa pp1a da pp1ab.
Ana kuma sarrafa sunadarai masu yawa don samar da sunadarai 16 marasa tsari, wanda ake kira nsp1~16.
Sauran ɓangaren kwayoyin halitta yana ɗauke da samfuran buɗewar furotin na tsarin, ciki har da Spike S, Sheath E, membrane M, da kuma DNA protein N.
Ƙari ga haka, ƙwayoyin cuta na corona iri dabam-dabam suna ɗauke da wasu sunadarai na musamman.
Bisa ga bambancin jerin sunayen sunadarai, an rarraba coronaviruses zuwa nau'ikan hudu (alpha coronavirus, beta coronavirus, gamma coronavirus, da delta coronavirus), daga cikinsu akwai nau'ikan beta coronavirus waɗanda suka haɗa da yawancin coronavirus na ɗan adam kuma an raba su zuwa nau'ikan hudu (A, W, C, D).
Shaidar juyin halitta ta nuna cewa jemage da kuma kwari suna aiki a matsayin asalin kwayoyin halitta na yawancin coronaviruses alpha da beta, yayin da tsuntsaye sune babban kantin kayan ajiya na coronaviruses gamma da delta.
A cikin dubban shekaru, coronaviruses sun ci gaba da ƙetare shingen jinsuna kuma wasu daga cikinsu sun zama masu haifar da cututtukan mutane masu tsanani.
An san nau'in cutar korona guda bakwai.
Daga cikin su akwai cutar coronavirus ta mutum 229E da kuma cutar coronavirus ta mutum-NL63, waɗanda ke cikin rukunin alpha.
Sauran kwayoyin cutar beta guda biyar sun haɗa da cutar OC43, HKU1, SARS-CoV, MERS-CoV, da SARS-CoV-2.
Kwayar cutar coronavirus-229E, OC43, HKU1, da NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi ko zawo ko duka biyun.
Akasin haka, SARS-CoV, MERS-CoV da sabon kwayar cutar SARS-CoV-2 duk suna haifar da rashin lafiya sosai, suna haifar da mummunan kamuwa da cutar na ƙananan numfashi ga yawancin marasa lafiya tare da yiwuwar kamuwa da cutar ta cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An ware kwayar cutar coronavirus ta mutum 229E, nau'in farko B814, daga ɓoyayyen hanci na marasa lafiya da mura a tsakiyar shekarun 1960.
Tun daga lokacin an tattara bayanai da yawa ta hanyar nazarin cutar HCoV-229E da HCoV-OC43, waɗanda ke warkar da alamun cutar ta atomatik.
A gaskiya, an yarda da cewa kamuwa da cutar coronavirus ba ta da lahani har sai SARS ya ɓarke.
Cutar SARS ta 2003 ta kasance daga cikin cututtuka mafi muni a tarihinmu, inda mutane 8,000 suka kamu da cutar tare da kusan kashi 10 cikin 100 na mutuwar.
Shekaru goma bayan haka, cutar MERS ta Gabas ta Tsakiya ta sake barkewa, ta zama babbar annoba a yankin Larabawa, kuma ta bazu zuwa sauran duniya.
Sabuwar cutar coronavirus ta mutum ta 2019 (HCoV-2019), wacce aka sake masa suna SARS-CoV-2, ita ce sanadin cutar coronavirus ta 2019 (COVID-19), wacce ta kashe mutane sama da 3,120 kuma ta kamu da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi gargadi kuma dole ne duniya ta shirya don fuskantar barkewar cutar SARS-CoV-2.
Dukkanin kwayoyin cutar corona guda bakwai na mutum sun samo asali ne daga dabbobi kamar su barawo, beraye, ko kuma dabbobin gida.
Akwai shaidu da yawa da ke nuna cewa dukkanin kwayar cutar coronavirus ta ɗan adam ta samo asali ne daga jemage, inda ƙwayoyin cuta ke da kyau kuma ba sa haifar da cuta amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da kalubale na kiwon lafiya, kimiyya, zamantakewa, da ɗabi'a ga China da duniya.
Binciken asalin dabbobi na coronavirus na mutum ya nuna tsarin fahimtar tarihin halitta, abubuwan motsawa da abubuwan da ke hana motsi tsakanin jinsuna.
Wannan zai iya jagorantar ko sauƙaƙa binciken mai ajiya, mai watsa shiri na tsakiya da kuma dabba mai karɓar baƙi don SARS-CoV-2, tare da mahimman tasiri don hana tasirin gaba.
A wannan bita mun ba da cikakken bayyani game da asalin dabbobi, sauyawa tsakanin nau'ikan halittu, da kuma cutar da ke haifar da cutar coronavirus.
Musamman, muna haskakawa da tattauna yarda da cewa kwayar cutar kwayar cutar coronavirus ta mutum ba ta haifar da cututtuka a cikin masu ba da gudummawar ta halitta amma ta zama mai cutarwa bayan an canza ta tsakanin jinsuna zuwa sabon mai ba da kyauta.
Muna kuma nazarin kimantawar hanyar cutar coronavirus ta mutum inda yawan kamuwa da cutar yakan kasance tare da rage yawan kamuwa da cutar.
A wannan mahallin, muna kuma tattauna sakamakon barkewar cutar SARS-CoV-2.
An san coronavirus na dabbobi tun daga ƙarshen 1930s.
Kafin a fara ware kwayar B814 na kwayar cutar coronavirus ta 229E daga ɓoyayyen hanci na marasa lafiya masu sanyi, an ware nau'ikan coronaviruses daban-daban daga dabbobi daban-daban da ke fama da cutar, gami da turkey, beraye, shanu, aladu, kuliyoyi, da karnuka.
A cikin shekarun da suka gabata, an gano nau'ikan coronaviruses guda bakwai.
Ga taƙaitaccen tarihin gano cutar coronavirus ta mutum a cikin jerin lokutan (Table 1) don ilimi da jagora.
An ware kwayar cutar coronavirus ta 229E ta farko daga tsarin numfashi na marasa lafiya da ke fama da kamuwa da cutar na sama a shekara ta 1966, kuma daga baya ta dace da rayuwa a cikin ƙwayoyin huhu WI-38.
Marasa lafiya da ke dauke da kwayar cutar coronavirus 229E suna fama da alamun sanyi na yau da kullun, gami da ciwon kai, hancin, rashin jin daɗi, kumburi, tare da zazzabi, tari a kusan kashi 10 ~ 20% na lokuta.
Daga baya a shekara ta 1967, an ware kwayar cutar OC-43 daga gonar kwayoyin halitta kuma an sake shi a cikin kwakwalwar jarirai.
Alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Kwayar cutar HCoV-229E da HCoV-OC43 sun bazu a duniya, kuma galibi suna yin yaduwa a lokacin hunturu a cikin yanayin zafi.
A yadda aka saba, lokacin haifuwar waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, sai kuma ji na rashin lafiya na kusan makonni biyu.
A cewar wani bincike da aka yi a kan mutane, kamuwa da cutar HCoV-229E a cikin mutane masu lafiya ya haifar da sanyi mai sauƙi.
Wasu marasa lafiya da ke fama da rashin rigakafi sun nuna mummunan rauni a cikin ƙananan numfashi.
SARS, wanda kuma aka fi sani da "ciwon huhu na rashin lafiya", shine annobar farko da aka fara ganowa a tarihin ɗan adam ta hanyar kwayar cutar coronavirus kuma wanda ya haifar da ita shine SARS-CoV, wanda shine kwayar cutar coronavirus ta uku da aka gano.
An fara samun cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na ƙasar Sin.
Cutar SARS ta haifar da kamuwa da cutar 8,096 da mutuwar 774, kuma ta bazu cikin ƙasashe da nahiyoyi da yawa.
Ba tare da la'akari da mai ɗaukar hoto ba, an kiyasta cewa kamuwa da cuta guda ɗaya na iya haifar da kusan kamuwa da cuta biyu, tare da lokacin ɗaukar ciki na kwanaki 4 zuwa 7 da kuma ƙaruwa na ƙwayoyin cuta a ranar 10 na cutar.
Alamun SARS-CoV sun fara da ciwon tsoka, ciwon kai, zazzabi, rashin lafiya, da jin tsoro, kuma suna biyo baya da wahalar numfashi, tari da kuma numfashi.
Rashin ƙwayoyin lymph, rashin aiki na hanta, da haɓaka kwayar halitta sune cututtukan da aka saba da su a cikin SARS.
An kuma lura a cikin marasa lafiya na SARS da lalacewar gemu, haɓakar ƙwayoyin cuta, da ƙaruwa da ƙwayoyin ƙwayoyin cuta.
Kimanin kashi 20 zuwa 30 cikin 100 na marasa lafiya suna bukatar kulawa mai tsanani da kuma numfashi na wucin gadi.
Baya ga ƙananan tsarin numfashi, a cikin mawuyacin yanayi, gabobin da yawa na iya kamuwa da cutar ciki har da narkewar abinci, hanta da koda kuma yawanci ana haɗuwa da guguwar cytokine wanda zai iya zama mai kisa musamman a cikin marasa lafiya marasa lafiya.
An fara gano kwayar cutar ne daga wani mutum da ya kamu da cutar a lokacin da aka yi masa allurar huhu daga wani dangin wanda ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi ƙoƙari sosai wajen yin bincike a kan cutar korona.
An ware kwayar cutar coronavirus ta mutum-NL63 daga jariri ɗan wata 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara ƙanana, tsofaffi, da marasa lafiya masu cutar HIV da ke fama da cututtukan numfashi.
Cutar sanyi, cututtukan da ke tattare da cutar, zazzabi, da cututtukan ƙwayar cuta sune alamun cututtukan da ke haifar da cutar coronavirus-NL63.
Wani bincike mai zaman kansa ya bayyana yadda aka ware kwayar cutar daga hancin wani yaro mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi ne a ƙasar Holland, amma ya yadu ko'ina a duniya.
An kiyasta cewa kwayar cutar ta HCV-NL63 tana da alhakin kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yawanta yana ƙaruwa a farkon bazara, bazara da hunturu.
Kwayar cutar coronavirus ta mutum-NL63 tana da alaƙa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A wannan shekarar, an gano kwayar cutar HKU1 daga wani mutum mai shekara 71 da aka kwantar da shi asibiti da cutar huhu da cutar sankarar bargo a Hong Kong.
Baya ga cutar huhu da cutar sankarar bargo, an kuma bayar da rahoton cewa kwayar cutar HKU-1 tana da alaƙa da ciwon asma mai tsanani.
An gano cewa kwayar cutar HKU-1 tana yaduwa a duk duniya kuma tana haifar da cututtukan numfashi masu sauƙi, kamar kwayar cutar HKU-NL63, HKU-229E, da HKU-OC43.
Dukkanin waɗannan kwayar cutar coronavirus guda huɗu da aka samo daga al'umma sun dace da mutane kuma gabaɗaya suna da ƙarancin yiwuwar canzawa don haifar da cututtukan da ke da ƙarancin yaduwa, amma haɗuwa ta faru ne saboda dalilan da ba a sani ba kamar a cikin yanayin da ba a sani ba na mafi munin kwayar cutar coronavirus-NL63, wanda aka ba da rahoton kwanan nan yana haifar da mummunan kamuwa da cutar ƙananan numfashi a China.
Gabaɗaya, idan waɗannan coronaviruses sun sami ikon yin aiki da kyau da kuma ci gaba da kasancewa a cikin mutane, suma ba sa cutarwa ko cutarwa.
An fara ware MERS-CoV a cikin 2012 daga huhu na wani mai shekaru 60 da haihuwa wanda ke fama da cutar huhu da ciwon koda a Saudi Arabia.
Duk da yake yawancin cututtukan da aka tabbatar da su a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ba da rahoton a ƙasashen Turai da yawa da Tunisia game da cututtukan da aka kawo daga waje da kuma saurin yaduwar cututtukan da ke tattare da kusanci na sirri.
Wani annobar ta biyu a Koriya ta Kudu a shekarar 2015 ta haifar da mutane 186 da suka kamu da cutar.
Alamomin MERS suna kama da na SARS, kuma suna da ciwon huhu mai tsanani.
Ba kamar SARS ba, mutane da yawa da ke da MERS sun kamu da ciwon koda, wanda ya bambanta MERS da sauran cututtukan da cutar korona ke haifarwa.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna fama da cututtukan hanji, kamar zawo da amai.
A ranar 14 ga Fabrairun 2020, an ba da rahoton sama da mutane 2,500 da aka tabbatar da su a cikin dakin gwaje-gwaje tare da yawan mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗaya daga cikin ƙwayoyin cuta mafi muni da aka sani ga mutane.
A tsakiyar zuwa ƙarshen watan Disamba na 2019, an gano wasu ƙwayoyin cuta na huhu da daga baya aka gano cewa cutar SARS-CoV-2 ce ta haifar da cutar a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar cututtukan numfashi ta SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a mai mahimmanci a duniya kamar yadda ta kira COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar 90,053 a duk duniya, kuma yawan mutuwar farko ya kai kashi 3.4%.
Ya kamata a lura cewa yawan mutuwar a lardin Hubei na kasar Sin ya kai kashi 4.2%, yayin da a waje da shi ya kai kashi 1.2%.
SARS-CoV-2 na haifar da mummunan kamuwa da cuta kamar SARS-CoV da MERS-CoV, kuma yana bayyana a cikin zazzabi, tari da wahalar numfashi.
Wasu mutane ma suna fama da zazzabin ciki.
Ciwon huhu yana cikin alamun da ke da haɗari kuma yana iya saurin zama ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 suna kama da juna saboda yawan daidaito a cikin jerin kwayoyin halitta na 82%, sun kasance daga rassan daban-daban na bishiyar juyin halitta.
SARS-CoV-2 ba shi da tsanani amma yana da saurin kamuwa da cuta fiye da SARS-CoV da MERS-CoV.
An bayar da rahoton cewa mutane ba su nuna alamun cutar SARS-CoV-2 ba, kuma waɗannan na iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta da bambancin SARS-CoV-2 da sauran kwayar cutar coronavirus guda shida sun nuna kamanceceniya da bambance-bambance masu mahimmanci.
Na farko, kwayar cutar korona ta mutum tana kama da juna a lokacin da take cikin ciki da kuma lokacin da take ciwo.
A wannan yanayin, SARS-CoV-2 yana bin tsarin sauran coronaviruses guda shida.
Na biyu, cutar COVID-19 tana da tsanani tsakanin SARS-CoV da kuma sauran cututtukan coronavirus guda huɗu da aka samu daga al'umma (wato, coronavirus-229E, coronavirus-OC43, coronavirus-HKU1, da coronavirus-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye da suka fi yawa a cikin kamuwa da cutar coronavirus na al'umma, gami da bayyanar da alamun bayyanar cututtuka marasa ƙayyadaddun ko masu sauƙi ko ma babu alamun bayyanar cututtuka.
A gefe guda, ana iya ganin ƙananan ƙananan ƙananan cututtukan COVID-19 kamar yadda yake a cikin SARS-CoV, kodayake ƙimar ta ɗan ƙasa.
Na uku, yaduwar SARS-CoV-2 ta nuna halaye masu ban sha'awa na duka COVID-19 da SARS-CoV.
A gefe guda, SARS-CoV-2 yana da sauƙin yaduwa fiye da kwayar cutar coronavirus ta al'umma.
A gefe guda, har yanzu ba a san ko cutar SARS-CoV-2 ta ragu ba bayan kamuwa da cutar ga mutane kamar yadda yake a cikin cututtukan SARS-CoV da MERS-CoV.
A ƙarshe, SARS-CoV-2 za a iya gano shi a cikin ƙwayoyin ƙwayoyin cuta kamar yadda yake a cikin sauran coronaviruses na mutum.
Ana buƙatar ƙarin nazarin nan gaba don bayyana ko SARS-CoV-2 yana motsawa ta hanyar hanyar bakin ciki yana taka muhimmiyar rawa kamar yadda yake a cikin SARS-CoV aƙalla a wasu hanyoyi.
Yana da muhimmanci a lura ko SARS-CoV-2 zai iya nuna yaduwar yanayi kamar yadda yake a cikin cututtukan coronavirus na al'umma.
Koyaya, halayen SARS-CoV-2, gami da yiwuwar yaduwa, tsarin cututtuka da ci gaba da yaduwa bayan yaduwar mutane zai yi tasiri a kan ƙarshen barkewar COVID-19 na yanzu.
Dukkanin kwayar cutar corona guda huɗu da ke haifar da alamun rashin lafiya sun dace da mutane.
Akwai wata ma'ana kuma, wadda za ta iya zama gaskiya, cewa mutane sun daidaita da kyau ga waɗannan coronaviruses guda huɗu.
Watau, wataƙila duka biyu sun tsira daga annobar cutar coronavirus ta ɗan adam.
An kawar da cututtukan da ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Don hakan ya faru, kwayar cutar coronavirus ta mutum dole ne ta kwafe a cikin mutane sosai don ba da damar haɓaka maye gurbin da ke fuskantar abubuwan hanawa a cikin mai masaukin.
Da wannan ra'ayin, idan SARS-CoV-2 ya ci gaba da yaduwa kuma yawan mutanen da ke fama da cutar ya karu, to zai iya zama mai dacewa da mutane.
Idan ya daidaita da kyau, zai yi wuya a hana shi yaduwa tsakanin mutane ta hanyar keɓewa ko wasu matakan hana kamuwa da cuta.
Kwayoyin cutar corona guda huɗu da ke tattare da al'umma suna yaduwa tsakanin mutane a cikin shekaru da yawa, suna haifar da mura a cikin mutanen da ke da rigakafi.
Waɗannan ƙwayoyin cuta ba sa bukatar ajiyar dabbobi.
Akasin haka, SARS-CoV da MERS-CoV, masu cutar cutar ta rashin lafiya, ba su daidaita da mutane sosai ba, kuma ba za su iya ci gaba da yaduwa tsakanin mutane ba.
Suna bukatar su zauna a cikin gidajen dabbobi kuma su haifu a can, sa'an nan kuma su nemi damar da ta dace don su matsa zuwa maƙasudin mutane, watakila ta hanyar ɗaya ko fiye da masu watsawa da masu haɓaka.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma sauran ƙwayoyin cuta na mutum huɗu da aka samu daga al'umma.
Yana da saurin yaduwa kamar kwayar cutar coronavirus ta al'umma, aƙalla a yanzu.
Duk da haka, yana haifar da rashin lafiya fiye da kwayar cutar coronavirus ta al'umma kuma ƙasa da SARS-CoV ko MERS-CoV.
Ba a san ko za su iya zama cikakke ga mutane ba kuma su yada tsakanin su ba tare da buƙatar wani mai ba da abinci ko mai watsa shiri na dabba ba.
Kafin mu tattauna asalin dabbobi na kwayar cutar korona, zai yi kyau mu sake nazarin ma'anoni da halayen masu karɓar baƙi na juyin halitta, na halitta, na ajiya, na matsakaici, da kuma na haɓaka na kwayar cutar corona.
Dabbar tana aiki a matsayin mai karɓar bakuncin juyin halitta na kwayar cutar coronavirus idan kwayar cutar tana da alaƙa da ita kuma suna da kamanceceniya sosai a matakin jerin nucleotides.
Kwayar cutar ta asali yawanci tana da kyau kuma ba ta cutar da mai gidan.
Hakazalika, mai gidan yana ba da kariya ga kwayar cutar coronavirus ta mutum a cikin dogon lokaci.
A kowane hali, masu karɓar cutar suna kamuwa da cutar ta al'ada kuma su ne masu karɓar cutar coronavirus na mutum ko kuma mahaifinsu.
Akasin haka, idan kwayar cutar coronavirus ta ɗan adam ta shiga cikin mai watsa shiri kafin ko kusa da kai hari ga mutane, ba ta daidaita da kyau ga sabon mai watsa shiri kuma sau da yawa yana haifar da rashin lafiya.
Wannan mai karɓar bakuncin na iya zama tushen dabba don kamuwa da cutar ɗan adam kuma yana yin aikin mai karɓar bakuncin ta hanyar barin kwayar cutar ta ninka na ɗan lokaci don haka ya watsa ta ga mutane don faɗaɗa kamuwa da cutar tsakanin mutane.
Kwayar cutar korona ta mutum za ta iya shiga cikin wani tsaka mai wuya idan kwayar cutar ta kasa shiga cikin mai watsawa.
Akasin haka, kwayar cutar korona na mutum tana iya daidaitawa da mai watsa shiri har ma ta zauna a cikinsa na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Bayanai na cutar da suka biyo baya sun nuna cewa cutar SARS ta farko tana da tarihin hulɗa da dabbobi.
Binciken cutar da aka yi a baya ya nuna cewa masu sayar da dabbobi suna da yawan cutar anti-SARS-CoV IgG fiye da mutane.
An gano cewa dabbobi masu cin nama da ake sayar da su a kasuwa suna dauke da kwayar cutar SARS-CoV wanda ya yi daidai da SARS-CoV.
Abin da ya tabbatar da hakan shi ne, ba a samu wani sabon kamuwa da cutar SARS ba bayan an kashe dukan dabbobin da ke kasuwa.
Koyaya, an ba da rahoton cewa sakamakon gwajin SARS-CoV a cikin masticated dabino da ke rayuwa a cikin daji ko gonaki ba tare da fuskantar kasuwannin dabbobi masu rai ba ya kasance mai ƙarancin tasiri, yana nuna cewa masticated dabino na iya zama matsakaiciyar mai watsa shiri mai girma, amma ba shine asalin sararin samaniya na SARS-CoV ba.
Wannan yana nuna cewa yayin da kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da ƙwayoyin cuta ga SARS-CoV, yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa da yawa suna taka rawa a matsayin babban mai watsa shiri na SARS-CoV ba a cire ba.
Da alama dukkan waɗannan baƙi ne waɗanda ba sa ɗaukar SARS-CoV.
Daga baya bincike kan dabba mai ba da gudummawa ga SARS-CoV ya haifar da gano kwayar cutar coronavirus mai alaƙa da juna, wanda ake kira HKU3 (HKU3 HCV), wanda ke cikin barbashi.
Sakamakon gwajin kwayoyin SARS-CoV a cikin waɗannan jemage da jerin kwayoyin halittar cutar ta batsa ta HKU3 da ke da alaƙa da cututtukan numfashi mai tsanani sun kasance masu kyau.
Wannan kwayar cutar da sauran coronaviruses na bat suna da daidaici na 88-92% na jerin nucleotides tare da SARS-CoV.
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa jemage suna ɗauke da cututtukan da ke ɓoye a cikin mutane.
An gano wasu cututtukan coronavirus masu kama da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan WIV1.
An san enzyme mai canza angiotensin 2 na mutum da mai karɓar SARS-CoV.
An nuna cewa WIV1 da aka samo daga samfurin ƙwanƙwasa na bat yana amfani da enzyme mai canza angiotensin 2 a cikin jemage, cat, da mutane a matsayin mai karɓar shigarwar tantanin halitta.
Abin sha'awa, ƙwayar warkewa daga mummunan cututtukan numfashi yana da ikon daidaita WIV1.
Zuwa yanzu, WIV1 shine mafi yawan asalin SARS-CoV a cikin jemage, suna da kwatankwacin jerin nucleotides 95%.
Duk da kamanceceniya tsakanin waɗannan ƙwayoyin cuta biyu, ana tsammanin cewa WIV1 ba kwayar cutar SARS-CoV ba ce kuma cewa jemage ba mai karɓar bakuncin SARS-CoV ba ne.
Binciken ci gaban jinsunan MERS-CoV a cikin rukunin coronavirus-HKU4 a cikin jemage da coronavirus-HKU5 a cikin jemage kanta.
Kwayar cutar Corona-HKU4 a cikin jemage da MERS-CoV tana amfani da mai karɓar mai karɓar mai karɓar, diphenylpeptide peptidase4, don shiga cikin kwayar.
MERS-CoV-Driven RNA-based RNA polymerization ya fi kusa da juna a cikin juyin halitta zuwa ga masu kama da beta-coronavirus a cikin bat da aka gano a Turai da Afirka.
Har yanzu ba a gano cewa Meers-Cove yana rayuwa ne a cikin dabbar daji ba.
MERS-CoV da HKU25 a cikin dangi na dangi suna da daidaito na nucleotide kawai kashi 87 cikin ɗari.
Saboda haka, ƙila wannan jemage ba shi ne mai ba da abinci na Mers-Cove ba.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa kyakkyawa ce kawai a cikin 'yan tsiraru masu kwayar cutar MERS-CoV, da kuma kyakkyawa daga Gabas ta Tsakiya a ƙasashen Afirka da yawa.
An ware MERS-CoV mai kama da kwayar cutar da ke cikin mutane daga binciken hanci na raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman
Ya kamata a lura cewa alamun cutar da aka nuna a cikin Jamal sun kasance masu saurin kamuwa da cutar MERS-CoV, amma an gano cewa akwai ƙwayoyin cuta da yawa.
Kafirai da suka kamu da cutar sun yada kwayar cutar sosai ba kawai ta hanyar numfashi ba amma kuma ta hanyar bakin baki, wanda shine hanyar da kwayar cutar ke yaduwa daga jemage.
Koyaya, har yanzu akwai tambayoyi saboda yawancin lokuta da aka tabbatar da cutar MERS ba su da tarihin haɗuwa da raƙumi kafin bayyanar cututtuka, kuma ana danganta waɗannan lokuta da hankali ga watsawa daga mutum zuwa mutum ko hanyoyin watsawa da ba a sani ba waɗanda suka haɗa da nau'ikan da ba a san su ba.
SARS-CoV-2 coronavirus RaTG13 a cikin fararen fata da aka ware daga fararen doki yana da hannu a cikin 96.2% nucleotide homology.
Bambancin jerin tsakanin SARS-CoV-2 da RaTG13 yana da tsayi sosai don haka yana da wahala a tantance alaƙar da ke tsakanin mahaifin, kamar yadda yake a cikin SARS-CoV da MERS-CoV.
Wannan yana nufin cewa ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwarƙun ƙwarƙun ƙwarƙun ƙwar ƙwar ƙwar ƙ
Ana zaton cewa dabbobin da ke dauke da SARS-CoV-2 sun kasance daga cikin dabbobin daji da aka sayar da su kuma aka kashe a kasuwar abincin teku ta Wuhan, wanda aka danganta da yawancin cututtukan farko na COVID-19, wanda ke nuna yiwuwar yaduwar dabba zuwa mutum.
Yawancin binciken da aka yi kwanan nan dangane da jerin abubuwan da ke cikin metagenome sun ba da shawarar cewa ƙananan ƙananan dabbobi masu shayarwa da ke cikin haɗari da aka sani da mai cin naman tururuwa (Manis javanica) na iya kasancewa suna da asalin beta-coronavirus da ke da alaƙa da SARS-CoV-2.
Kwayoyin halittar wannan sabon kwayar cutar coronavirus da SARS-CoV-2 suna da daidaito tsakanin 85-92% na jerin nucleotides.
Duk da haka, suna da alaƙa da RaTG13 tare da kusan 90% kamanceceniya a matakin jerin nucleotides.
An haɗa su cikin ƙananan ƙwayoyin cuta guda biyu na SARS-CoV-2 a cikin bishiyar juyin halitta, ɗayan yana da yanki na haɗin mai karɓa (domain binding domain) mai kama da SARS-CoV-2, tare da daidaiton amino acid na 97.4%.
A cikin bambanci mai ban mamaki, yankunan haɗin gwiwar masu karɓar SARS-CoV-2 daga RaTG13 sun bambanta sosai, kodayake daidaitattun tsarin kwayoyin halitta ya fi girma.
Wani bincike da aka yi a baya a kan wani mai ciwon ciwon ƙwayar cuta ya nuna cewa akwai ƙwayoyin cuta daga ƙwayar huhu, kuma an gano cewa suna da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tattarawa da sarrafawa na hannu don samar da jerin kwayoyin halittar ɗan lokaci wanda ya ƙunshi kusan 86.3% na cikakken kwayar cutar kwayar cuta.
Ba za mu iya ƙyale yiwuwar cewa wannan mai cin ganyayyaki mai cin ganyayyaki yana ɗaya daga cikin masu karɓar SARS-CoV-2.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa cewa mai cin tururuwa mai cin tururuwa shine asalin SARS-CoV-2 kai tsaye saboda bambancin tsari tsakanin SARS-CoV-2 da SARS-CoV-2 masu alaƙa da beta-coronavirus a cikin mai cin tururuwa.
Bugu da ƙari, bambancin tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da bambancin tsakanin SARS-CoV-2 da kuma SARS-CoV-2 da ke da alaƙa da beta-coronavirus a cikin masu cin tururuwa.
Har yanzu ana ci gaba da gano hanyar juyin halitta na SARS-CoV-2 a cikin jemage, masu cin nama, da sauran dabbobi masu shayarwa.
Yayinda aka sami daidaito mafi girma a cikin abubuwan haɗin mai karɓar tsakanin SARS-CoV-2 da ant-eater, SARS-CoV-2, SARS-CoV-2, da kuma RaTG13-related coronaviruses suna da daidaito mafi girma a cikin jerin kwayoyin halitta.
Ana iya cewa babban kamanceceniya tsakanin yankunan haɗin mai karɓar SARS-CoV-2 a cikin masu cin ganyayyaki na beta-CoV da SARS-CoV-2 ya samo asali ne daga juyin halitta na zaɓaɓɓen kusanci.
Akwai wata shawara da ta nuna cewa SARS-CoV-2 zai iya sake haɗuwa tsakanin kwayar cutar beta da RaTG13 a cikin dabbobi na daji.
Sake haɗuwa ya zama ruwan dare gama gari tsakanin beta coronaviruses a matsayin ƙarfin juyin halitta.
Har yanzu ba a tabbatar da asalin dabba na SARS-CoV-2 ba.
Baya ga cututtukan coronavirus na mutum, an kuma bincika asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar juyin halitta ta nuna cewa duka kwayar cutar NL-63 da 229E sun samo asali ne daga kwayar cutar bat, yayin da aka sami kwayar cutar OC-43 da HKU-1 a cikin rodents.
An ba da rahoton cewa cutar coronavirus a cikin jemage da ake kira ARCoV.2 (Appalachian Highlands Coronavirus) da aka gano a cikin jemage masu launin fata a Arewacin Amurka suna da alaƙa da cutar coronavirus ta ɗan adam-NL63.
A gefe guda, an gano cewa kwayar cutar coronavirus ta 229E tana da alaƙa da wani kwayar cutar coronavirus a cikin jemage, wanda ake kira Hipposideros / GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana tsammanin cewa kwayar cutar ma ta kasance mai watsa shiri.
Don bayyanawa, an taƙaita bayanan yanzu game da asalin dabbobi na sanannun coronavirus na mutum a cikin hoto 1 da tebur 2.
Binciken juyin halitta ya ba da tabbacin cewa an sami yaduwar kwayar cutar coronavirus tsakanin jinsuna a tarihi.
Lokacin da kwayar cutar OC43 ta wuce daga dabbobi zuwa mutane a shekara ta 1890, an sami annobar cutar numfashi.
Tarihin yaduwar kwayar cutar coronavirus 229E tsakanin jinsuna har yanzu ba a bayyana ba.
An gano cewa kwayar cutar corona alfa a cikin jemage tana da alaƙa da kwayar cutar corona 229E ta mutum.
Daga cikinsu akwai cutar Corona Alpha a cikin alpacas.
Akwai shaidu da yawa da ke nuna cewa kwayar cutar ta bazu daga jemage zuwa mutane kai tsaye.
Na farko, mutane, ba alpacas ba, suna iya haɗuwa da bat a cikin yanayin rayuwa.
A wani bangare kuma, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, kwayar cutar coronavirus ta mutum-229E ta kwayar cutar alpha ta Batman tana da yawa kuma ba ta haifar da cututtuka a cikin bat, yayin da kwayar cutar Alpha ta Alpaca ke haifar da barkewar cututtukan numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a gano cutar alpaca-related coronavirus a cikin dabbobin daji ba.
Saboda haka, ba za a iya kawar da yiwuwar alpacas sun kamu da cutar coronavirus ta 229E ba.
A gaskiya, jemage ne tushen ƙwayoyin cuta da ke haifar da cututtuka ga mutane, ciki har da cutar rabies, Ebola, Nipah, da kuma Hendra.
Saboda haka ba abin mamaki ba ne cewa jemage na iya kawo cutar coronavirus 229E kai tsaye ga mutane.
Yayin da kwayar cutar alpha a cikin jemage ke aiki a matsayin kwayar halittar kwayar cutar coronavirus 229E, alpacas da kuma alligators na iya aiki a matsayin matsakaitan runduna don watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin Mers-Cove.
Myres-Cove misali ne mai kyau na sauyawar jinsuna, daga barawo zuwa dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dabbar dab
An san asalin juyin halitta na Mers-Cove daga jemage tun lokacin da aka fara gano shi kuma an ƙarfafa shi ta hanyar binciken da aka yi.
A bayyane yake cewa jemage suna da tarin ƙwayoyin cuta don musayar kwayoyin halitta a cikin jinsin kuma suna motsawa tsakanin jinsuna.
Ƙwari suna da tsawon rai, suna zama a cikin ƙauyuka masu yawa, suna da dangantaka mai kyau da mutane, kuma suna iya tashi sosai, kuma waɗannan abubuwa ne da suka sa su zama masu kawo ƙwayoyin cuta.
A wani ɓangare kuma, Mers-Cove ya koma kan kyakkyawan ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙolin ƙwanƙƙƙƙ.
Wannan kyakkyawa ta iya daidaitawa sosai har ta canza daga mai watsa shiri na matsakaici zuwa mai watsa shiri na halitta da kwanciyar hankali.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan ƙananan kwayoyin halitta a cikin waɗannan dabbobi.
Ana samun sa a wasu lokatai a cikin mutane ta hanyar haɗari kuma mutum ba mai watsawa bane ga MERS-CoV saboda ba zai iya ci gaba da watsawa ba.
Ba kamar yadda raƙumi ke da rawar da ya taka wajen canja wurin MERS-CoV ba, mai cin naman tururuwa, idan akwai, yana da rawar da ya taka wajen canja wurin SARS-CoV-2.
Musamman, beta-coronavirus da ke da alaƙa da masu cin tururuwa suna sa su rashin lafiya sosai.
Suna iya zama masu ba da baƙi ga SARS-CoV-2 na beta-coronavirus, kamar yadda cat butter yake a cikin SARS-CoV.
Nazarin da za a yi nan gaba zai warware yiwuwar yaduwar SARS-CoV-2 daga dabbobi zuwa mutane ta hanyar tabbatar da ko kuma hana shi.
Na farko, ƙila jemage ne ke ɗauke da kwayar cutar SARS-CoV-2, wadda ta fi kama da SARS-CoV-2.
Mutane da kuma jemage na iya raba mazaunin ta hanyar yanka ko hakar ma'adinai.
Na biyu, tururuwan da ke cin nama suna iya zama ɗaya daga cikin masu karɓar cutar SARS-CoV-2 da aka gano kwanan nan.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman dabbobi.
Da alama dabbobi masu shayarwa da yawa, har da dabbobin gida suna iya kamuwa da cutar SARS-CoV-2.
Akwai hujja da za a yi amfani da shi wajen bincika ƙwayoyin cuta a dabbobi da kuma dabbobin daji.
Na uku, kamar yadda aka ambata a sama, wataƙila SARS-CoV-2 ya sake haɗuwa kuma ya daidaita cikin nau'in na uku wanda ke da alaƙa da jemage da kuma masu cin tururuwa.
Har yanzu ana ci gaba da binciken asalin SARS-CoV-2.
Baya ga nau'ikan dabbobi daban-daban, daga bangaren kwayar cutar akwai manyan abubuwa guda uku masu mahimmanci waɗanda ke sauƙaƙa kamuwa da coronavirus don ƙetare shingen jinsuna.
Na farko, suna da yawan maye gurbi a cikin ninki biyu na ribose DNA.
Matsakaicin canjin canjin kwayar cutar Corona, idan aka kwatanta da sauran kwayoyin cutar RNA, ana iya ɗaukar su "matsakaici" ko "mai girma" tare da matsakaicin canjin canji na ~ 10-4 sauyawa a kowace shekara don wuri na 2, dangane da matakin daidaitawar kwayar cutar Corona ga sabbin masu karɓar baƙi.
Kwayar cutar Corona tana da enzyme mai gyarawa, wanda cire shi yana haifar da canji mai yawa ko rashin iya ci gaba.
Abin sha'awa, maganin Remdesivir, wanda yake da nau'in nucleotide, an san shi da iyawa don hana kwayar cutar coronavirus ta hanyar hana enzyme ribonuclease da kuma RNA-based RNA polymerase.
Remdesivir magani ne mai saurin kamuwa da SARS-CoV-2, kuma ana shirin gwada shi a gwaji.
Duk da haka, yawan canjin kwayoyin cutar korona ya ninka na masu dauke da ita sau miliyan.
Bugu da ƙari, yawan maye gurbi yana da yawa idan coronaviruses ba su dace da mai gidan ba.
Yawan maye gurbin SARS-CoV-2 ya yi ƙasa sosai idan aka kwatanta da SARS-CoV mai yawan maye gurbin, wanda ke nuna matakin daidaitawa da ɗan adam.
Da alama ya riga ya daidaita da wani mai masaukin da yake kusa da mutum.
Ban da SARS-CoV-2, wannan ma gaskiya ne ga Meers-Cove, wanda ya dace da kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyan kyankyasan kyan kyan kyan kyan kyan kyankyasan kyan kyan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyasan kyankyashin.
A ka'idar, ba zai yiwu ba cewa maye gurbin kwayoyin halitta zai taimaka wa alluran rigakafi da magungunan rigakafin cutar SARS-CoV-2 ta hanyar rage tasirinsa da sauri.
Na biyu, babban kwayoyin halittar RNA a cikin coronaviruses yana ba da ƙarin lokaci don gyara kwayoyin halittar da sake haɗawa, don haka haɓaka yiwuwar juyin halitta tsakanin jinsuna, wanda ke haifar da sababbin coronaviruses lokacin da yanayi ya dace.
Wannan yana da goyon baya ta hanyar samfurori masu mahimmanci da kuma aikin gina jiki a kusa da ƙarshen 3 'na genome.
Na uku, coronaviruses suna canza siffar su a bazuwar kuma akai-akai yayin kwafin ribose DNA ta hanyar "zaɓar kwafi" na musamman.
A cikin mai masaukin da yake kamar tukunyar hadawa, sauya jerin abubuwa yana faruwa sau da yawa yayin kwafin kwayar cutar corona.
Babban nau'in DNA mai kama da na gaba da kuma na gaba zai iya sake haɗuwa don samar da sabon coronavirus.
An gano hujja game da ci gaban kwayoyin halitta don sake haɗuwa a cikin HKU1 da OC43, da kuma coronavirus na dabbobi kamar su SARS-CoV-2 da HKU9.
Yadda kwayar cutar ke hulɗa da mai watsa shiri
Baya ga waɗannan abubuwa uku na kwayar cutar da aka ambata a baya, hulɗar kwayar cutar da mai karɓar baƙi wani babban abu ne mai tasiri a cikin sauyawa tsakanin jinsuna.
A wannan yanayin, mun ɗauki sake haɗuwa da SARS-CoV a matsayin misali mai kyau, wanda kuma ya nuna hujja na zaɓin zaɓi a lokacin abubuwan da suka faru na ƙaura tsakanin jinsuna.
Bisa ga nazarin kwatancen SARS-CoV a cikin mutum da kuma zamba cat, an yi imanin cewa SARS-CoV yana fuskantar saurin daidaitawa a cikin baƙi daban-daban, musamman ta hanyar maye gurbi da ke faruwa a yankin haɗin mai karɓar S.
Gabaɗaya, ƙwayar cuta ta S ta kwayar cuta tana hulɗa da mai karɓar ƙwayoyin cuta kuma ana zaɓar ta ta hanyar amsawar ƙwayoyin cuta ga mai masaukin.
A cikin SARS-CoV, yankin haɗin mai karɓar amino acid daga 318 zuwa 510 yana faruwa a cikin yanki S1, wanda ke haɗuwa da enzyme mai canza angiotensin 2 ban da masu karɓar masu karɓar ƙwayar cuta.
Yankin da ke ɗaure da masu karɓar SARS-CoV yana iya gane masu karɓar ƙwayar cuta na Angiotensin 2 wanda ke taimakawa dabbobi daban-daban, ciki har da jemage, cat, linzamin kwamfuta, da kuma kare raccoon, wanda ke ba da damar cutar ta wuce tsakanin jinsuna.
A zahiri, ragowar amino acid guda shida ne kawai aka gano waɗanda suka bambanta da waɗanda aka ware daga kwayar cutar daga ɗan adam da cat butterfly a cikin yankin haɗin mai karɓar, kuma 4 daga cikinsu suna cikin tsarin haɗin mai karɓar don hulɗa tare da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar 2.
Akwai nau'ikan K479N da S487T a cikin sarkar Sars-Kov a cikin cat cat, wanda zai iya ƙara yiwuwar hulɗar da furotin na Spike a cikin gaba na mai canzawa na Angiotensin 2.
A wasu kalmomi, waɗannan nau'ikan amino acid biyu na iya zama masu mahimmanci ga daidaitawar kwayar cutar a cikin mutane.
Yana da kyau a lura cewa SARS-CoV-2 yana da mai karɓar ƙwayar halitta ɗaya da SARS-CoV.
Akwai bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein wanda ke nuna cewa yiwuwar ɗaure S-protein a cikin kwayar halittar mutum ta canza angiotensin 2 ya canza.
A gaskiya, wani bincike da aka yi da na'urar daukar hotan lantarki ya nuna cewa akwai yiwuwar wannan dangantaka ta ninka sau 10 zuwa 20 fiye da yadda take tsakanin kwayar halittar mutum mai canza angiotensin-2 da kuma Sars-CoV.
Yana da ban sha'awa kuma don sanin ko akwai wasu nau'ikan masu karɓar masu karɓar taimako waɗanda za a buƙaci don canja wurin SARS-CoV-2.
Abin sha'awa kuma shine cewa kwayar cutar HCoV-NL63 tana da alaƙa da enzyme mai canza angiotensin 2 amma a wani ɓangare na S-protein.
Akwai wasu masu karɓar kwayar cutar coronavirus da yawa, kamar su mai nazarin furotin N don kwayar cutar coronavirus-229E, da kuma sialic acid mai ƙarancin 9-O don kwayar cutar coronavirus-OC43.
Hakanan suna iya zama masu alhakin nasarar daidaita waɗannan coronaviruses a cikin ɗan adam bayan sun canza daga nau'in dabbobi zuwa na dabbobi.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon sauyawar jinsin kwayar cutar coronavirus na mutum yana ƙarƙashin sarrafawa ta wasu abubuwan dogaro da iyakancewar mai masaukin.
Rarraba waɗannan sunadarai tsakanin mutane da kuma masu karɓar bakunan ajiyar kwayar cutar coronavirus, kamar su bat, unicorns, slugs, da rodents na iya zama cikas ga motsi tsakanin jinsuna.
Kwayar cutar coronavirus ta mutum tana buƙatar sarrafa abubuwan dogaro da mai masaukin kuma ta raunana abubuwan da ke hana shi don aiwatar da nasarar sauyawa tsakanin jinsuna.
A wannan yanayin, ƙwayoyin halittar kwayoyin halitta a wannan muhimmin yanki na hulɗar kwayar cutar da mai masaukin baki suna ci gaba da kasancewa masu ganowa da kuma ƙayyade halaye.
Ana iya amfani da bincike mai zurfi na genome don bincika abubuwan dogaro da ƙuntatawa na SARS-CoV-2 ta amfani da fasahar CRISPR mai tasowa.
Fitowar sabbin cututtukan coronavirus: Komawa zuwa farkon farawa
Bambancin coronaviruses a cikin jemage yana ba da dama mai yawa don sabon coronavirus na ɗan adam.
A wannan yanayin, coronaviruses a cikin bat suna da tsarin kwayoyin halitta na coronaviruses na mutum.
Bugu da ƙari, sauye-sauye da sauye-sauyen kwayoyin halitta suna sa kwayar cutar coronavirus ta mutum ta ci gaba kuma suna da muhimmanci a wannan yanayin.
Alal misali, samun ko rasa sababbin kwayoyin halittar furotin yana nufin iyawar gyara tsarin kwayar cutar sosai.
Daga cikin sunadarai masu tsara SARS-CoV, an yi imanin cewa ORF8 yana da mahimmanci wajen daidaitawa da mutane, inda aka ware SARS-CoV mai alaƙa da ƙwayoyin cuta a cikin jemage amma an gano cewa yana ɓoye sunadarai daban-daban na ORF8.
An gano cewa dukkanin halaye 29 na cire nucleotide na SARS-CoV sun kasance a cikin jinsunan da aka ware a farkon cutar.
Wannan sharewa ya haifar da rarrabuwa na ORF8 zuwa ORF8a da ORF8b, kuma ana tsammanin juyin halittar daidaitawa ne wanda ke haɓaka musayar baƙi.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa ta hanyar kwayar cutar coronavirus ta alpha da gamma, inda aka gano ƙananan yankuna masu yawa a cikin polymerase na RNA mai dogara da RNA.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10, da kuma sassan nsp14.
Hakazalika, bincike ya nuna cewa annobar MERS-CoV ta sami wasu nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'in nau'ikan nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Baya ga SARS-CoV da MERS-CoV, an kuma lura da sake haɗuwa a cikin sauran coronaviruses na ɗan adam, inda coronaviruses na ɗan adam suka haɗu tare da sauran coronaviruses na dabbobi a cikin kwayoyin halittar su.
Ya kamata a lura cewa zabin na wucin gadi zai iya taimakawa canje-canje da ba a so a cikin kwayar cutar ba, wanda yawanci yakan haifar da cutar ta kawar da matsin lamba, kamar yadda tsarin garkuwar jiki na mai masaukin yake.
Rashin cikakkiyar furotin ORF4 a cikin kwayar halittar kwayar cutar coronavirus 229E saboda cire nucleotides biyu misali ne na waɗannan tasirin.
Kodayake ana iya lura da ORF4 mai kyau a cikin camel da bat viruses wanda ke da alaƙa da kwayar cutar coronavirus 229E, kwayar cutar alpavirus tana nuna ƙwayar nucleotide guda ɗaya, wanda ke haifar da maye gurbin tsarin kwayar halitta.
A ƙarshe, kuma ba mafi ƙaranci ba, ana kuma haifar da ci gaban sabbin ƙwayoyin cuta na corona ta hanyar zaɓin matsin lamba a cikin masu karɓar su.
An gano wasu marasa alamun cutar ko kuma marasa alamun cutar a cikin ƙwari da suka kamu da cutar korona, wanda ke nuna cewa ƙwayoyin cutar korona da ƙwari sun daidaita.
Ya nuna cewa jemage sun daidaita da kwayar cutar corona a jiki da kuma a jiki.
Alal misali, rashin ƙarfafa amsar ƙwayoyin cuta a cikin ƙwari ya rage tasirin cututtukan da ƙwayoyin cuta na corona suke haifarwa.
Bugu da ƙari, an hana ayyukan salula na halitta a cikin bat saboda karuwar ƙwayoyin halitta na NKG2/CD94 da kuma rage yawan maganganun kwayoyin halitta na I.
Bugu da ƙari, babban matakin nau'ikan mahaɗan oxygen masu aiki (ROS) wanda ke haifar da haɓakar haɓakar ƙwayar cuta na ƙwanƙwasawa na iya haifar da duka hana kwayar cutar coronavirus da tasirin gyara ta hanyar enzyme na ribonuclease na waje, don haka samar da zaɓi na zaɓi don haifar da ƙwayoyin cuta na ƙwayoyin cuta waɗanda ke haifar da cututtuka sosai lokacin kamuwa da sabon mai masaukin.
Ƙarin ƙwayoyin cuta na korona za su iya tasowa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don daidaitawa da mai masaukin.
Saboda haka, ba daidaituwa ba ce cewa wasu sabbin cututtukan corona guda uku sun bayyana a cikin shekaru 20 da suka gabata.
Kwayar cutar corona ba ta haifar da cututtuka ko kuma ta haifar da alamun rashin lafiya a cikin masu ba da abinci kamar su bat da raƙumi.
Suna yin kwafi sosai ba tare da haifar da amsa mai karfi daga mai gidan ba.
Wannan shine sirrin da ke bayyana dalilin da yasa ake ganin masu dauke da cutar ba tare da nuna alamun cutar ba da kuma dalilin da yasa ake samun mummunan kamuwa da cutar ga mutane.
Abubuwan cututtuka masu tsanani galibi suna faruwa ne saboda yawan aiki da tsarin garkuwar jiki da kuma guguwar cytokine, inda idan ƙarfin garkuwar jiki ya fi ƙarfi, cutar huhu ta fi tsanani.
Akasin haka, a cikin masu dauke da cutar ba tare da alamomi ba, tsarin garkuwar jiki ya rabu da kwafin kwayar cutar coronavirus.
Irin wannan dabarar ta kawar da amsawar rigakafi na iya samun fa'idodi masu amfani a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin jemage.
Saboda haka, ana iya amfana daga shan maganin cutar ta Interferon Type I aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin ɗan adam.
Bugu da ƙari, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
A wannan yanayin, hana ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Tushen SARS-CoV-2 ya biyo bayan tsarin SARS-CoV da MERS-CoV.
A lokacin da aka gano cewa cutar beta-corona a cikin jemage tana da kashi 95% na kwayar halittar SARS-CoV, akwai kuma cutar corona a cikin jemage wanda ke da kashi 96% na kwayar halittar SARS-CoV-2.
Yayin da aka gano cewa kuliyoyi da sauran dabbobi a kasuwa suna dauke da kwayar cutar SARS-CoV-2 ba su gano masu karɓar SARS-CoV-2 kai tsaye ba.
An gano beta-coronavirus a cikin masu cin tururuwa masu ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Ko da yake har yanzu ana ci gaba da yin tambayoyi, babu wata shaida da ta nuna cewa SARS-CoV-2 na mutum ne ko da gangan ko kuma ba da gangan ba.
Kwayoyin cutar Corona sun sake zama abin lura saboda barkewar cutar SARS-CoV-2.
Nazarin coronaviruses a cikin jemage da sauran dabbobi ya canza tunaninmu game da mahimmancin asalin dabbobi da kuma mahimmancin ajiyar dabbobi na coronavirus na mutum don watsawa ga mutane.
Shaida mai ƙarfi ta nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 duk sun samo asali ne daga jemage kuma sun shiga cikin mutane ta hanyar masu karɓar baƙi.
Tun da yake kamuwa da SARS-CoV ya samo asali ne daga hulɗar ɗan adam da litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litattafan litatta litatta litatta litattafan litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litatta litat li
A wannan tunanin, ya kamata a cire dabbobi masu cin tururuwa daga kasuwar kayan abinci don hana yaduwar cutar dabbobi, saboda an gano wasu kwayoyin cutar beta a cikin masu cin tururuwa waɗanda suka yi kama da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 ya wuce zuwa ga mutane ko a'a, kuma ko ta wace hanya ce aka watsa shi, ta hanyar dabbobi masu cin tururuwa da sauran dabbobi masu shayarwa, har yanzu yana da batun da ke buƙatar bayyanawa a cikin binciken gaba.
A wani ɓangare kuma, an yi dogon lokaci ana samun Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'aikatar Ma'a.
Wannan kyakkyawan wuri yana da muhimmanci wajen sufuri kuma yana da muhimmanci wajen samar da nama, madara, fata da kuma kayan ulu ga mazauna yankin.
An yadu da su a duk yankin Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a sadaukar da dukan kyawawan abubuwa don a shawo kan MERS ba, kamar yadda jami'an kasuwar namun daji a China suka yi don hana yaduwar SARS-CoV-2 da SARS-CoV-2.
Don dakatar da barkewar MERS, ya kamata a bi tsarin da ya dace don samar da alluran rigakafin MERS-CoV mai kyau, ban da sauran matakan magance kamuwa da cuta.
Idan ba mu iya kawar da waɗannan ƙwayoyin cuta ba, sababbin nau'ikan ƙwayoyin cuta na iya tasowa kuma su haifar da ɓarkewa.
Akwai wasu cututtuka na coronaviruses da ke da alaƙa da cututtukan dabbobi da suka samo asali daga namun daji.
Musamman, coronaviruses a cikin jemage suna da bambancin gaske wanda ke da yiwuwar haifar da cututtukan dabbobi.
Akwai dama da yawa don coronavirus da ke da alaƙa da cututtukan dabbobi su sake haɗuwa, wanda ke haifar da sababbin coronaviruses waɗanda zasu iya zama masu saurin yaduwa da / ko kisa ga mutane a nan gaba.
A wasu wurare a kasar Sin, ya kamata a daina cin namun daji domin a rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
A cikin wahalar da SARS, MERS da COVID-19 suka haifar, ya kamata a tsara shirin shiri da amsawa mai dacewa.
Gaskiyar ita ce, yawancin ƙwayoyin cuta sun daɗe suna cikin duniyarmu.
Suna rayuwa a cikin ɗakunan ajiyarsu na halitta har sai sun sami damar yaduwa da yawa.
Ko da yake jemage suna da halaye da yawa da ke sa ƙwayoyin cuta su yadu, amma za a iya rage damar da mutum zai iya haɗuwa da jemage da sauran dabbobin daji idan mutane suka koyi al'ada da ke hana su.
Kulawa da dabbobi masu shayarwa a kai a kai hanya ce mai mahimmanci don samun kyakkyawar fahimta game da yanayin coronavirus da kuma masu karɓar baƙi na halitta, wanda ya tabbatar da fa'ida wajen hana su yaduwa daga dabbobi zuwa mutane da hana bayyanar su a nan gaba.
A ƙarshe, hanya mafi kyau ta hana cututtukan dabbobin daji ita ce ta nisanta mutum daga wuraren da ke tattare da ƙwayoyin cuta na dabbobi.
Asirin asalin cutar SARS-CoV-2 har yanzu yana kewaye da tambayoyi da yawa da ke buƙatar amsawa.
Na farko, idan jemage ya kawo SARS-CoV-2 ga masu cin tururuwa, yana da muhimmanci a san yanayin da ya sa jemage da dabbobi masu cin tururuwa suka yi tarayya a cikin irin wannan yanayin.
Na biyu, idan jemage suna da matsayi mafi girma wajen yaduwar cutar ga mutane, to ya kamata a gano yadda mutum zai iya yin hulɗa da su.
Na uku, idan nau'in dabbobi masu shayarwa na uku ne ke aiki a matsayin mai karɓar bakuncin, to, ya kamata a bayyana yadda yake hulɗa da nau'ikan daban-daban, ciki har da mutane, bats, da kuma masu cin nama.
A ƙarshe, tun da yawancin dabbobi masu shayarwa, har da dabbobin gida, ana iya zargin su da SARS-CoV-2, ya kamata a gudanar da bincike da kuma gwaji.
Ko dai mai watsa shiri ɗan leƙen asiri ne, mai cin naman tururuwa ko kuma wasu dabbobi masu shayarwa, ana sa ran gano SARS-CoV-2 ko kuma kwayar cutar da ta fito daga ciki wanda kusan ya yi kama da na masu watsa shirye-shiryen ta na gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman matakan rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ma'aunin "ainihin yanayin" da "ainihin yanayin" don ganewar asali na COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar gaggawa game da ganewar asali da magani na cutar coronavirus ta 2019, wanda ya ba da kwarewarmu da kuma samar da bayanan da suka dace don magance cutar a duniya.
Kodayake cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa sakamakon binciken da ke gudana da gwajin gwaji; saboda haka ana ci gaba da sabunta dabarun bincike da magani.
A cikin wannan wasikar, mun amsa ga bayanin da Ward ya yi game da jagorarmu kuma mun ba da sababbin ka'idodin ganewar asali na "halaliyar da ake zargi" da "halaliyar da aka tabbatar" daidai da sabuwar Jagorar Ganowa da Kula da COVID-19 (Fitowa ta Bakwai) da Hukumar Kiwon Lafiyar Jama'ar Sin ta bayar.
A watan Disamba na 2019, an sami barkewar cutar coronavirus ta 2019 (Novel Coronavirus-2019), wanda yanzu aka sani da cutar coronavirus ta 2019 (COVID-19) kuma an ba da sunan coronavirus 2 wanda ke da alaƙa da mummunan cututtukan numfashi (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba.
Don yaƙar SARS-CoV-2, ƙungiyarmu ta tsara jagora mai sauri kuma ta buga ta kan layi a cikin Jaridar Binciken Likita ta Soja a ranar 6 ga Fabrairu, 2020.
An yi ta sauraronsa tun lokacin da aka buga shi.
Da fatan za a lura cewa ko da yake COVID-19 sabuwar cuta ce, hankali da iliminmu suna ƙaruwa a hankali bisa sakamakon binciken da ake yi da kuma gwajin asibiti; saboda haka, ana ci gaba da sabunta hanyoyin bincike da magani.
Alal misali, an fitar da jagororin ganewar asali da kuma maganin COVID-19 daga Hukumar Kiwon Lafiyar Jama'ar Sin (http://www.nhc.gov.cn), tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, a cikin jimlar fitowa bakwai tare da wasu canje-canje masu mahimmanci.
Yanzu, jagorarmu ta amsa da tsokaci daga Chow da sauransu, waɗanda suka ba da shawara mai sauƙi don lura da maki bisa gwajin asibiti.
Kokarinsu ya kara sabon jagora ga jagorancinmu kuma ya zama mai amfani ga wannan annoba a duk duniya.
Muna goyon bayan wannan aiki mai girma kuma muna godiya.
Duk da haka, aikin su yana buƙatar sabuntawa bisa ga sabbin jagororin ganowa da maganin COVID-19 (Fitarwa ta gwaji ta bakwai) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris 2020), tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan da ke tattare da yanayin cutar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututut
Tarihin cutar: (1) Tarihin da ya haɗa da tafiya zuwa Wuhan da kewaye, ko wasu al'ummomin da aka ba da rahoton cutar COVID-19, ko zama a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin da ya haɗa da hulɗa da masu kamuwa da cutar SARS-CoV-2 (tare da sakamako mai kyau na gwajin DNA); (3) Tarihin da ya haɗa da hulɗa da marasa lafiya da zazzabi ko cututtukan numfashi daga Wuhan da kewaye, ko wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin da ya haɗa da hulɗa da masu kamuwa da cutar da aka tabbatar (2 ko fiye da makonni) da ke tattare da rashin ƙarfi ko cututtuka, kamar su tashin hankali a cikin gida ko makarantu ko ƙananan wuraren aiki.
Bayyanar asibiti: (1) zazzabi da/ko cututtukan numfashi; (2) tare da halaye da ke nuna hoto na kamuwa da cutar COVID-19; (3) yawan adadin ƙwayoyin jini na yau da kullun, kaɗan, ko ƙarancin ƙwayoyin lymph a farkon farkon kamuwa da cutar.
Dole ne a gina ganewar asali na yanayin da aka tabbatar akan yanayin da ake zargi wanda ya ƙunshi kowane ɗayan abubuwan da ke nuna alamun cutar ko hulɗar ƙwayar cuta ta hanyar: (1) tabbataccen sakamakon gwajin PCR na SARS-CoV-2; (2) daidaituwa mai kyau na cikakken tsarin kwayar cutar tare da halaye na sabbin coronavirus da aka sani; (3) tabbataccen gwajin IgM da IgG na SARS-CoV-2 a cikin ƙwayar; ko canzawar IgG na SARS-CoV-2 daga mara kyau zuwa IgG, ko kuma ƙaruwa a cikin matakin warkewa ya zama daidai ko fiye da sau 4 na matakin a wannan matakin.
Mun ga cewa an ƙara gwajin polymerase mai aiki tare na ainihi don DNA a cikin hanyoyin numfashi ko samfuran jini zuwa sigar ta biyu (Janairu 18, 2020) da ta uku (Janairu 22, 2020).
An ƙara gano cututtukan cututtuka a cikin samfurin jini zuwa na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan an ƙara Jagorar hulɗar serum zuwa na bakwai.
Waɗannan gyare-gyare sun dogara ne da ci gaba da aikin masu bincike don isa ga ƙirar kayan aikin ganowa na DNA mai kyau don saurin ganewar asali, ban da samfuran numfashi ciki har da samfuran jini, wanda ya haifar da ƙarin wadatar samfuran daban-daban, da tallafawa watsa sakamako mai kyau na kwayar cutar zuwa ƙa'idodin yanayin da aka tabbatar.
Bugu da ƙari, akwai ƙarin shaida da ke nuna cewa ya kamata mu yi hankali sa'ad da muke bi da marasa lafiya da ke da alamun da ba su da kyau.
Don haka, ya kamata a sabunta abubuwan da ke cikin tsarin kwararar bayanai na Chow da sauransu, inda suka sanya mutumin da ba shi da alamun asibiti a matsayin "mai ƙarancin haɗari".
Tsarin sa ido kan maki yana buƙatar tabbatar da ingancinsa a aikace da ƙarin nazarin asibiti.
A ƙarshe, muna fatan samun ƙarin hujjoji na kai tsaye kuma muna gayyatar masu karatu su ba mu ra'ayoyinsu.
Don ganewar asali na "halalin da ake zargi" da "halalin da aka tabbatar", muna kira da a bi kuma a bi sabbin jagororin da aka bayar daga ƙasashen da mutane ke zaune.
Ƙungiyarmu za ta kuma sabunta umurninmu na taimako a kan kari.
Bangladesh ta samu karin mutane biyar da suka mutu a rana daya sakamakon cutar COVID-19.
Bangladesh ta tabbatar da karin mutane biyar da suka mutu a ranar sakamakon cutar COVID-19.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
Cibiyar Kula da Cututtuka da Kula da Cututtuka da Bincike (IEDCR) a Bangladesh ta ba da rahoton cewa, har zuwa jiya, adadin masu cutar da aka yi wa rajista ya kai 114 da ke aiki da kuma 33 da ke warkewa a gida.
An samu mutuwar mutane 17.
Daraktan Cibiyar Kula da Cututtuka da Kula da Cututtuka, Dokta Mirjadi Sabrina Flora, ta ba da rahoton a wani taron manema labarai ta yanar gizo cewa mutuwar ta haɗa da maza huɗu da mace ɗaya.
Kamar yadda Dr. Mirgadi ya bayyana, akwai mutane biyu da suka haura shekaru 60, biyu da ke tsakanin shekaru 51 zuwa 60, da kuma mutum ɗaya da ke tsakanin shekaru 41 zuwa 50.
Ta kuma ce duka mutuwar biyu daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu cewa, daya daga cikin wadanda suka mutu shine Jalal Saif Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda ke karbar magani a asibitin Kuwait Maitre.
Ministan sufuri da gadoji na Bangladesh, Ubayd al-Qadir, ya fada a cikin wata sanarwa ta bidiyo a ranar Asabar cewa za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa ranar Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya dakatarwar a ranar Asabar 4 ga Afrilu.
Har ila yau, ana ba da izinin jigilar kayayyaki na asali, wato, kayayyakin magani, mai da abinci.
An samu mutum biyu da suka dawo daga Italiya da matar wani daga cikin mutanen da suka kamu da cutar a ranar 8 ga watan Maris.
Dukkanin ukun sun warke a ranar 19 ga watan Maris.
Yawan masu kamuwa da cutar SARS-CoV-2 ya zarce miliyan daya a duniya.
Bayanai da Jami'ar Johns Hopkins ta fitar a ranar Alhamis sun nuna cewa adadin adadin masu kamuwa da cutar coronavirus mai saurin kamuwa da cutar SARS-CoV-2 ya zarce miliyan daya a duniya.
Cutar COVID-19 ta haifar da mutuwar mutane akalla 52,000.
Wannan mummunan ci gaban ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko, kuma an samu mutuwar farko da ta shafi cutar a Zambia.
Koriya ta Arewa ta yi ikirarin cewa, tun ranar Alhamis, tana ɗaya daga cikin ƙasashe kaɗan da har yanzu ba su da cutar coronavirus.
Hukumar Lafiya ta Duniya ta sanar da mutane 1051635 da suka kamu da cutar, daga cikinsu akwai mutane 79332 a cikin sa'o'i 24 kafin karfe 10 na safe agogon Turai na tsakiya (karfe 0800 UTC) a ranar 4 ga Afrilu.
An samu mutane sama da 244,000 da suka kamu da cutar korona a Amurka, kuma an samu mutuwar mutane 5,900.
CBS News ta ruwaito, ta ambato bayanan Jami'ar Johns Hopkins, cewa an samu mutuwar mutane sama da 1,000 a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
Kasashe a duniya sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya sanar da tsawaita dokar rufe garin har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da ci gaba da biyan albashi ga mutanen Rasha ba tare da zuwa aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci ta kasa na kwanaki 15; ta amince da kuri'u 215, ta ki amincewa da kuri'u 10, ta ki amincewa da kuri'u daya.
Saudiyya ta tsawaita dokar hana fita a Makka da Madina zuwa yau, daga karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin kafa dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan jihar Ohio, Mista Mike D. Wayne, ya sanar da cewa jihar ta kara dokar hana fita har zuwa ranar 1 ga watan Mayu.
Shagunan Australiya suna rage yawan takarda bayan gida da ake saya.
Shafukan kantin sayar da kayayyaki na Wall Worth da Coles na Australiya sun tsaurara takunkumin sayan takarda na gidan wanka a daren Asabar da Lahadi don rage su zuwa fakiti biyu daga Shagunan Wall Worth da fakiti ɗaya daga Shagunan Coles a kowane ma'amala a duk rassan ƙasar.
Har ila yau, kantin sayar da kayayyaki na Aldi ya ƙayyade wata takarda, kuma wannan ranar Litinin ne.
An wallafa waɗannan ƙuntatawa a matsayin saƙonni a wuraren biya a shagunan da kuma a shafukan Facebook.
Rahotanni sun nuna cewa masu sayen sun yi jinkirin adana su saboda tsoron kamuwa da cutar COVID-19 idan mutane suna bukatar keɓe kansu.
Shagunan Wall Worth a ranar Laraba sun amince da iyakancewar isar da takardar bayan gida zuwa gidaje don zama dunƙule ɗaya ga kowane sayan.
Waɗannan canje-canjen sun zo ne bayan ƙuntatawa na baya da shagunan Wall Worth suka amince da su a ranar 4 ga Maris da kuma Kalls a ranar 5 ga Maris don ba da izinin siyan takardu huɗu kawai a kowane ma'amala.
A cikin sanarwar da ta fitar a ranar 8 ga Maris, Kalls Stores ta ba da rahoton cewa duk da dokar ta'addanci ta rufe makullin guda huɗu, "shaguna da yawa suna ci gaba da sayar da duk abin da suke da shi a cikin awa ɗaya bayan karɓar sa", kuma ta bayyana bukatar a matsayin "marasa misali", kamar yadda Aldi Stores ta bayyana a cikin wani sakon Facebook a ranar Talata a matsayin "ba zato ba tsammani".
Tallace-tallace sun karu "da yawa" a makon da ya gabata, a cewar mai magana da yawun kantin sayar da kayayyaki na Wall Worth.
A makon da ya gabata, kantin sayar da kayayyaki na Costco da ke Canberra ya ce adadin da aka yarda a saya shi ne lita biyu.
Don rage ƙarancin, Shagunan Kalls sun nemi masu samar da kayayyaki su yi girma da sauri kuma su ba da sauri, kuma Shagunan Wall Worth sun nemi ƙarin kaya, yayin da Shagunan Aldi suka buɗe kayan su don abubuwan da aka shirya na ranar Laraba da wuri.
Russell Zimmerman, darektan zartarwa na Ƙungiyar Masu Sayarwa ta Australiya, ya ce masu sayarwa suna ƙoƙarin ƙara kaya, amma ƙuntatawa na majalisa game da lokacin da ake kawo motoci yana hana su.
Yana tsammanin farashin samarwa zai tashi, yayin da masu samar da kayayyaki ke ƙoƙarin biyan buƙata, tare da ƙarancin kayayyaki na musamman.
A ranar Talata, shagunan Aldi sun sanar da cewa saboda samar da kaya da wuri, wasu shagunan ba za su iya ba da tayin na musamman na Laraba ba.
Dokta Mortimer, masanin sayar da kayayyaki a Jami'ar Queensland ta Fasaha, ya ba da rahoto ga News.com.au cewa shaguna suna cika shaguna kowane dare.
Ya ce takardar bayan gida abu ne mai girma, wanda ke haifar da ƙarancin kaya, kuma idan aka sayar da shi, yana barin sarari a kan ɗakunan ajiya, yana ƙara jin ƙarancin.
"Kosai a ce akwai abubuwa da yawa a kan ɗakunan sayar da kayayyaki, kuma idan za a iya sayen kayayyaki kamar su labulen bayan gida da kuma maganin kashe ƙwari, hakan zai rage tsoro", in ji Russell Zimmerman, in ji ABC News.
Kamfanin Who Gives a Crap, wanda ke kera takardar bayan gida da aka sake amfani da ita, ya ba da rahoton ranar Laraba da ta gabata cewa kayayyakin da suke da su sun ƙare.
A cewar wani rahoto daga News.com.au, Kamfanin Kimberly-Clark, wanda ke kera tawul din wanka na Clinix, da Solaris Pepper, wanda ke kera tawul din Surgent, sun tabbatar da cewa suna aiki 24/7 don ci gaba da samar da kayayyakinsu.
Domain.com, wani shafin yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon yanar gizon
A ranar Alhamis, jaridar NT News, wata jarida da ake bugawa a garin Darwin, ta buga da tallace-tallace masu shafi takwas da aka yi da za a iya yanke su kuma a yi amfani da su a matsayin takardar bayan gida.
A farkon, shagunan sun yi jinkirin sanya takunkumi, a cewar rahoton ABC Australia na ranar 3 ga Maris; inda shagunan suka bayyana cewa ba su da shirin sanya takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa akwai kuma bukatar wasu kayayyaki, ciki har da kayan kwalliya, masu kashe kwayoyin cuta, kayan bushewa, wanke hannu da gari.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma, an lura cewa wani kantin sayar da yanar gizo na Burtaniya mai suna Okado yana siyar da takardar bayan gida ta Andres a cikin kwalabe biyu na 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba.
Hukumar Lafiya ta Duniya (WHO) ta sanar a ranar Laraba cewa barkewar cutar COVID-19 - cutar da ke haifar da cutar coronavirus da ke da alaƙa da mummunan cututtukan numfashi mai tsanani da aka fi sani da SARS-CoV-2 - ta kai matakin annoba.
Ko da yake kalmar "annoba" tana nufin yaduwar cutar ne kawai, ba yadda wasu abubuwa ke da hatsari ba, WHO ta yi gargadin bukatar tilasta gwamnatoci su dauki matakan da suka dace:
"Dukkan kasashen duniya na iya canza yanayin annobar.
Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom Ghebreyesus ya ce: "Idan ƙasashe suka gano kuma suka gwada mutane, suka kula da su, suka ware su, suka bi diddigin yanayin su, kuma suka tattara su don fuskantar su".
"Dukkanmu muna cikin damuwa game da yawan yaduwar cutar da kuma haɗarin da ke tattare da cutar da kuma rashin aikin da ake yi".
Dokta Tom Friedan, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amirka, ya ce wannan annoba "ba ta da misali".
A wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce, "Babu wata kwayar cutar numfashi da aka gano daga farkon bayyanarta zuwa ci gaba da yaduwa a duniya, sai mura".
Gibrisus ya bayyana irin wannan ra'ayi, yana cewa: "Ba mu taɓa fuskantar annobar da wata kwayar cutar Corona ta haifar ba".
Ya ci gaba: "Ba mu taɓa ganin annoba da za a iya sarrafawa a lokaci ɗaya ba".
An bayyana sabon yanayin a matsayin annoba bayan da Hukumar Lafiya ta Duniya ta yanke shawarar a watan Janairu cewa cutar ta zama gaggawa ta kiwon lafiya da ke haifar da damuwa a duniya.
Dokta Anthony Fauci, darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amirka, ya ce game da annobar: "Ainihin abin da za a ce shi ne, abubuwa za su daɗa muni".
Kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya tun ranar Alhamis, kuma sama da 4,600 sun mutu.
Cutar kwayar cutar coronavirus ta 2019-20 cuta ce ta cutar kwayar cutar coronavirus ta 2019 (Covid-19), wacce kwayar cutar coronavirus 2 ke haifarwa wacce ke da alaƙa da mummunan cututtukan numfashi (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta damuwa ta duniya a ranar 30 ga Janairu, 2020, kuma an gane ta a matsayin annoba a ranar 11 ga Maris, 2020.
Tun daga ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a ƙasashe 210 da yankuna, wanda ya haifar da mutuwar mutane 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta yawan mutuwar a China ya kai kashi 4 cikin dari, yayin da a duniya ya kai kashi 13.04 cikin dari a Algeria da kashi 0.08 cikin dari a New Zealand.
Alamomin da ake yawan gani a cikin wannan cuta sun haɗa da zazzabi, tari da kuma numfashi.
Ƙari ga haka, yana iya sa mutum ya kamu da ciwon huhu da kuma ciwon numfashi.
Yawancin lokaci, lokaci tsakanin kamuwa da cutar da bayyanar cututtuka yana da kwana biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu wani rigakafi ko magani da aka sani da zai iya magance cutar.
Maganin farko shi ne magani na taimako da kuma na alamomi. Abubuwan da ake ba da shawara na rigakafi sun haɗa da wanke hannu, rufe baki lokacin tari, nisantawa, lura, da kuma ware waɗanda ake zargi da cutar.
Hukumomi a duk faɗin duniya suna amsa wannan haɗarin ta hanyar ƙuntata tafiye-tafiye, keɓewa, dokar hana fita, sarrafa haɗarin wurin aiki da rufe wuraren aiki.
Wannan annoba ta haifar da rikicewar zamantakewa da tattalin arziki a duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa, da al'adu, da kuma ƙarancin kayayyaki da aka ƙara ta da tashin hankali.
An rufe makarantu da jami'o'i a ƙasashe 193 ko a yankuna, kuma hakan ya shafi kashi 99.4 na ɗaliban duniya.
An samu karuwar rashin gaskiya game da cutar a yanar gizo, kuma an samu rashin adalci da nuna wariyar launin fata da nuna wariya ga Sinawa, da sauran mutanen da ke da asalin Gabas da kudu maso gabashin Asiya, da kuma sauran yankunan da aka samu karuwar masu kamuwa da cutar.
Sakamakon rage yawan tafiye-tafiye da rufe masana'antun masana'antu, an rage gurbataccen iska da fitar da iskar carbon.
Hukumomin kiwon lafiya a birnin Wuhan (babban birnin lardin Hubei), China sun ba da rahoton tarin cututtukan huhu da ba a san dalilin su ba a ranar 31 ga Disamba, 2019, kuma an fara binciken a farkon Janairu, 2020.
Yawancin lokuta ana danganta su da kasuwar sayar da abincin teku ta Wuhan, don haka ana tsammanin kwayar cutar ta samo asali ne daga dabbobi.
An san kwayar cutar da ta haifar da barkewar cutar da SARS-CoV-2, sabuwar kwayar cuta da aka gano wacce ke da alaƙa da kwayar cutar corona a cikin jemage, da kwayar cutar corona a cikin abincin tururuwa, da SARS-CoV. Daga baya an gano cewa mutum na farko da ya nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da wata ma'amala ta bayyananniya tare da rukunin kasuwa mai laushi da aka gano daga baya.
Daga cikin rukunin farkon lokuta da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance masu alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba wanda jaridar South China Morning Post ta buga ya nuna cewa wani mutum mai shekaru 55 daga lardin Hubei, mai yiwuwa shine farkon lamarin. A ranar 26 ga Fabrairun, 2020, Hukumar Lafiya ta Duniya ta ruwaito cewa duk da cewa an samu raguwar sabbin cututtukan da aka ruwaito a kasar Sin, amma sun tashi ba zato ba tsammani a Italiya, Iran da Koriya ta Kudu, inda yawan sabbin cututtukan da ke wajen kasar Sin ya zarce adadin sabbin cututtukan da ke cikinta a karon farko.
Ana iya samun ƙarancin rahoto, musamman a tsakanin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga Fabrairu, an ba da rahoton ƙananan ƙananan lokuta tsakanin matasa, tare da masu shekaru 19 da ƙasa da kashi 2.4% na lokuta a duk duniya. Babban masanin kimiyya na Burtaniya, Patrick Valance, ya kiyasta cewa ana buƙatar kamuwa da kashi 60% na Biritaniya kafin a aiwatar da aikin kiwo mai tasiri.
Yanayin yana nufin yawan mutanen da aka gwada su don COVID-19 kuma aka tabbatar da cutar bisa ga ƙa'idodin hukuma.
Tun daga ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma ƙasashe da yawa suna da manufofi na doka da suka hana yin gwaji ga waɗanda ke da alamun rashin lafiya, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa kimanin kashi 86 cikin 100 na masu kamuwa da COVID-19 ba a gano su ba a China, har zuwa ranar 23 ga Janairu, kuma waɗannan marasa kamuwa da cutar sun kasance tushen kamuwa da kashi 79 cikin ɗari na waɗanda aka yi wa rajista.
Wani bincike da aka fitar a ranar 30 ga watan Maris ya nuna cewa adadin masu kamuwa da cutar a Italiya ya fi na da aka samu.
Ƙididdigar farko na ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar
Wani bincike da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da cutar COVID-19 suna murmurewa.
Ga waɗanda ba su warke ba, lokaci daga lalacewar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, kuma mafi yawan lokuta kwanaki 14.
Ya zuwa ranar 10 ga Afrilu, 2020, COVID-19 ya haifar da kusan mutuwar 97,000.
Kimanin kashi 80% na mutuwar da aka yi a China tun daga ranar 5 ga watan Fabrairu sun ta'allaka ne da mutanen da suka haura shekaru 60, kuma kashi 75% suna da cututtuka da suka riga sun wanzu kamar cututtukan zuciya da jini da ciwon sukari.
Adadin mutanen da suka mutu da COVID-19 zai iya zama mafi girma, domin ba zai haɗa da mutanen da suka mutu ba tare da an gwada su ba - misali, a gida, ko a gidajen tsofaffi, da dai sauransu.
Bayanai na Italiya sun nuna cewa yawan mutuwar da aka yi a lokacin annobar ya ninka adadin mutuwar COVID da aka yi a hukumance da sau 4-5.
"Mun san cewa [adadin mutuwar da aka bayyana] yana nuna ƙididdigar da ba ta dace ba", in ji mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka. Irin wannan rashin ƙididdigar yana faruwa a cikin annoba; kamar cutar sankarar alade ta H1N1 a 2009.
Mutuwar farko a waje da babban yankin China ita ce a ranar 1 ga Fabrairu a Philippines, kuma mutuwar farko a waje da Asiya ita ce a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da 12 a kasashen waje kamar Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, sama da ƙasashe da yankuna arba'in sun ba da rahoton mutuwar, a duk nahiyoyi ban da Antarctica. Ana amfani da matakan da yawa don ƙayyade yawan mutuwar.
Waɗannan lambobi sun bambanta ta yanki da lokaci, kuma suna shafar girman gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya ɗauka tun lokacin da cutar ta fara, da halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar jama'a.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya zuwa kamuwa da cutar ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu 2020.
Adadin ya bambanta bisa ga yanki.
A China, ƙididdigar yawan mutuwar cututtukan ya ragu daga kashi 17.3% (ga waɗanda suka nuna alamun cutar daga 1 zuwa 10 ga Janairu, 2020) zuwa 0.7% (ga waɗanda suka nuna alamun cutar bayan 1 ga Fabrairu, 2020). Sauran ma'aunin suna nuna yawan mutuwar yanayin (CFR) wanda ke nuna yawan mutanen da suka kamu da cutar da suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da ke kamuwa da cutar (wadanda aka tabbatar da cutar da waɗanda ba a tabbatar da cutar ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da lokaci kuma suna bin wani yanki na mutane daga kamuwa da cutar zuwa sanin makomar yanayin.
Masana da dama sun yi ƙoƙarin lissafa waɗannan adadi ga wasu mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a cikin annobar gaba ɗaya ya kasance tsakanin kashi 0.1 zuwa 0.39%.
Ƙididdigar da aka yi a kan wannan zangon ya yi daidai da sakamakon gwajin COVID-19 na farko da aka yi a Jamus, da kuma nazarin ƙididdigar da ke nazarin tasirin gwajin a cikin ƙididdigar yawan mutuwar.
Hukumar Lafiya ta Duniya ta tabbatar da cewa za a iya sarrafa annobar.
Ba a san lokacin da za a kai ga barkewar cutar ba kuma zai iya bambanta dangane da wurin da ake.
"Cutar da ake kira cututtuka da ba a sarrafa su ba sukan kai ƙwanƙolin su kuma su soma raguwa bayan haka sa'ad da cutar ba ta da magunguna", in ji M. Bonnie na Jami'ar Pennsylvania.
Amma yanzu ba zai yiwu a yi wani zato mai ma'ana ba game da lokacin da hakan zai faru".
Babban mai ba da shawara kan lafiya a gwamnatin kasar Sin, Zhong Nanchan ya ce "za a iya kammala shi a watan Yuni" idan aka iya karfafa dukkan kasashen da su bi shawarar WHO kan matakan dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kocharsky na Makarantar Kula da Lafiya da Magungunan Yanayi ta London ya ba da rahoton cewa SARS-CoV-2 "zai iya zama sananne na wata shekara ko biyu".
A cewar wani bincike da kwalejin Imperial ta London ta gudanar karkashin jagorancin masanin kimiyya Neil Ferguson, za mu bukaci mu dogara da nisantawa da sauran matakan "har sai an samu allurar rigakafi (wataƙila cikin watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu wannan kwayar cutar ta coronavirus ta ɓace gaba ɗaya ba saboda tana da sauƙin yaduwa", kuma tana iya "zama cuta ta yanayi don dawowa kowace shekara".
Yadda cutar ta koma baya zai dangana ne a kan yadda mutane suke da rigakafi da kuma yadda cutar ta canja.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma waɗanda ke da cutar ba za su iya nuna alamun cutar ba.
Abubuwa biyu da aka fi sani da zazzabi (88%) da kuma tari (68%).
Alamomin da ba a saba gani ba sun haɗa da gajiya, ɓarkewar kumburi na numfashi (kumburi), rashin jin ƙamshi, numfashi mai wuya, ciwon tsoka da haɗin gwiwa, ƙonewar makogwaro, ciwon kai, jin ƙishi, amai, zubar da jini, zawo, ko haushi. Hukumar Lafiya ta Duniya ta tabbatar da cewa kusan mutum ɗaya cikin shida yana fama da cutar sosai kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ta iyakance alamun gaggawa zuwa wahalar numfashi, ciwo ko ci gaba da damuwa a kirji, rikicewa kwatsam, wahalar farkawa, fuska ko leɓunan launin shuɗi. Ana ba da shawarar kulawar likita nan da nan idan waɗannan alamun suka bayyana.
Wasu mutane da ba su da alamun cututtuka na asibiti amma gwajin da aka yi musu ya nuna cewa suna da cutar, suna iya rashin alamun cututtuka. Saboda haka, masana sun ba da shawara cewa a riƙa lura da mutanen da ke da cutar sosai don a hana su kamuwa da cutar.
A cewar kididdigar kasar Sin, adadin marasa alamun cutar ya kai kashi 44 cikin dari.
Lokacin haifuwa na yau da kullun (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa 14; galibi kwanaki biyar. Misali na rikicewa, an kiyasta kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙamshi da farko ya kai 30% sannan kwanan nan ya ragu zuwa 15%.
Har yanzu ana ci gaba da bincike kan yadda cutar ke yaduwa.
Ana ganin cewa cutar tana yaduwa ne a lokacin haɗuwa ko ta hanyar yayyafa fesawa lokacin tari, hancinsa ko magana; lokacin haɗuwa a tazarar mita 1 zuwa 2.
Bincike ya nuna cewa tari ba tare da rufe baki ba zai iya haifar da fesawa daga mita 4.5 zuwa mita 8.2.
Wasu sun yi tunanin cewa kwayar cutar za ta iya yaduwa ta hanyar fesawa da ke cikin iska na dogon lokaci, wanda zai iya haifar da yayin magana. Hakanan yana iya haifar da fesawar numfashi yayin numfashi, gami da lokacin magana, kodayake ba a yawan watsa kwayar cutar ta iska.
Ana iya shafa shi a bakin mutane ko kuma a hancin mutane ko kuma a sha shi cikin huhu.
Wasu hanyoyin magani kamar su CPR da CPR suna iya sa a saki ƙwayoyin numfashi a matsayin fesawa kuma hakan yana sa su yadu ta iska.
Hakanan yana iya yaduwa idan mutum ya taɓa gurbataccen abu, gami da fata, sannan ya taɓa idanunsa, hanci, ko bakinsa.
Ko da yake akwai damuwa game da yiwuwar yaduwar daga bayan gida zuwa baki, ana ganin cewa wannan haɗarin yana da iyaka.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV-2 daga bayan gida zuwa baki. Kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake tana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
An tabbatar da cewa mutane sun kamu da cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya yaduwa kafin bayyanar cututtuka mai tsanani.
Akwai rahotanni kaɗan na marasa alamun cutar da aka tabbatar a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano cutar ba tare da alamun cutar ba yayin binciken masu haɗuwa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta tabbatar da cewa duk da rashin tabbas game da yadda cutar ke yaduwa, mutum ɗaya zai iya cutar da mutane biyu zuwa uku gaba ɗaya. Kwayar cutar tana ci gaba da kasancewa a saman daga awanni zuwa kwanaki.
Musamman, an gano cewa za a iya gano kwayar cutar har tsawon kwanaki uku a kan filastik (polypropylene) da ƙarfe mai ƙarfe 304, kwana ɗaya a kan kwali, har zuwa awanni huɗu a kan tagulla.
Koyaya, wannan ya bambanta dangane da danshi da zafin jiki. An tabbatar da cutar COVID-19 a cikin dabbobin gida da sauran dabbobi.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar ga mutane, duk da haka hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun taɓa dabbobi, kamar lokacin taɓa wasu abubuwa da wani mai cutar ya taɓa.
Cutar coronavirus 2 da ke da alaƙa da cutar SARS-CoV-2 sabuwar cuta ce, an fara gano ta daga mutane uku da ke fama da cutar huhu a Wuhan.
Kwayar cutar SARS-CoV-2 tana da dukkan halaye tare da coronaviruses da ke cikin yanayi. A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, yana narkar da murfinta na kariya.
Ana zaton cewa yana da asalin dabba.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar Corona tana da alaƙa da kwayoyin halitta tare da kwayar cutar Corona beta, kuma tana cikin ƙananan kwayar cutar Coronaviruses (B-strain) da kuma nau'ikan biyu na bat.
Ya dace da kashi 96% a cikin dukkanin kwayoyin halitta tare da wasu samfuran coronaviruses a cikin Batman (Pat Cove Rat G13)
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya kawai a cikin amino acid a wasu sassan tsarin kwayoyin halittar mutum tsakanin ƙwayoyin cuta da suka samo asali daga masu cin tururuwa da kuma ƙwayoyin cuta na ɗan adam.
Kwatanta dukkanin kwayoyin halitta ya kawo kashi 92 cikin dari na kwayoyin halitta tsakanin kwayar cutar SARS-CoV-2 da kwayar cutar ant-CoV-2 amma wannan bai isa ya tabbatar da cewa kwayar cutar ant-CoV ce ta haifar da cutar ba.
Ana iya gano kamuwa da kwayar cutar ta hanyar bayyanar cututtuka, kodayake a ƙarshe ana tabbatar da shi ta hanyar maganin polymerase reverse transcriptase (RT-PCR) na ɓoyayyen ƙwayar cuta ko CT.
Wani bincike da aka yi a birnin Wuhan da ya kwatanta polymerase chain reaction da CT ya nuna cewa CT ya fi na polymerase chain reaction hankali, ko da yake ba shi da kyau, saboda yawancin siffofinsa suna da alaƙa da cututtukan huhu da sauran matakan rashin lafiya.
A watan Maris na 2020, Kwalejin Hoton Hoton Amurka ta ba da shawarar "kada a yi amfani da CT don gano COVID-19 ko a ɗauka a matsayin gwajin farko don gane cutar".
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwajin RNA na SARS-CoV-2, a karo na farko a ranar 17 ga Janairu.
Gwajin yana amfani da kwayar halitta mai juyawa ta polymerase chain reaction (RT-PCR) a ainihin lokacin.
Ana iya yin gwajin ne a kan jini ko kuma na numfashi.
Ana samun sakamako a cikin sa'o'i da yawa ko kwanaki.
Ana yin wannan gwajin ne ta hanyar shafawa da hanci, kuma ana iya amfani da shafawa daga makogwaro.
Tun daga ranar 6 ga Afrilu, 2020, babu ɗayan da aka tabbatar da ingancinsa don amfani da shi sosai.
Gwajin da aka yi da Silex ya sami izini don amfani da gaggawa a Amurka a cikin dakunan gwaje-gwaje masu izini kawai.
Abubuwan da ke nunawa na radiography da CT don mutanen da ke da alamun cutar sun haɗa da rashin haske na gefe kamar ƙarancin gilashin gilashi da kuma ɓarna mai haske.
Ƙungiyar Radiology ta Italiya tana tattara bayanan duniya na kan layi na sakamakon hotuna na waɗanda suka kamu da cutar.
Yin amfani da hoton radiation ba tare da amfani da polymerase chain reaction ba, yana da iyakantaccen aiki don gano COVID-19 saboda yana shafar wasu cututtuka kamar kamuwa da cutar gland.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da polymerase chain reaction kuma ya tabbatar da cewa duk da cewa daukar hoto bai da cikakkiyar tabbaci game da kamuwa da cutar, yana da sauri kuma ya fi dacewa, wanda aka ba da shawarar a matsayin kayan aikin gwaji a yankunan da ke fama da cutar.
An tsara hanyoyin sadarwa na AI don gano halayen hoto na kwayar cutar a duka hotunan radiation da CT.
Dabaru na hana yaduwar cutar sun haɗa da tsabtace jiki, wanke hannu, guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba, amfani da tawul lokacin da kake tari ko hancinka kuma zubar da shi kai tsaye cikin kwandon shara.
Ana ba da shawara ga waɗanda suka riga sun kamu da cutar su sa abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar nisantar da jiki don hana yaduwar kamuwa da cuta. Gwamnatoci da yawa sun hana balaguron da ba dole ba daga ƙasashe da yankuna da cutar ta shafa ko kuma sun ba da shawarar kada su yi balaguro.
Duk da haka, cutar ta kai ga yaduwar al'umma a yawancin sassan duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma wasu mutane ba su san inda ko yadda suka kamu da ita ba. Ana ba da shawara ga masu kula da lafiya, waɗanda ke kula da wanda ke da wataƙila yana da cutar, su yi amfani da matakan da aka tsara, kariya ta haɗuwa da kariya ta ido. Binciken waɗanda ke da cutar hanya ce mai tasiri don taimaka wa hukumomin kiwon lafiya su gano asalin kamuwa da cuta da hana yaduwar ta.
Amfani da gwamnatoci ke yi da bayanan wurin wayar salula don bin diddigin ya haifar da damuwa game da sirri, inda Amnesty International da wasu kungiyoyi sama da 100 suka fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
An tsara ko kuma an gabatar da aikace-aikacen wayar hannu da yawa don amfani da son rai, kuma tun daga 7 ga Afrilu, 2020, sama da ƙungiyoyi goma sha biyu sun yi aiki don samar da hanyoyin magance sirrin sirri, kamar amfani da Bluetooth don yin rikodin kusancin mai amfani da sauran wayoyin hannu.
Masu amfani za su sami saƙo idan sun kusanci wani da aka tabbatar yana da cutar COVID-19. Ana yada ra'ayoyin da ba daidai ba game da yadda za a hana kamuwa da cutar; misali, wanke hanci da kuma gurguntawa da ruwan baki ba mafita ba ce mai amfani.
Har yanzu babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da yawa suna aiki kan samar da allurar rigakafi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
Cibiyar Kula da Cututtuka ta ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa aƙalla na dakika ashirin, musamman bayan sun je bayan gida ko kuma idan sun yi datti a hannu, kafin su ci abinci, bayan sun hura hanci ko kuma sun tari ko kuma sun yi fitsari.
Wannan saboda sabulu na gida yana kashe kwayar cutar a waje da jiki, yana lalata garkuwar jikinta.
Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar yin amfani da maganin kashe ƙwari da ke ɗauke da giya aƙalla kashi 60 cikin ɗari idan ba a sami sabulu da ruwa ba.
Hukumar Lafiya ta Duniya ta shawarci mutane su guji taɓa idanunsu, hancinsu ko bakinsu da hannayensu da ba a wanke ba.
Ana iya tsabtace farfajiyoyi da yawa ta amfani da kayan tsabtace jiki (a cikin minti ɗaya na sanya kayan tsabtace jiki a kan bakin karfe), ciki har da; ethanol 6271%; isopropanol 50100%; sodium hypochlorite 0.1%; hydrogen peroxide 0.5%; da iodophobidone 0.27.5%.
Akwai wasu magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate, da ba su da tasiri sosai.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa idan aka yi zargin ko kuma an tabbatar da cewa wani yana da cutar COVID a wani wuri kamar ofis ko cibiyar kula da lafiya, ya kamata a kashe duk wuraren da aka yi amfani da su, kamar ofisoshi, dakunan wanka, wuraren da mutane suke zama tare da na'urorin lantarki kamar su allunan kwamfutar hannu, allon taɓawa, mabuɗan rubutu, na'urorin sarrafawa ta nesa da na'urorin ATM.
Ƙungiyoyin kiwon lafiya sun ce idan mutum yana tari ko hancinsa, ya rufe bakinsa da hancinsa ta wajen sunkuyar da gwiwar hannu a gaban hancinsa ko kuma ta wajen amfani da takardar wanki da kuma zubar da duk wani takardar nan da nan.
Ana ba da shawarar yin amfani da abin rufe fuska na likita ga waɗanda za su iya kamuwa da cutar. Yin amfani da abin rufe fuska yana rage yawan iska da kuma nisan da yake fita daga magana, hancinsa da tari.
Hukumar Lafiya ta Duniya ta ba da umurni game da lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"Shirye-shiryen rufe fuska suna iya rage sha'awar [mutane] su taɓa fuskokinsu, kuma hakan yana da muhimmanci wajen kamuwa da cuta idan ba a tsabtace hannayensu yadda ya kamata ba", in ji Stephen Griffin, masanin ƙwayoyin cuta a Jami'ar Leeds.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa mutane masu lafiya kada su sa abin rufe fuska sai dai idan suna cikin haɗarin kamuwa da cutar, kamar waɗanda ke kula da wanda ke da cutar COVID-19, ko da yake ta kuma yarda cewa saka abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara ƙarfafa mutane su sa abin rufe fuska.
Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka ta ba da shawarar sanya abin rufe fuska na masana'anta. China ta ba da shawarar musamman ga masu lafiya su yi amfani da abin rufe fuska na likita, musamman idan sun haɗu da mutane (a tazarar mita 1 (ƙafa 3) ko ƙasa da haka) kai tsaye.
Hong Kong ta ba da shawarar saka abin rufe fuska na likita lokacin da kake amfani da sufuri na jama'a ko kuma kana zama a wuraren da jama'a suke da yawa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska daga masana'anta a gida kuma su wanke su kowace rana.
An hana fita waje a cikin jama'a ba tare da rufe baki da hanci ba a Jamhuriyar Czech da Slovakia.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska yayin da yake zuwa wuraren jama'a don kare kansa da wasu.
Gwamnatin Austriya ta tilasta wa duk wanda ya shiga kantin sayar da abinci saka abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna da su sanya abin rufe fuska a wuraren jama'a.
Taiwan, wadda ke samar da abin rufe fuska miliyan 10 a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas da su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta sanya sanya abin rufe fuska a waje ya zama tilas, tare da ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya siyan abin rufe fuska ba.
Ana kuma amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisa da jama'a (wanda kuma ake kira nesa da jiki) ya ƙunshi matakan hana kamuwa da cuta da ke nufin rage yaduwar cutar ta hanyar rage haɗuwa tsakanin mutane.
Waɗannan sun haɗa da keɓewa; ƙuntatawa na tafiya; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, ko cibiyoyin kasuwanci.
Mutane za su iya yin amfani da hanyoyin nisantar da kansu ta wajen kasancewa a gida, rage tafiye-tafiye, guje wa wuraren da mutane suke da yawa, yin gaisuwa ba tare da taɓa juna ba, da kuma nisanta kansu da wasu.
A yanzu haka gwamnatoci da yawa suna tilasta ko kuma ba da shawarar nisantar da mutane a yankunan da cutar ta bulla.
An rage yawan taron da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar daga mutane 250 (idan ba a gano yaduwar COVID-19 a yankin ba) zuwa mutane 50, da kuma mutane 10 daga baya.
Tsofaffi da waɗanda ke fama da cututtukan da ke fama da su kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da raunana tsarin garkuwar jiki suna fuskantar ƙarin haɗarin kamuwa da cututtuka masu tsanani da rikitarwa kuma Cibiyar Kula da Cututtuka da Cututtuka ta ba da shawarar su zauna a gida kamar yadda ya yiwu a wuraren da cutar ta barke tsakanin al'ummomi. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin kalmar "nisanci" da kalmar "nisan jiki", suna mai bayyana cewa makasudin shine rage hulɗar jiki tare da kiyaye alaƙar zamantakewa, a zahiri ko a nesa.
Amfani da kalmar "nisanci" ya nuna cewa mutane su shiga cikin keɓewar zamantakewar gaba ɗaya, maimakon ƙarfafa su su haɗu da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani a lokacin annobar.
Wannan ya haɗa da shawarwari cewa kada ka yi jima'i sai da wanda kake zama da shi wanda ba shi da cutar ko kuma wanda yake da alamun cutar.
Ana ba da shawarar keɓewa a gida ga waɗanda ke da COVID-19 da kuma waɗanda ake zargi da kamuwa da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai game da keɓe kai. Gwamnatoci da yawa sun ba da umarnin keɓe kai ko kuma sun ba da shawarar ga duk mazauna da ke zaune a yankunan da cutar ta shafa.
An ba da umarnin keɓe kai mafi ƙarfi ga waɗanda ke cikin haɗari.
Ana ba da shawara ga waɗanda suka taɓa yin cuta da wanda ke da cutar COVID-19 da waɗanda suka yi tafiya zuwa wata ƙasa ko yanki da ke da yaduwar cutar su keɓe kansu na kwanaki 14 daga lokacin da za su iya kamuwa da cutar.
Hanyoyin da za a bi don magance cutar su ne hanawa ko hanawa da kuma rage yaduwar cutar.
Ana amfani da hana yaduwar cutar a farkon lokacin barkewar cutar kuma ana nufin bin sawun waɗanda ke da cutar da keɓe su da kuma gabatar da wasu matakan hana kamuwa da cuta da allurar rigakafi don hana cutar yaduwa ga sauran jama'a.
Sa'ad da ya zama ba zai yiwu a hana yaduwar cutar ba, sai a mai da hankali ga rage yaduwar cutar: ana yin matakan rage yaduwar cutar da kuma rage tasirin ta a tsarin kiwon lafiya da kuma al'umma.
Za a iya yin haɗuwa da matakan hanawa da ragewa a lokaci guda.
Yin amfani da maganin cutar yana buƙatar ɗaukar matakan da suka fi ƙarfin juyawa hanyar cutar ta hanyar rage yawan ƙwayoyin cuta zuwa ƙasa da 1. Wani ɓangare na kula da cututtukan cututtuka yana ƙoƙarin rage ƙimar cutar, wanda aka sani da daidaitawa.
Wannan yana rage haɗarin damuwa ga ayyukan kiwon lafiya kuma yana ba da ƙarin lokaci don haɓaka alluran rigakafi da magunguna.
Abubuwan da ba magunguna ba waɗanda za su iya magance barkewar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓe kai; ayyukan al'umma da ke nufin nisantar jiki kamar rufe makarantu da soke manyan taron jama'a; da haɗin kan al'umma don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace rufi. An ɗauki ƙarin tsauraran matakai da nufin hana barkewar cutar a China da zarar tsananin cutar ya zama bayyananne, kamar aiwatar da keɓewa ga birane duka da sanya dokar hana fita.
Sauran ƙasashe ma sun ɗauki matakan da suka shafi rage yaduwar cutar.
Koriya ta Kudu ta gabatar da gwajin jama'a da keɓewar gida, kuma ta ba da faɗakarwa game da motsin waɗanda ke da cutar.
Singapore ta ba da tallafi na kuɗi ga waɗanda suka keɓe kansu kuma ta ɗora manyan tarar waɗanda ba su yi hakan ba.
Taiwan ta kara samar da abin rufe fuska kuma ta kara yawan kayayyakin kiwon lafiya. Kwatantawar Burtaniya da Amurka sun nuna cewa ragewa (rage yaduwar cutar amma ba dakatar da ita ba) da kuma dakile (juya cutar) suna fuskantar manyan kalubale.
Manufofin rage yawan cututtuka na iya rage yawan bukatar kiwon lafiya da kashi biyu cikin uku da kuma mutuwar mutane da rabi, amma har yanzu suna haifar da dubban daruruwan mutuwar da kuma matsa lamba ga tsarin kiwon lafiya.
Ana iya son hana yaduwar cutar amma ya kamata a ci gaba da yin hakan har sai cutar ta yadu a cikin mutane (ko har sai an sami allurar rigakafi, idan ta fara faruwa), saboda yaduwar cutar tana saurin dawowa idan aka sauƙaƙa matakan.
Matsaloli na dogon lokaci na hana annobar suna haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar da aka amince da ita don COVID-19, amma ana ci gaba da ƙoƙarin haɓakawa, gami da gwajin magungunan da ke akwai.
Shan magani da ruwa da kuma hutawa zai iya taimaka maka ka rage ciwon sanyi.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, ruwan jini, da taimakon numfashi.
Yin amfani da magungunan ƙwayoyi na iya sa sakamakon ya yi muni.
Ana gwada magunguna da yawa da aka riga aka amince da su don magance wasu cututtukan ƙwayoyin cuta don amfani da su a maganin COVID-19.
Hukumar Lafiya ta Duniya ta kuma ba da rahoton cewa wasu "magungunan gargajiya da na gida" na iya ba da sauƙi ga alamun da SARS-CoV-19 ke haifarwa.
Ƙara iya aiki da daidaita cibiyoyin kiwon lafiya don biyan bukatun marasa lafiya na COVID-19 an bayyana su a matsayin manyan matakan amsawa ga barkewar cutar.
Cibiyar Kula da Cututtuka ta Turai da Hukumar Kula da Lafiya ta Duniya ta fitar da jagororin asibitoci da sabis na kula da kiwon lafiya na farko don canja wurin albarkatu a matakai da yawa, gami da mai da hankali kan ayyukan gwaji na COVID-19, kawar da hanyoyin zaɓi idan ya yiwu, warewa da keɓewar mutanen da ke da COVID-19, haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan kayan aikin numfashi da gadaje.
Akwai ra'ayoyi da yawa game da inda yanayin farko ya samo asali (wanda ake kira mai haƙuri zero).
Ana iya sanin cewa an samu mutum na farko da ya kamu da sabon kwayar cutar korona a ranar 1 ga watan Disamba na shekarar 2019 a birnin Wuhan, a lardin Hubei, a kasar Sin.
A cikin wata guda, adadin masu kamuwa da cutar korona a Hubei ya karu a hankali.
Wadannan sun fi dacewa da kasuwar sayar da kayan kifin teku ta Wuhan, wanda kuma ke sayar da dabbobi masu rai. Wata ka'idar ta ce kwayar cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma a wasu kalmomin, ta samo asali ne daga dabbobi. An lura da rukunin da ke fama da cutar huhu ta wata sananniyar dalili a ranar 26 ga Disamba kuma an kula da su ta hanyar Dr. Zhang Jixian a asibitin lardin Hubei, wanda ya sanar da Cibiyar Kula da Cututtuka ta Jianghan a Wuhan a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wasu likitoci a asibitin Wuhan suka gargadi abokan aikinsu game da "Covid-19 mai kama da SARS".
'Yan sanda sun gargadi likitoci takwas, ciki har da Li Wenliang, don yada jita-jita, kuma wani likita, Ai Feng, shugabanninta sun tsawata mata saboda tayar da hankali.
Daga baya, kwamitin kiwon lafiya na Wuhan ya ba da sanarwar jama'a a ranar 31 ga Disamba kuma ya sanar da WHO.
An ba da rahoton isassun cututtukan cutar huhu da ba a sani ba ga hukumomin kiwon lafiya a Wuhan wanda ya sa suka fara bincike a farkon watan Janairu. A farkon lokacin barkewar cutar, yawan masu kamuwa da cutar yana ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, kwayar cutar ta yadu zuwa wasu lardunan China, tare da taimakon motsi a lokacin Sabuwar Shekarar China da kuma Wuhan a matsayin cibiyar sufuri da kuma babbar hanyar jirgin ƙasa.
A ranar 20 ga watan Janairu, kasar Sin ta samu kusan sabbin mutane 140 a rana guda, ciki har da mutum biyu a birnin Beijing da kuma mutum daya a birnin Shenzhen.
Bayanai na hukuma da aka bayyana daga baya sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar ta hanyar Janairu 20, 2020. Kamar yadda na 26 ga Maris, Amurka ta zarce China da Italiya a cikin adadin adadin mutanen da aka tabbatar da cutar a duniya. Kamar yadda na 9 ga Afrilu, 2020, rahotanni sun nuna cewa akwai sama da mutane miliyan 1.61 a duk duniya, tare da mutane sama da 97,000 da suka mutu da kuma sama da mutane 364,000 da suka warke.
Kimanin kasashe da yankuna 200 sun yi rahoton aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun ƙuntata 'yancin motsi kuma sun kafa takunkumin kan iyaka.
Sakamakon amsawar ƙasa ya haɗa da matakan kariya, kamar keɓewa (wanda aka sani da umarnin zama a gida, ko umarnin ɓoyewa, ko kullewa) da dokar hana fita. Kamar yadda ta kasance a ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, sun shiga cikin wasu nau'ikan kullewa a Amurka, sama da mutane miliyan 50 sun shiga cikin kullewa a Philippines, kusan mutane miliyan 59 sun shiga cikin kullewa a Afirka ta Kudu, kuma mutane biliyan 1.3 sun shiga cikin kullewa a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a dukan duniya sun shiga cikin wani irin kullewa, kuma adadin ya ƙaru zuwa biliyan 2.6 bayan kwana biyu - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
Rahoton farko na tabbatar da cutar COVID-19 ya fara ne a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya kasance a ranar 17 ga Nuwamba.
Likita Zhang Jixian ta lura da tarin cututtukan huhu da ba a san dalilin su ba a ranar 26 ga Disamba, kuma asibitin ta ya sanar da Cibiyar Kula da Cututtuka ta Jianghan Wuhan a ranar 27 ga Disamba.
Gwajin farko na kwayoyin halitta na samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai kwayar cutar coronavirus mai kama da SARS.
Kwamitin Kiwon Lafiya na Wuhan ya ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
A yayin da ake samun irin wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan game da "fadada jita-jita" game da barkewar cutar.
Hukumar Lafiya ta Kasa ta kasar Sin a farko ta yi ikirarin cewa babu "tabbaci bayyananne" na yaduwar cutar daga mutum zuwa wani.
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da wani babban kamfen da Sakatare Janar na Jam'iyyar Kwaminis ta Sin Xi Jinping ya bayyana a matsayin "yaƙin mutane" don hana yaduwar cutar.
A cikin abin da aka bayyana a matsayin "mafi girma keɓewa a tarihin ɗan adam", an ba da sanarwar dokar hana fita daga Wuhan a ranar 23 ga Janairu, wanda ya shafi birane 15 a Hubei, ya shafi mutane kusan miliyan 57.
An hana amfani da motocin masu zaman kansu a cikin gari.
An soke bikin sabuwar shekara ta kasar Sin a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, asibitin Huchinchan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti kuma, asibitin Lichenchan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka kafa, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakan da za su dakile barkewar COVID-19, ciki har da bayar da sanarwa ga matafiya da kuma tsawaita hutun bikin bazara.
An rufe jami'o'i da makarantu a duk fadin kasar.
Yankunan Hong Kong da Macao sun ɗauki matakai da yawa, musamman game da makarantu da jami'o'i.
An ɗauki matakan aiki daga nesa a yankuna da dama na ƙasar Sin.
An sanya takunkumin hana tafiya a cikin da kuma wajen Hubei.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk faɗin ƙasar Sin.
An tsaurara matakan sarrafa zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) sun shiga cikin wasu nau'ikan ƙuntatawa. Bayan barkewar cutar a duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana "kawo" cutar daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar keɓewa ta kwanaki 14 ga duk wanda ya dawo birnin daga wasu ƙasashe. A ranar 23 ga watan Maris, mutum ɗaya ya kamu da cutar a ƙasar Sin a cikin kwanaki biyar da suka gabata, ta hanyar matafiyi da ke dawowa Guangzhou daga Istanbul.
A ranar 24 ga watan Maris na 2020, Shugaban Majalisar Jiha na kasar Sin Li Keqiang ya ba da sanarwar raguwar yaduwar cututtukan da ke yaduwa a cikin gida da kuma kula da barkewar cutar a kasar Sin.
An sassauta takunkumin tafiye-tafiye a Hubei a ranar, ban da Wuhan, bayan watanni biyu da sanya dokar kulle. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 dakatar da shigar da masu biza ko izinin zama daga ranar 28 ga Maris zuwa gaba, ba tare da wani takamaiman bayani game da lokacin da wannan manufar za ta kare ba.
Waɗanda suke son shiga ƙasar Sin za su nemi biza a ofisoshin jakadancin ƙasar Sin.
Gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu da su ci gaba da aiki a ranar 30 ga watan Maris, kuma ta ba da wasu kudade don karfafawa kamfanoni. Majalisar Jiha ta ayyana ranar makoki da za ta fara da minti uku na shiru a ranar 4 ga Afrilu da karfe 10:00, daidai da bikin Qing Ming, kodayake gwamnatin tsakiya ta bukaci iyalai su nuna girmamawa ta yanar gizo ta hanyar nisantar jiki don kauce wa sake barkewar COVID-19.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar Lafiya ta Kasa ta sanar da karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya danganta da taron da aka yi a Daegu na wata sabuwar kungiyar addini da ake kira Shincheonji Jesus Church.
Ana zargin cewa mutanen Shincheongji da ke ziyartar Daegu daga Wuhan ne suka haddasa cutar.
Tun daga ranar 22 ga watan Fabrairu, mutane 1,261 ko kusan kashi 13 cikin dari na masu bin coci 9,336 sun ba da rahoton bayyanar cututtuka. Koriya ta Kudu ta sanar da matakan tsaro mafi girma a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, inda suka kai 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Koriya ta Kudu ta aiwatar da shirin da ake ganin ya fi girma kuma mafi kyau a duniya na tantance mutane don cutar, ware duk wanda ya kamu da cutar da kuma bin diddigin waɗanda suka yi hulɗa da su da kuma keɓe su.
Hanyoyin gwajin sun haɗa da buƙatar sabbin masu shigowa ƙasashen duniya su ba da rahoton kansu game da alamun cutar ta hanyar aikace-aikacen wayar hannu, gwada mutane a cikin motocin su don sakamakon gwajin ya kasance a rana mai zuwa, da haɓaka ƙarfin gwaji zuwa mutane 20,000 kowace rana.
Shirin Koriya ta Kudu ya kasance nasara wajen sarrafa barkewar cutar duk da cewa ba a aiwatar da keɓewa a cikin birane gaba ɗaya ba. Da farko dai al'ummar Koriya ta Kudu sun rabu biyu game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman ko dai a tsige Moon, wanda ake zargi da cin zarafin gwamnati a lokacin barkewar cutar, ko kuma ya yaba da yadda ya amsa.
A ranar 23 ga watan Maris, an sanar da cewa Koriya ta Kudu tana da mafi karancin adadin masu kamuwa da cutar a rana guda cikin makonni hudu.
A ranar 29 ga watan Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu, duk sabbin masu shigowa daga ƙasashen waje za su kasance cikin keɓewa na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatu daga ƙasashe 121 daban-daban don taimakawa gwajin cutar.
Iran ta bayar da rahoton farkon kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda mutane biyu suka mutu a ranar, a cewar ma'aikatar lafiya da ilimin likitanci.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da sauran al'adu da wasanni, sallar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware Riyal tiriliyan biyar domin yaki da cutar.
Shugaba Hassan Rouhani ya bayyana a ranar 26 ga Fabrairun 2020 cewa babu wani shiri na killace yankunan da cutar ta shafa, za a killace mutane ne kawai.
An sanar da tsare-tsaren rage zirga-zirgar jiragen sama tsakanin biranen a watan Maris, duk da ci gaba da cunkoson ababen hawa tsakanin biranen kafin sabuwar shekarar Farisa ta Nowruz.
An bude wuraren ibada na Shi'a a Qom har zuwa ranar 16 ga watan Maris na 2020. A watan Fabrairu Iran ta zama cibiyar yaduwar cutar bayan China.
A yayin da ake zargin Iran ta rufe matsalar, fiye da kasashe goma sun fara bibiyar cututtukan da suka dawo daga Iran tun daga ranar 28 ga watan Fabrairu, wanda ke nuna cewa cutar za ta iya wuce adadin mutane 388 da gwamnatin Iran ta ruwaito a ranar.
An rufe majalisar dokokin Iran, inda aka bayar da rahoton cewa mambobi 23 daga cikin 290 sun kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkukun Iran da su saki masu kare hakkin dan adam da aka tsare saboda adawa da zaman lafiya ba tare da wani sharadi ba, da kuma sakin fursunonin da suka cancanta.
Ta ce akwai babban hadarin yaduwar cutar a wuraren da ba a iya shiga ba kamar gidajen yari, wanda kuma ba su da isasshen kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shi ne mafi yawan wadanda aka taba samu a kasar tun lokacin da annobar ta fara.
A kalla 'yan siyasa 12 da tsoffin jami'an gwamnati sun mutu a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran tana samun sabbin kamuwa da cutar korona 50 a kowace awa, kuma mutum daya ke mutuwa a kowace minti 10.
A cewar wani jami'in Hukumar Lafiya ta Duniya, adadin masu cutar a Iran zai iya zama ninki biyar na adadin da aka sanar.
Ana kuma tunanin cewa takunkumin da Amurka ta kakaba wa Iran na iya shafar karfin kudin kasar na magance cutar.
Hukumar kare hakkin bil adama ta Majalisar Dinkin Duniya ta bukaci a sassauta takunkumin tattalin arziki kan kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da gwaje-gwajen SARS-CoV-2 na masu yawon bude ido 'yan China biyu a Rome suka fito da kyau.
Yanayin ya fara karuwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da dukkan jiragen sama daga China da kuma zuwa kasar ta kuma ayyana dokar ta baci.
Daga baya an gano wasu mutane da ba su da alaƙa da COVID-19, farawa da tabbatar da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar ministoci ta ba da sanarwar sabon doka don ƙuntata barkewar cutar, gami da keɓe mutane sama da 50,000 daga garuruwa 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "Ba za a bar kowa ya shiga ko ya fita daga wuraren da cutar ta bulla ba.
A ranar 4 ga watan Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da mutuwar a Italiya ta kai 100.
An shirya gudanar da duk manyan wasannin wasanni, gami da wasannin gasar kwallon kafa ta farko, a rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci, ban da manyan kantuna da kantin magani. A ranar 6 ga Maris, Kwalejin Italiya na Anesthesiology, Sedation, Rehabilitation and Intensive Care (SIAARTI) ta buga shawarwarin ɗabi'ar likita game da hanyoyin rarrabewa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin ƙasa da ta fi yawan mutanen da suka mutu sakamakon cutar korona a duniya bayan da ta ba da rahoton mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, Rasha ta aika da jiragen sama tara na soji dauke da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, an tabbatar da kamuwa da cutar a Italiya, mutum 128,948, mutum 15,887 sun mutu, kuma mutum 21,815 sun warke, kuma yawancin waɗannan sun kasance a yankin Lombardy.
Rahoton CNN ya nuna cewa haɗuwa da yawan tsofaffi da rashin iya gwada duk waɗanda ke da cutar a Italiya ya taimaka wajen ƙaruwar yawan mutuwar.
Amsar da Burtaniya ta bayar ga kwayar cutar ta kasance mafi sassaucin hali a cikin ƙasashen da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane nau'i na nisantar zamantakewa ko matakan keɓewa ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda rashin gaggawa da rashin ƙarfi wajen amsa damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar guje wa balaguro ko hulɗar zamantakewar da ba ta da mahimmanci, yana ba da shawarar mutane su yi aiki daga gida gwargwadon iko kuma su guji wurare da yawa, kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa za ta rufe dukkan wuraren nishaɗi kamar mashaya da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata zuwa iyakar £ 2,500 a wata don rage rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nisantar zamantakewa, inda aka hana tarurruka sama da mutane biyu kuma an hana tafiya da yin aiki a waje da gida sai dai idan ya zama dole.
Ba kamar matakan da suka gabata ba, 'yan sanda sun aiwatar da waɗannan ƙuntatawa ta hanyar tara kuɗi da tarwatsa tarurruka.
An ba da umarnin rufe yawancin kasuwancin, ban da kasuwancin "mahimmanci", gami da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin mai, da gareji.
A ranar 20 ga Janairu, an tabbatar da sanannen mutum na farko da ya kamu da cutar COVID-19 a jihar Washington da ke arewa maso yammacin Pacific a wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rukunin aikin Gidan Fadar White House don yaki da cutar coronavirus a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, kuma ta sanya takunkumi kan shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Amurka (CDC), babbar cibiyar kula da lafiyar jama'a ta Amurka, ta sanar da cewa ta samar da nata kayan gwajin.
Duk da haka, Amurka ta jinkirta fara gwajin, wanda ya ɓoye ainihin yaduwar cutar a lokacin.
Gwajin ya lalata gwajin gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga gwaje-gwajen gwaji na gwamnati (ta hanyar ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntataccen ka'idodin mutane don cancanta don gwaji har zuwa farkon Maris (ana buƙatar umarnin likita bayan haka).
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwaji ƙasa da 4,000 a Amurka.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa an yi gwaje-gwaje ƙasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cututtuka kuma suna da umarnin likita suna jira na sa'o'i ko kwanaki don yin gwaji". Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, matakin da wasu jihohi suka bi.
Makarantun birnin Seattle sun soke karatun a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, an sanar da Amurka game da tsammanin tasirin sabon coronavirus a ƙasar ta masana ilmin cututtuka a Jami'ar Imperial College London.
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Kuɗaɗen Shirye-shiryen Cutar Korona da Amsar ta, wanda ya ba da dala biliyan 8.3 na kuɗin gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun hana ma'aikata tafiya, sun soke taro, kuma sun umurci ma'aikata su yi aiki daga gida.
An soke ayyukan wasanni da lokutan wasanni. A ranar 11 ga Maris, Trump ya ba da sanarwar hana tafiye-tafiye zuwa yawancin Turai, ban da Burtaniya, na kwanaki 30, daga ranar 13 ga Maris.
A rana mai zuwa, an ƙara ƙuntatawa zuwa Burtaniya da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya ba da damar amfani da kudaden tarayya don amsa rikicin.
Tun daga ranar 15 ga watan Maris, kamfanoni da yawa sun rufe ko rage sa'o'in aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da cutar a duk jihohi 50 da gundumar Columbia. A ranar 23 ga watan Maris, an samu mutum 10,700 da suka kamu da cutar a birnin New York, wanda ya fi yawan mutanen da ke Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya ce ana ganin cewa nisantar da mutane daga juna ta yi nasara, inda aka kiyasta cewa an rage adadin masu kamuwa da cutar daga kwanaki 2.0 zuwa 4.7.
A ranar 28 ga Maris, an tabbatar da kamuwa da cutar a cikin New York City, kuma mutane 672 sun mutu saboda kwayar cutar. A ranar 26 ga Maris, an ba da rahoton ƙarin kamuwa da cutar coronavirus a Amurka fiye da kowace ƙasa a duniya, gami da China da Italiya.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga watan Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita umarnin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan ranar, jirgin ruwan da ake kira USS Comfort, wato, wani jirgin asibiti mai gadaje 1,000, ya sauka a birnin New York.
A ranar 3 ga Afrilu, Amurka ta samu mutuwar mutum 884 sakamakon cutar korona a cikin sa'o'i 24.
A jihar New York, adadin masu kamuwa da cutar ya zarce mutane 100,000 a ranar 3 ga Afrilu. An soki Fadar White House saboda rage girman barazanar da kuma sarrafa labaran labarai ta hanyar umarci jami'an kiwon lafiya da masana kimiyya da su daidaita bayanan jama'a da wallafe-wallafe game da kwayar cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
Gwamnatin Trump ba ta yi farin ciki da rikicin ba, kuma hakan ya haifar da rikici tsakanin jam'iyyun.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyakin da ake bukata, ciki har da kayayyakin kiwon lafiya na asali, daga China.
An yi amfani da nazarin yanayin tafiye-tafiyen iska don zana taswirar yanayin yaduwa da hasashen su kuma an buga shi a cikin mujallar Magungunan Balaguro a tsakiyar Janairu 2020.
Dangane da bayanan 2018 na International Air Transport Association, Bangkok, Hong Kong, Tokyo, da Taipei suna da fasinjoji da yawa daga Wuhan.
An kuma ba da rahoton cewa Dubai, Sydney, da Melbourne sanannun wurare ne ga matafiya daga Wuhan.
An ba da rahoton cewa Bali ita ce mafi ƙarancin ƙarfi a cikin shahararrun wurare sama da 20 dangane da shiri, yayin da biranen Ostiraliya suka fi ƙarfin ƙarfi. Ostiraliya ta fitar da shirinta na gaggawa don sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ta ce ba a san abubuwa da yawa game da cutar COVID-19 ba, kuma Ostiraliya za ta ƙara tsaurara matakan kula da kan iyakoki da sadarwa don magance cutar.
A ranar 21 ga Maris, an sanar da dokar ta baci ta lafiyar dan adam a Ostiraliya.
Saboda yadda keɓaɓɓun hanyoyin sufuri na jama'a suka shafi keɓewar kai a Wuhan da Hubei, ƙasashe da yawa sun shirya kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen sama da aka yi haya daga ƙasashensu, tare da ba da izini daga hukumomin China.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostareliya, Faransa, Argentina, Jamus, da Thailand na cikin ƙasashe na farko da suka fara shirin kwashe 'yan ƙasarsu.
Pakistan ta sanar da cewa ba za ta kori wani daga cikin 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu da 'yan Poland hudu, da wani dan kasar Sin, da kuma wani dan kasar Indiya.
'Yan kasar Poland, Sinawa da Indiya sun sauka daga jirgin a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka tafi Wuhan a wani sansanin soji kusa da Brasilia.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko, 39 daga jirgin sama na biyu da gwamnatin Amurka ta yi hayar) daga Wuhan zuwa sansanin sojojin Kanada na Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 daga Wuhan ya sauka a sansanin sojojin Kanada na Trenton.
Hukumomin Australia sun kwashe 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu zuwa cibiyar tsare mutane ta tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin wurin keɓewa, inda suka zauna na kwanaki 14.
Jirgin sama na New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma an killace fasinjojinsa (gami da mutanen da ke daga Ostiraliya da Pacific) a sansanin jiragen ruwa a Wanjaparasawa a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama ya sauka a Trenton, Ontario dauke da fasinjojin Kanada 129 da aka kwashe daga jirgin Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris, wani jirgin saman jirgin saman Afirka ta Kudu wanda gwamnatin Afirka ta Kudu ta yi hayar ya dawo da' yan Afirka ta Kudu 112.
An yi gwajin likita kafin a tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
An mayar da 'yan Afirka ta Kudu da gwajin su ya kasance ba daidai ba.
Sakamakon gwajin ya nuna cewa 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda, da sojoji da ke cikin aikin jin kai waɗanda duk, a matsayin kariya, an tsare su a cikin keɓewa da keɓewa a Ranch Resort na kwanaki 14, ba su kamu da cutar ba.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta ba da rahoton cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad, Tobago, Masar, da Iran) sun aika da taimako ga China.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don aika da agaji zuwa yankunan da ke fama da cutar a kasar Sin. Rahotanni sun ce wata kungiya a yankin Chicago ta samu nasarar aika da abin rufe fuska N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga Hukumar Lafiya ta Duniya don tallafawa binciken allurar rigakafi da kokarin magani, tare da kare "mutanen da ke cikin haɗari a Afirka da Kudancin Asiya".
Intraction ya ruwaito cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta aika da tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba Wuhan abin rufe fuska miliyan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da fiye da tan 13 na kayayyakin kiwon lafiya zuwa Wuhan, Malaysia ta sanar da ba da gudummawar safar hannu miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya da dama ciki har da riguna 10,000, Amurka ta ba da gudummawar tan 17.8 na kayayyakin kiwon lafiya ga China, kuma ta yi alkawarin ba da ƙarin tallafin kuɗi na dala miliyan 100 ga ƙasashen da cutar ta shafa. Bayan da lamura a China suka daidaita, kasar tana aika da taimako ga ƙasashe daban-daban da cutar ta shafa.
A watan Maris, China, Cuba, da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya wajen magance annobar korona.
Wani dan kasuwa mai suna Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa, Habasha, da abin rufe fuska miliyan 6, da riguna 60,000 da Kungiyar Tarayyar Afirka ta rarraba.
Daga baya ya aika wa Panama da kayan gwaji 5,000, da abin rufe fuska 100,000 da na'urorin numfashi guda biyar.
Kasashen Holland, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwaji da aka yi a China.
Alal misali, Spain ta janye gwaje-gwaje 58,000 na cutar korona da aka yi a China da ke da daidaito kashi 30 cikin ɗari kawai, kuma a lokaci guda, Netherlands ta mayar da abin rufe fuska 600,000 da aka yi a China da ke da lahani.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba da aka yi zaton sun fito ne daga China, amma a zahiri sun fito ne daga Colombia.
A wani bangare kuma, sassan Latin Amurka da Afirka sun yi maraba da karɓar taimakon China. A ranar 2 ga Afrilu, Bankin Duniya ya ƙaddamar da ayyukan tallafi na gaggawa ga ƙasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da hukumomin kasar Sin ke yi na sarrafa cutar.
Hukumar Lafiya ta Duniya ta lura da bambanci tsakanin barkewar cutar SARS tsakanin 2002 da 2004, inda aka zargi hukumomin kasar Sin da yin watsi da ayyukan rigakafi da kuma rikitarwa, da kuma rikicin yanzu, inda gwamnatin tsakiya ta samar da "sabuntawa na yau da kullun don kauce wa firgici kafin hutun Sabuwar Shekarar Lunar".
A ranar 23 ga watan Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da dokar hana zirga-zirga a Wuhan, wakilin Hukumar Lafiya ta Duniya Goodin Galya ya lura cewa yayin da wannan "ba lallai ba ne shawarar da Hukumar Lafiya ta Duniya ta bayar", amma "mai matukar muhimmanci ne ga alƙawarin da aka yi na ƙuntata annobar a inda ta fi mayar da hankali", yana mai bayyana ta a matsayin "marasa misali a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan tabbatar da yaduwar mutum zuwa mutum a wajen China, da kuma karuwar adadin masu cutar a wasu ƙasashe, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta kula da lafiyar jama'a ta duniya (HICP Concern), lamarin na shida na gaggawa na lafiyar jama'a tun lokacin da aka fara kula da wannan matakin a lokacin annobar a 2009.
Darakta Janar na Hukumar Lafiya ta Duniya ya ce, an ɗauki barkewar cutar a matsayin gaggawa ta lafiyar jama'a da ke da muhimmanci a duniya domin "yana da haɗarin yaduwa a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi da ba su da tsarin kiwon lafiya mai ƙarfi.
Dangane da aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a ɗauki matakan da ba su dace ba tare da tafiya da cinikayya ta duniya" kuma "WHO ba ta ba da shawarar rage kasuwanci da motsi ba".
A ranar 5 ga watan Fabrairu, Hukumar Lafiya ta Duniya ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 ga asusun dabarun da aka tsara a ƙasashe masu ƙarancin kuɗi, suna mai nuna gaggawa don tallafawa ƙasashen da "ba su da tsarin gano mutanen da ke da cutar, koda kuwa sun bayyana".
Tedros ya kuma yi jawabai inda ya bayyana cewa "an auna ƙarfinmu ne da ƙarfin wanda ya fi rauni a cikinmu" kuma ya bukaci al'ummar duniya da su "sanya hannun jari a yau ko kuma su biya babban farashi daga baya". A ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya ta ba da sunan cutar, a wani taron manema labarai, COVID-19.
A wannan ranar, Tedros ya ba da rahoton cewa Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da gabatar da "dukan damar tsarin Majalisar Dinkin Duniya a cikin martani".
Sakamakon haka an kafa ƙungiyar kula da rikice-rikice ta Majalisar Dinkin Duniya, wanda ya ba da damar daidaita dukkanin martani na Majalisar Dinkin Duniya, kuma zai ba WHO damar "mai da hankali kan amsawar kiwon lafiya yayin da za a iya amfani da ƙwarewar sauran hukumomi don sanin tasirin zamantakewa, tattalin arziki, da ci gaban ci gaba na barkewar cutar".
A ranar 14 ga watan Fabrairu, an kafa wata ƙungiya ta haɗin gwiwa ta WHO tare da China don kawo masana na duniya da masana daga WHO a ƙasar Sin don taimakawa cikin kula da gida da kuma kimanta "tsananin cutar da kuma saurin kamuwa da ita" ta hanyar karɓar bakuncin bita da tarurruka tare da manyan cibiyoyin ƙasa, da yin ziyarar filin don tantance "tasirin ayyukan amsawa a lardin da birni, gami da birane da yankuna. A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "duniya na bukatar yin ƙarin shiri don annobar cutar coronavirus mai ban tsoro", tana mai cewa tun da wuri don bayyana ta a matsayin annoba, amma ƙasashe su kasance "a cikin shiri".
A cikin martani ga yaduwar barkewar cutar a Iran, Hukumar Lafiya ta Duniya ta aika da ƙungiyar haɗin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga ƙimar barazanar coronavirus a duniya daga "babba" zuwa "mai girma sosai", wannan shine matakin da ya fi girma don faɗakarwa da kimanta haɗari.
Mike Ryan, darektan shirin gaggawa na lafiya na Hukumar Lafiya ta Duniya, ya yi gargadin cewa: "Wannan gwaji ne na gaske ga kowace gwamnati a duniya: don haka dole ne mu kasance a shirye.
Wannan kwayar cutar na iya zuwa kuma dole ne ku kasance a shirye don ta", ya yi kira da a dauki matakan da suka dace da za su iya taimaka wa duniya ta guje wa "mafi muni".
Ryan ya kuma ce bayanan da ake da su yanzu ba su ba jami'an kiwon lafiya hujja su ayyana cutar a matsayin annoba ta duniya ba, yana mai cewa irin wannan sanarwar na nufin "muna yarda da cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana cutar korona a matsayin annoba.
Darakta Janar ya ce WHO "ta damu matuka da irin mummunan yaduwar cutar da kuma yadda ta ke fama da ita, da kuma yadda ta ke kasawa". WHO ta fuskanci tsauraran suka kan abin da ake ganin bai isa magance cutar ba, ciki har da jinkirin ayyana dokar ta baci ta kiwon lafiya, da kuma sanya kwayar cutar a matsayin annoba.
Amsar da aka bayar ta hada da takardar neman izinin janar na Hukumar Lafiya ta Duniya, Tedros Adhanom, ya yi murabus, kuma mutane 733,000 ne suka sanya hannu a kan takardar tun daga ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, masana da dama na kare hakkin bil'adama a Majalisar Dinkin Duniya sun tabbatar da girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin yin aikin ceto rai kuma gwamnati ce ke da wannan hakkin.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama hujja don nuna bambanci ga wata ƙungiya ba.
Masana sun tabbatar da cewa kowa yana da hakkin samun lafiya, gami da nakasassu, 'yan tsiraru, tsofaffi, marasa gida, marasa gida, waɗanda ke rayuwa cikin mawuyacin yanayi, waɗanda aka tsare, da kuma 'yan gudun hijira da sauran rukunin da ba a bayyana su ba waɗanda ke buƙatar tallafin gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kaddamar da wani dandamali don samar da cikakken bayani da kuma lokaci game da manufofin da ake yi a kasashen duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya don magance tasirin kulle-kulle da ƙuntatawa na balaguro, jigon dijital ya haɗa da kayan aikin bin diddigin manufofin ƙasa, da nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martanin duniya don magance cutar coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Sakataren Ofishin Firayim Minista na Burtaniya Michael Gove, da Edward Bolsonaro dan shugaban Brazil Jair Bolsonaro kan yadda ta bi da annobar, wacce ta fara a lardin Hubei na kasar Sin.
An kori wasu shugabannin jam'iyyar CPC a bangarori daban-daban saboda yadda suka bi da kokarin killace mutane a tsakiyar kasar Sin, a wata sanarwa da ta nuna rashin jin dadin yadda siyasa ta amsa barkewar cutar a yankunan.
Wasu masu sharhi sun yi amannar cewa wannan matakin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da amincewar da aka yi a baya cewa annobar korona ta fara ne a Wuhan, don amincewa da ka'idodin makircin da Amurka ko Italiya suka yi game da cutar COVID-19.
Gwamnatin Donald Trump ta Amurka ta kira coronavirus "Covid-19" ko "Covid-19", tana mai cewa China "ta sanya murfin labarai wanda ya kara tsananta cutar da ta zama annoba ta duniya", wanda wasu masu sukar suka soki saboda nuna wariyar launin fata da kuma "karkatar da hankali daga gazawar gudanar da cutar".
Daily Beast ta samu wata wasikar gwamnatin Amurka da ke duba tsarin sadarwa daga majiyoyin da ke cikin majalisar tsaron kasa, tare da bayyana cewa, "Dukkanin yana da alaka da China.
An nemi mu nemi mu yada wadannan sakonni ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma nunawa a talabijin. "Masu ruwayar labarai kamar su Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da China ke yi na tura tallafi ga kasashen da cutar ta shafa wani bangare ne na kokarin tallatawa don samun tasiri a duniya.
Jami'in harkokin wajen Tarayyar Turai, Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa wanda ya hada da gwagwarmayar samun iko ta hanyar yin amfani da siyasa da karimci".
Burrell ya kuma ce, "China tana tura sakon cewa, ba kamar Amurka ba, ita abokiyar aiki ce mai dogaro da abin dogaro".
China ta kuma bukaci Amurka ta dage takunkumin da ta kakaba wa Syria, Venezuela da Iran, yayin da ta bayar da rahoton cewa tana tura tallafi ga kasashen biyu na karshe.
Takunkumin Amurka ya hana Jack Ma bayar da abin rufe fuska 100,000 ga Cuba a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da karkatar da tallafin da aka yi wa wasu kasashe zuwa kasarsu.
Kuma an samu rahoton rikice-rikice da suka shafi abin rufe fuska a wasu ƙasashe, kamar Jamus, Austria, Switzerland, Jamhuriyar Czech, da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin numfashi da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin haɗin kai na EU ga Italiya da cutar korona ta shafa.
Mauritsso Massari, jakadan Italiya a EU, ya ce, "China ce kawai ta amsa a matakin biyu.
Hakika, wannan ba alama ce mai kyau ba game da haɗin kan Turai".
A ranar 22 ga Maris, bayan kiran waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da likitocin soja, motocin tsabtace jiki na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta ambaci "babban majiyar siyasa" da ba a ambaci sunanta ba cewa kashi 80 cikin dari na taimakon da Rasha ta bayar "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Majiyar ta zargi Rasha da kaddamar da wani mummunan harin "yan siyasa da diflomasiyya".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahotannin jaridu kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin sama mai dauke da kayan aikin likita zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce "a cikin ba da taimako ga abokan aikinsa na Amurka, [Putin] ya ɗauka cewa lokacin da kamfanonin Amurka da ke kera kayan aikin likita suka sake aiki, su ma za su iya ba da gudummawa idan ya cancanta".
Za a gudanar da atisayen sojin NATO na "Guns 2020" a Jamus, Poland, da Baltic, wanda shine mafi girman atisayen soji da NATO za ta gudanar tun bayan ƙarshen Cold War a ƙaramin sikelin.
Sakatariyar Kamfanin Yaki da Nukiliya Kate Hudson ta soki horon 2020 na masu kare lafiya, tana cewa: "A cikin halin da ake ciki na matsalar lafiyar jama'a, horon ba wai kawai yana barazanar rayukan sojojin Amurka da na kasashen Turai da ke halarta ba amma har da al'ummomin kasashen da za a gudanar da shi". Gwamnatin Iran ta kamu da cutar sosai, inda kusan 'yan majalisa 20 da wasu manyan jami'ai goma sha biyar suka kamu da cutar.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ga shugabannin duniya a ranar 14 ga Maris, 2020 yana neman taimako, yana cewa kasarsa na fama da yaki da barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka da aka sanya wa Iran. Cutar ta haifar da kira ga Amurka don karɓar manufofin zamantakewar da suka shahara a wasu ƙasashe masu arziki, gami da samar da kiwon lafiya, kula da yara, izinin dangi da aka biya, da kuma matakan kula da lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump zai samu na sake zaben shugaban kasa a shekarar 2020.
Koriya ta Kudu ta soki "ƙoƙarin keɓewa da rashin aiki" na Japan bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi a wasu wuraren gwamnati na tsawon makonni biyu.
Da farko al'ummar Koriya ta Kudu sun kasance masu tsaka tsaki game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman ko dai a ware Moon saboda zargin da suka yi cewa gwamnati ta yi wa barkewar cutar ko kuma ta yaba da yadda ta amsa. Cutar ta ba da damar ƙasashe su zartar da dokokin gaggawa a cikin martani.
Wasu masu sharhi sun nuna damuwarsu cewa hakan zai ba gwamnatoci damar karfafa ikon su.
A Hungary, majalisar ta kada kuri'ar barin Firayim Minista, Viktor Orban, ya yi mulki ta hanyar dokar da ba ta da iyaka, dakatar da majalisar da kuma zaben da kuma hukunta wadanda suka yada bayanan karya game da kwayar cutar da kuma yadda gwamnati ke magance rikicin.
An zargi cutar coronavirus da barkewar cutar da ta haifar da karancin kayayyaki saboda karuwar amfani da kayan aiki a duniya don magance barkewar cutar, sayayya ta firgici, da katsewar masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kayayyaki da kuma dakatar da masu samar da kayayyaki.
An kuma ga yankuna da dama da suka yi sayayya cikin tsoro, wanda ya sa ɗakunan ajiya suka zama marasa kayan abinci kamar abinci, takarda na bayan gida, da kwalaben ruwa, wanda hakan ya haifar da karancin kayayyaki.
Musamman masana'antar fasaha sun yi gargadi game da jinkirin jigilar kayayyakin lantarki.
A cewar Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom, bukatar kayan kariya na mutum zai ninka sau 100.
Wannan buƙatar ta haifar da farashin da ya ninka sau ashirin fiye da yadda ya saba kuma ya haifar da jinkirin samar da magani na tsakanin watanni huɗu zuwa shida.
Ya kuma haifar da karancin kayan kariya na mutum a duk duniya, tare da Hukumar Lafiya ta Duniya ta yi gargadin cewa hakan zai jefa ma'aikatan lafiya cikin hadari.
A Ostiraliya, annobar ta ba masu sayayya damar sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin madarar jarirai a wasu manyan kantunan sayar da abinci kuma daga baya gwamnatin Australiya ta hana shi. Duk da yaduwar cututtukan COVID-19 a arewacin Italiya da yankin Wuhan, da kuma sakamakon karuwar bukatar kayayyakin abinci, yankuna biyu sun tsira daga matsanancin karancin abinci.
Matakan da China da Italiya suka dauka don magance adana kayayyakin abinci da cinikin su ya yi nasarar kauce wa tsananin karancin abinci da ake tsammani a Turai da kuma Arewacin Amurka.
Arewacin Italiya ba ta ga raguwar yawan amfanin gona ba, amma farashin na iya tashi kamar yadda masana'antun ke tsammani.
Har ma a birnin Wuhan, kantunan abinci sun zama fanko na ɗan lokaci, yayin da jami'an gwamnatin China suka saki naman alade don tabbatar da wadataccen abinci ga jama'a.
A ƙasar Italiya, akwai irin wannan dokar da ta bukaci masu sayar da abinci su adana kayayyaki don irin wannan gaggawa.
Kasar Sin ta ji rauni a tattalin arzikin duniya: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi mummunan rauni a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar kwayar cutar, kuma tallace-tallace na kasuwanci ya ragu da kashi 20.5%.
Tun da yake babban yankin kasar Sin babban cibiyar tattalin arziki da masana'antu ne, an lura cewa barkewar cutar ta zama babbar barazana ga tattalin arzikin duniya.
Agatha Demaris na Sashen Kula da Harkokin Tattalin Arziki ta yi hasashen cewa kasuwanni za su ci gaba da yin canji har sai an bayyana sakamakon da za a iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin cutar a kan ci gaban duniya zai iya wuce waɗanda suka faru sakamakon barkewar SARS tsakanin 2002 zuwa 2004.
Wani gwani a Jami'ar Washington a St. Louis ya kiyasta cewa sarkar samar da kayayyaki ta duniya ta shafi sama da dala biliyan 300 wanda zai iya wucewa har zuwa shekaru biyu.
Rahotanni sun ce kungiyar kasashen da ke fitar da man fetur ta OPEC ta samu "rashin daidaituwa" bayan da farashin man ya fadi kasa saboda karancin bukatar da kasar Sin ke yi.
Kasuwannin hannayen jari na duniya sun ragu a ranar 24 ga Fabrairu saboda karuwar yawan masu kamuwa da COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, yawancin alamun kasuwancin Amurka, gami da Nasdaq-100, Standard & Poor's 500, da Dow Jones Industrial Average sun sami mafi girman raguwa tun 2008, tare da Dow ya faɗi da maki 1,191, wanda shine mafi girman raguwar rana ɗaya tun rikicin kuɗi a 200708.
Abubuwan da ke nuna alamun sun ƙare mako da raguwa da kashi 10%.
A ranar 28 ga watan Fabrairu, kamfanin Scop Ratings GmbH ya tabbatar da darajar bashi na kasar Sin, amma ya ci gaba da kasancewa da mummunan fata.
Hannun jari sun sake faɗuwa saboda tsoron cutar korona, kuma mafi girman raguwar ya kasance a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa ana iya samun koma bayan tattalin arziki.
Masanin tattalin arziki Mohammed Al-Arian ya yaba da matakan gaggawa da manyan bankuna da kasashe ke dauka a kan lokaci.
Bankunan tsakiya suna amsawa da sauri fiye da yadda suka yi a lokacin matsalar kudi a 2008.
Yawon shakatawa yana ɗaya daga cikin ɓangarorin da ya fi fama da ƙuntatawa na balaguro, rufe wuraren jama'a da abubuwan jan hankali, da kuma gargaɗin gwamnatoci game da balaguro a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar su saboda karancin buƙata, gami da British Airways, China Eastern Airlines, da Kantac, yayin da kamfanin jirgin saman yankin na Burtaniya, FlyBey ya lalace.
Tasirin da aka yi wa masana'antar jiragen ruwa ya kasance mai girma sosai.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta zo daidai da lokacin tafiye-tafiye na bikin bazara da aka sani da Chunyun, babban lokacin tafiye-tafiye da ke da alaƙa da hutun Sabuwar Shekarar China.
Gwamnatocin ƙasa da na yanki sun soke wasu manyan abubuwan da suka shafi taron jama'a, gami da bikin Sabuwar Shekara, yayin da kamfanoni masu zaman kansu kuma ke rufe shagunan su da wuraren jan hankalin masu yawon buɗe ido kamar Disneyland Hong Kong da Disneyland Shanghai.
An rufe yawancin abubuwan bikin Sabuwar Shekarar Lunar da wuraren jan hankalin masu yawon bude ido don hana manyan tarurruka, gami da Haramtaccen Birni a Beijing da wuraren baje kolin haikalin gargajiya.
A larduna 24 daga cikin larduna 31, da kuma kananan hukumomi da yankuna a kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara har zuwa ranar 10 ga watan Fabrairu, kuma sun ba da umarnin cewa yawancin wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Waɗannan yankuna suna da kashi 80% na GDP na ƙasar da kashi 90% na fitarwa.
Hong Kong ta ɗaga matakin amsawa ga cututtukan cututtuka zuwa matakin mafi girma kuma ta ayyana dokar ta baci, an rufe makarantu har zuwa Maris kuma an soke bikin Sabuwar Shekara. An shafi sashin sayar da kayayyaki a duniya ta hanyar rage sa'o'in aiki a shaguna ko rufewa na ɗan lokaci.
Ziyarci kantunan sayar da kayayyaki a Turai da Latin Amurka ya ragu da kashi 40 cikin ɗari.
Masu sayarwa a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar tsakanin kashi 50 zuwa 60 cikin dari.
Hakan kuma ya haifar da raguwar tsakanin kashi 33 zuwa 43 cikin dari na zirga-zirgar ƙafa zuwa cibiyoyin kasuwanci a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duniya sun sanya ƙarin matakan, kamar ƙara tsaftacewa, sanya masu duba zafin jiki don bincika zafin jiki na masu siyayya, da soke abubuwan. A cewar kimantawar Kwamitin Tattalin Arziki na Majalisar Dinkin Duniya na Latin Amurka, koma bayan da annobar ta haifar na iya barin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda za su sha wahala ba tare da annobar ba.
A watan Janairu da Fabrairu na 2020, a lokacin da annobar ta kai kololuwa a birnin Wuhan, mutane kusan miliyan biyar a China sun rasa ayyukansu.
Yawancin ma'aikatan baƙi na karkara na China kusan miliyan 300 sun makale a gidajensu a lardunan ciki, ko a lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Barkewar cutar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka, kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis. An rufe Indiya ya bar miliyoyin ma'aikatan baƙi na Indiya (waɗanda ake biyan su ta hanyar albashi na yau da kullun). Binciken da Angus Reid Institute ya yi ya gano cewa kashi 44% na iyalai na Kanada sun sha wahala wani nau'in rashin aikin yi.
A cikin rabin rabin watan Maris, ma'aikata Faransanci miliyan 4 sun nemi taimakon rashin aikin yi na wucin gadi kuma ma'aikata Biritaniya miliyan 1 sun nemi shirin bashi mai ma'ana. Kusan kamfanoni miliyan rabin a Jamus sun tura ma'aikatansu cikin shirye-shiryen aiki na gajeren lokaci da gwamnati ke tallafawa da ake kira Kurzarbit.
Faransa da Britaniya sun amince da tsarin biyan diyya na ɗan gajeren lokaci.
Masana'antar wasan kwaikwayo da al'adun gargajiya sun sami mummunan tasiri ta hanyar cutar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane - ma'aikata da masu zaman kansu - a duniya.
Cibiyoyin al'adu da al'adu sun nemi tallafawa aikin su (galibi ana tallafawa su da gwamnati) don samar da damar zuwa al'adun al'adu na al'umma, kiyaye lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha gwargwadon iko.
A watan Maris na 2020, a duk duniya kuma zuwa wani mataki daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu sun rufe har abada tare da soke ko jinkirta baje kolin su, abubuwan da suka faru, da nunin su.
A cikin martani ga wannan an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Daga cikin sauran abubuwan da ke faruwa a cikin cutar da ke hanzarta cutar an soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide, taron fasaha, da nunin kayan kwalliya.
Har ila yau, masana'antar fim ta sha wahala. Vatican ta sanar da soke bukukuwan mako mai tsarki a Rome, wanda ke faruwa a makon ƙarshe na lokacin tuba na Kirista a babban Lent.
Yawancin majami'u sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar ibadar ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, ko watsa shirye-shiryen kan layi ko talabijin yayin da wasu ke yin bautar ba tare da barin motocinsu ba.
Tare da Roman Katolika na Roma ta rufe majami'un ta da ɗakin sujada, da kuma kwashe St. Peter's Square daga mahajjata na Kirista, sauran ƙungiyoyin addinai sun soke ayyukan da kuma iyakance taron jama'a a majami'u, masallatai, majami'un majami'u, majami'u, da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da annobar ta shafa sannan kuma an rufe wuraren ibadar, yayin da Saudiyya ta hana masu aikin hajji na kasashen waje da mazauna cikinta shiga wuraren alfarma a Makka da Madina.
Wannan annoba ta haifar da rikice-rikice mafi girma a cikin kalandar wasanni na duniya tun bayan Yaƙin Duniya na II.
Yawancin manyan abubuwan wasanni an soke su ko an jinkirta su, gami da gasar zakarun Turai ta 2019-20, gasar Premier ta 2019-20, gasar zakarun Turai ta 2020, kakar wasan kwando ta Amurka ta 2019-20, da kakar wasan hockey ta kasa ta 2019-20.
Cutar ta katse shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya fara a ƙarshen Yuli, kuma Kwamitin Olympics na Duniya ya ba da sanarwar a ranar 24 ga Maris cewa za a "sake tsara taron zuwa bayan 2020 amma a lokacin bazara na 2021". An rufe kulab ɗin caca da sauran wuraren wasa a duniya kuma an jinkirta ko an soke wasannin caca kai tsaye.
Wannan ya sa yawancin masu caca suka koma yin wasa ta yanar gizo, inda yawancin shafukan caca na kan layi suka ba da rahoton ƙaruwa sosai a cikin sababbin biyan kuɗi. Masana'antar nishaɗi ma ta sami matsala, inda ƙungiyoyin kiɗa daban-daban suka dakatar ko soke rangadin kide kide.
Yawancin manyan gidajen wasan kwaikwayo kamar waɗanda ke Broadway sun dakatar da duk wasan kwaikwayon ma.
Wasu masu fasaha sun gano hanyoyin da za su ci gaba da samar da aiki da raba shi ta yanar gizo a matsayin madadin wasan kwaikwayon rayuwa na gargajiya, kamar bukukuwan raye-raye ko ƙirƙirar "bikin" na kan layi don masu fasaha don yin, rarrabawa da kuma yada ayyukansu.
An yi ta yada labarai da dama a yanar gizo game da cutar korona, inda da yawa daga cikinsu suka zama abin dariya da nishadi a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da nuna bambanci, ƙiyayya da wariyar launin fata ga mutanen asalin Sinawa da Gabashin Asiya, da kuma mutanen da ke cikin wuraren da ake fama da cutar a Turai, Amurka da sauran ƙasashe.
An lura da abubuwan tsoro, shakka da ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka, da yankin Asiya da Pacific.
Rahotanni da aka bayar a watan Fabrairu (lokacin da yawancin masu cutar ke cikin kasar Sin) sun nuna bambancin launin fata da kungiyoyi daban-daban a duniya suka nuna game da Sinawa da suka cancanci kamuwa da cutar ko kuma suna karɓar abin da ake zargi da cewa hukunci ne mai kyau.
Har ila yau, wasu ƙasashen Afirka sun ga ƙiyayya da kasar Sin.
Mutane da yawa da ke Wuhan da Hubei sun ba da rahoton nuna bambanci saboda asalin yankin.
Akwai goyon baya ga Sinawa a yanar gizo da wajen layi, da kuma wadanda ke zaune a yankunan da cutar ta shafa.
Bayan barkewar cutar a wasu sabbin wuraren zafi, mutane daga Italiya, ƙasa ta farko a Turai da ta fara fuskantar mummunar barkewar COVID-19, na iya fuskantar shakku da ƙiyayya da baƙi. 'Yan ƙasa a ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan takardun neman izinin hana Sinawa shiga ƙasarsu a ƙoƙarin dakatar da cutar.
A Japan, hashtag ɗin ChineseDontComeToJapan# yana aiki a shafin Twitter.
Sinawa da sauran mutanen Asiya a Burtaniya da Amurka sun ba da rahoton karuwar cin zarafin launin fata, da kuma cin zarafi.
Shugaban Amurka Donald Trump ya fuskanci suka kan cewa an kira coronavirus "Covid-19", kalmar da masu sukar suka dauka ta nuna wariyar launin fata da kuma nuna ƙiyayya ga Sinawa.
Masu zanga-zanga a Ukraine sun kai hari kan bas din da ke dauke da 'yan Ukraine da kasashen waje da ake kwashewa daga Wuhan zuwa Novi Sanjari.
Daliban da ke zuwa daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya, sun fuskanci tsangwama saboda barkewar cutar coronavirus.
Shugaban jam'iyyar BJP a jihar West Bengal, Dilip Ghosh ya ce Sinawa sun lalata yanayi kuma "don haka Allah ya rama musu".
A China, annobar ta haifar da ƙiyayya da ƙiyayya da baƙi da mazauna ƙasar da ba Sinawa ba, inda aka kwatanta baƙi a matsayin "sharar waje" kuma aka yi niyyar "kashe su".
Jaridu da yawa sun cire shafukan biyan kuɗi don wasu ko duk labaran da suka yi game da cutar korona.
Masu wallafa littattafai da yawa sun buɗe takardun kimiyya game da cutar.
Wasu masana kimiyya sun zaɓi su raba sakamakon su da sauri a kan sabobin da aka riga aka buga kamar bioRxiv.
Sau da yawa cututtuka masu saukowa  cututtuka masu saukowa ne, sababbi dangane da yadda suke yaduwa ko kuma yadda suke yaduwa
Duniya da cututtuka  Bayani game da duniya da kuma yaduwar cututtuka
Jerin cututtuka da annoba  Jerin yawan mutuwar cututtuka masu yaduwa
Cinikin namun daji da cututtukan dabbobi  haɗarin kiwon lafiya da ke tattare da cinikin namun daji
Gwajin gwaji na cutar coronavirus na numfashi ta 2019 (COVID-19) da kuma SARS-CoV-2 ya haɗa da hanyoyin gano cutar ta hanyar gano ƙwayoyin cuta waɗanda ke haifar da amsawar kamuwa da cuta.
RT-PCR yana tabbatar da cewa akwai ƙwayoyin cuta a cikin samfurin, yana gano RNA na coronavirus.
Wannan gwajin yana da kyau kuma an tsara shi ne kawai don gano SARS-CoV-2 ribose DNA.
Ana amfani da shi don tabbatar da sababbin cututtuka ko masu aiki.
Ana amfani da maganin rigakafi don ganewar asali da kuma lura da yawan jama'a.
Gwajin rigakafi yana nuna yawan mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar ko kuma waɗanda ba su da alamun cutar.
Ana iya sanin ainihin yawan mutuwar cutar da kuma yawan rigakafin cutar a cikin jama'a bisa ga sakamakon wannan gwajin.
Saboda ƙarancin gwaji, babu wata ƙasa da a watan Maris na 2020 take da ingantaccen bayani game da yaduwar cutar a tsakanin jama'arta.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi uku na yawanta, kuma akwai bambanci sosai a yawan gwaje-gwajen da aka yi a ƙasashe.
Wannan bambancin zai iya shafar yawan mutuwar mutane da ke fama da cutar, wanda a wasu ƙasashe ana iya nuna cewa an yi ƙari sosai.
Ana iya yin amfani da tsarin polymerase chain reaction reverse transcription (RT-PCR) don bincika samfurori na numfashi da aka samo ta hanyoyi daban-daban, ciki har da allurar hanci ko samfurin kumburi.
Ana samun sakamako a cikin sa'o'i da yawa zuwa kwanaki biyu.
Ana amfani da RT-PCR da aka yi ta hanyar sashen makogwaro a cikin mako na farko na cutar.
Bayan haka, kwayar cutar za ta iya fita daga makogwaro yayin da take ci gaba da yawaita a cikin huhu.
A cikin mutane da suka kamu da cutar da ake gwadawa a mako na biyu, za a iya ɗaukar samfurin zurfin iska ta hanyar tsotsa ko amfani da maganin tari.
An ƙirƙiri ɗayan gwaje-gwajen PCR na farko a Charité a Berlin a cikin Janairu 2020 ta amfani da jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju
Hakanan Burtaniya ta haɓaka gwaji a ranar 23 ga Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya ƙirƙiri kayan bincike na SARS-CoV-2 (PowerChek Coronavirus) wanda ya dace da amfanin asibiti mai aminci kuma ya dogara da PCR a ranar 28 ga Janairu 2020.
BGI Group ta kasance ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Kayan Lafiya ta Kasa ta China don kayan bincike na SARS-CoV-2 wanda ya dogara da PCR. A Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta rarraba allon bincikensa na COVID-19 wanda ya dogara da RT-PCR a cikin dakunan gwaje-gwaje na kiwon lafiya ta hanyar samar da kayan bincike na duniya.
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin nau'ikan kayan gwaji ya haifar da sakamakon da ba shi da kyau saboda abubuwan bincike marasa kyau, kuma an jinkirta wani ɓangare na gwajin fiye da sauran a CDC a Atlanta; wannan ya haifar da gwajin ƙasa da samfurori 100 a kowace rana a matsakaita cikin nasara a cikin watan Fabrairun 2020.
Gwaje-gwaje da ke amfani da abubuwa biyu ba su da tabbaci har zuwa 28 ga Fabrairu, 2020 kuma har zuwa lokacin ba a ba da izinin dakunan gwaje-gwaje na gwamnati da na gida su fara yin gwaje-gwaje ba.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa. Dakunan gwaje-gwaje na kasuwanci a Amurka sun fara gudanar da gwaje-gwaje a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da samar da gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Hakazalika, Quest Diagnostics ya samar da gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu ƙuntatawa na adadi da aka sanar; dole ne a cire samfurin kuma a sarrafa shi bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kwayoyin Cutar da Fasaha ta Biyotechnology ta samar da gwajin COVID-19 Victor.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta haɓaka gwajin don gano kamuwa da cutar COVID-19. A ranar 13 ga Maris, 2020, Rosh Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a kan manyan lambobi, wanda ke ba da damar na'ura ɗaya ta gudanar da gwaje-gwaje kusan 4128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna ta Amurka (FDA) ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don yin gwaji a kan Abbott m2000; FDA ta ba da izini iri ɗaya ga Hologic, LapCorp da ThermoFisher Scientific.
A ranar 21 ga Maris, 2020, Cifid ta sami irin wannan izinin amfani da gaggawa daga Hukumar Abinci da Magunguna don gwajin da ke ɗaukar kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar ƙara yawan zafin jiki na DNA maimakon PCR.
Tun da yake ba a bukatar jerin zafin jiki, wannan hanyar tana iya nuna sakamako mai kyau cikin ƙasa da minti biyar da kuma sakamako mara kyau cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a Amurka kuma Abbott yana tsammanin haɓaka masana'antu don yin gwaje-gwaje 50,000 a rana. Taiwan tana kuma haɓaka gwajin da ke amfani da kwayar cutar guda ɗaya wacce ke da alaƙa da ƙwayoyin cuta na ƙwayar cuta (protein N) na sabon coronavirus, da fatan zai iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin saurin mura.
Binciken binciken a watan Maris na 2020 ya kammala cewa "Hotunan kirji ba su da ƙimar bincike a farkon matakan, yayin da sakamakon CT [CT] na iya bayyana tun kafin bayyanar cututtuka".
Abubuwan da aka saba gani a cikin CT sun haɗa da tabarau na gilashin gilashi masu gefe biyu masu yawa tare da rarrabawa da baya.
Ƙarƙashin ƙugu yana yaduwa kuma yana nuna ɓarna da kuma ƙaruwa yayin da cutar ta ci gaba.
Wani bincike a Wuhan da ya kwatanta PCR da CT dangane da asalin annobar ta nuna cewa CT ya fi PCR hankali, kodayake ba shi da ƙwarewa, tare da yawancin halayen hoto da ke rikicewa tare da cututtukan huhu da sauran matakan rashin lafiya.
A watan Maris na 2020, Kwalejin Hoton Hoton Amurka ta ba da shawarar "kada a yi amfani da CT don gano COVID-19 ko a ɗauka a matsayin gwajin farko don gano cutar". A watan Maris na 2020, CDC ta ba da shawarar yin amfani da PCR don gwajin farko.
Wani ɓangare na amsawar rigakafi ga kamuwa da cuta ya ƙunshi samar da ƙwayoyin cuta, ciki har da IgM da IgG.
Ana iya amfani da su don gano mutane a cikin kwanaki 7 ko bayan bayyanar cututtuka, don ƙayyade ƙarfin rigakafi, da kuma a cikin yanayin kula da jama'a. Ana iya yin gwaje-gwaje a cikin cibiyoyin bincike na tsakiya (CLT) ko ta hanyar gwajin asibiti (POCT).
Za a iya yin waɗannan gwaje-gwajen ta hanyar na'urori masu aiki da kai a dakunan gwaje-gwaje da yawa, amma yadda za a iya samun su zai dangana ne a kan yawan aikin da kowane tsarin yake yi.
A cikin cibiyar bincike, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfuran da aka yi a jere don lura da amsar rigakafi.
Don gwajin asibiti, ana yawan shan jini guda ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar ɗaukar matakin cirewa kafin gwaji. A ranar 26 ga Maris, 2020, Hukumar Abinci da Magunguna ta gano ƙungiyoyi 29 da suka ba da sanarwar hukumar bisa ga buƙatun kuma saboda haka waɗannan ƙungiyoyin za su iya rarraba abin da suke da shi na gwajin antibodies.
A ranar 7 ga Afrilu, 2020, Hukumar Abinci da Magunguna ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan aikin gwajin su, wanda zai iya gano ƙwayoyin cuta na IgG da IgA a cikin samfuran jini.
Gwajin yana iya yin ɗaruruwan samfurori a cikin sa'o'i kaɗan kuma yana da sauri fiye da PCR na gargajiya na cutar RNA.
Ana iya gano ƙwayoyin cuta sau da yawa bayan kwanaki 14 bayan kamuwa da cuta. A farkon watan Afrilu, Burtaniya ta gano cewa kayan gwajin ƙwayoyin cuta da ta saya ba su da kyau don amfani.
Hong Kong ta tsara wani shiri wanda marasa lafiya da ake zargi da kamuwa da cutar za su iya zama a gidajensu, "sashen gaggawa ya ba marasa lafiya bututun samfurin", su yi tahowa cikin bututun, kuma su sake dawowa don samun sakamakon gwajin bayan ɗan lokaci. Hukumar Kula da Lafiya ta Burtaniya ta ce tana gwada wani shiri don gwada waɗanda ake zargi da kamuwa da cutar a gida, don haka an cire haɗarin kamuwa da cutar daga waɗanda ke da cutar lokacin da suka isa asibiti ko buƙatar kashe motar motar da ake amfani da ita.
Cibiyoyin gwajin cikin mota a Koriya ta Kudu sun ba da damar yin wasu gwaje-gwaje mafi sauri da kuma cikakke a duniya. A Jamus, Kungiyar Likitocin Inshorar Lafiya ta Kasa ta bayyana a ranar 2 ga Maris cewa ta sami damar yin gwaje-gwaje kusan 12,000 a kowace rana ga marasa lafiya na waje kuma an gwada mutane 10,700 a makon da ya gabata.
Inshorar lafiya tana biyan kuɗin idan likita ya ba da umarnin yin gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwaji 160,000 a mako.
A ranar 19 ga watan Maris, an yi gwajin gano cutar a cikin mota a manyan birane da yawa.
A ranar 26 ga Maris, 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda sakamakon tabbatacce ne kawai aka sanar.
Wani binciken farko na dakin gwaje-gwaje ya bayyana cewa tun daga makon kalandar 12/2020, aƙalla samfura 483,295 sun gwada har zuwa ƙarshen makon 12/2020, kuma sakamakon 33,491 (6.9%) sun kasance masu kyau ga kamuwa da cutar SARS-CoV-2. A Isra'ila, masu bincike a Technion da Rambam Hospital sun ƙirƙiri wata hanya don bincika samfuran da aka ɗauka daga marasa lafiya 64 a lokaci guda kuma sun gwada wannan hanyar, ta hanyar tattara samfuran kuma ba a sake yin ƙarin gwaji ba sai idan samfurin da aka tattara ya tabbatar da tabbatacce. A Wuhan, BGI ta buɗe dakin gwaje-gwaje na wucin gadi don gano gaggawa tare da murfin murabba'i 2000 da ake kira "Yan-Huo Eye" (Fuo Fire Eye ko "Fire Eye" a Turanci), wanda zai iya bincika sama da 10,000 a cikin 2020 .
Da yake Wang Jian, wanda ya kafa BGI, ya jagoranci aikin kuma ya ɗauki kwanaki 5 don yin hakan, tsarin ya nuna cewa lokuta a Hubei za su karu da kashi 47% kuma farashin keɓewa zai ninka idan ba a sami damar yin gwajin ba.
Nan da nan, an kafa wasu dakunan gwaje-gwaje a birnin Shenzhen, Tianjin, Beijing, Shanghai da kuma wasu birane 12 a kasar Sin.
A ranar 4 ga Maris, 2020, yawan aikin yau da kullun ya kai gwaje-gwaje 50,000 a kowace rana. Origami Assays ya fitar da zane-zane masu buɗewa da watsawa da yawa waɗanda zasu iya gwada har zuwa samfurin mai haƙuri 1,122 don gano COVID-19 tare da gwaji 93 kawai. Ana iya amfani da waɗannan ƙirar daidaitaccen a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa ruwa na atomatik ba.
A watan Maris, karancin kayan bincike da rashin isasshen su ya haifar da matsala yayin da ake gudanar da gwaji da yawa a Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu masana suka binciko ka'idojin shirya samfurin da suka hada da dumama samfuran a 98 ° C (208 ° F) na tsawon mintuna 5 don sakin kwayoyin halittar RNA don ƙarin gwaji. A ranar 31 ga Maris, an ba da sanarwar cewa UAE tana kan gaba a duniya dangane da yawan yawan gwajin coronavirus ga jama'arta, kuma tana kan hanyar ɗaga matakin gwajin zuwa yawancin jama'a.
Wannan ya kasance ta hanyar haɗuwa da kunna ƙarfin gwaji a cikin mota, da siyan dakin gwaje-gwaje mai ƙwarewa mai ƙwarewa daga Group 42 da BGI (dangane da dakin gwaje-gwajen gaggawa na "Huo-Yan" a China).
An gina wannan dakin gwaje-gwaje cikin kwanaki 14 kawai, yana da damar yin dubun dubatan gwaje-gwaje na RT-PCR a kowace rana kuma shi ne na farko a duniya da ya yi aiki a waje da kasar Sin.
An kirkiro hanyoyin gwaji daban-daban da ke nufin sassa daban-daban na kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta amince da shirin Jamus na yin kayan aiki da za a tura wa ƙasashe masu ƙarancin kuɗi da ba su da isashen kuɗi don ƙirƙirar nasu.
An sanar da shirin Jamus a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta tsara ba ta kasance ba har zuwa 28 ga Janairu, wanda ya haifar da jinkirin gwaje-gwaje da ke cikin Amurka. China da Amurka sun fuskanci matsaloli game da yadda za a iya amincewa da kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe biyu da Ostiraliya ba su iya samar da isassun kayan aiki don biyan buƙata da bin shawarwarin yin gwaje-gwaje da masana kiwon lafiya suka bayar ba.
A akasin wannan, masana sun bayyana cewa yawan gwajin a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta inganta ƙarfin gwaji sosai a dakunan gwaje-gwaje masu zaman kansu a cikin shekaru da yawa.
A ranar 16 ga Maris, WHO ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin mafita mafi kyau don rage ci gaban cutar COVID-19. Haɓaka buƙatun gwaji sakamakon yaduwar kwayar cutar ya haifar da ɗaruruwan dubban gwaje-gwaje a cikin dakunan gwaje-gwaje na Amurka masu zaman kansu, kuma samar da kayan bincike da masu gano sinadarai ya ragu.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton cewa akwai matsaloli a cikin daidaiton kayan aikin gwajin su.
A Amurka, an sami "rauni" a cikin kayan gwajin da CDC ta ƙirƙira; don haka gwamnati ta kawar da shingen da ke hana yin gwajin a cikin gida. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Ltd na China, amma ta gano cewa sakamakon bai dace ba.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya zama saboda rashin nasarar tattara samfurin ko rashin amfani da kayan aiki yadda ya kamata.
Ma'aikatar ta Spain ta bayyana cewa za ta janye daga siyan kayan aikin da suka ba da sakamakon da ba daidai ba, kuma za ta maye gurbinsu da wasu kayan aikin gwaji daga Shenzhen Bioeasy. 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da ba daidai ba. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China wanda ya nuna ba daidai ba.
Firayim Minista Matovic ya ba da shawarar jefa su a cikin kogin Danube. Farfesa Ahtash Kara na Ma'aikatar Lafiya ta Turkiyya ya ba da rahoton cewa kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure" kuma an "hana amfani da su".
Gwaje-gwajen, tare da keɓewar waɗanda ke da cutar da kuma bin waɗanda suka haɗu da waɗanda ke da cutar SARS-CoV-2, sun ba da sakamako mai kyau.
Masu bincike a birnin Fo, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gwada mutane 3,400 sau biyu, kuma sun ɗauki kwanaki goma a kowane lokaci.
Kusan rabin mutanen da suka gwada sun sami lafiya ba su nuna alamun cutar ba, kuma an ware duk waɗanda aka gano.
Saboda dokar hana fita tsakanin garuruwa, an kawar da sababbin cututtuka.
Cutar kwayar cutar coronavirus ta 2020 a Singapore ta sami raguwar yaduwar cutar sosai idan aka kwatanta da sauran ƙasashe masu tasowa, amma ba tare da tsauraran matakan hanawa ba kamar rufe gidajen abinci da wuraren sayar da kayayyaki; ta hanyar bin diddigin masu shiga da kuma ƙuntatawa kan balaguron cikin gida, gwaji da keɓewa.
An soke abubuwa da yawa, kuma Singapore ta riga ta fara ƙarfafa mazauna su zauna a gidajensu a ranar 28 ga Maris, amma an sake buɗe makarantu a ranar 23 ga Maris a lokacin da aka tsara bayan hutu ya ƙare.
Wasu ƙasashe da dama sun shawo kan annobar ta hanyar bin diddigin masu shiga cikin gida da ƙuntatawa kan tafiye-tafiye na cikin gida, gwaji da keɓewa, amma tare da ƙuntatawa masu sauƙi, kamar Iceland da Koriya ta Kudu.
Wani bincike ya nuna cewa ƙasashen da suka yi gwaje-gwaje da yawa fiye da waɗanda suka mutu, ba su da yawan mutuwa, wataƙila domin waɗannan ƙasashe sun fi iya gano waɗanda suke da alamun rashin lafiya ko kuma waɗanda ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashen da ba su da ikon yin gwaje-gwaje ko kuma waɗanda ke da dakunan gwaje-gwaje na gida da ke da ƙarancin ƙwarewa game da COVID-19 su aika da samfuran farko biyar masu kyau da na farko goma marasa kyau don COVID-19 zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 da WHO ta amince da su don tabbatar da gwajin.
Daga cikin dakunan gwaje-gwaje 16 da aka amince da su, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin zane mai zuwa, shafi na "% na gwajin da suka dace" yana da nasaba da tsarin gwajin da ƙasar ta bi.
Ƙasar da ke gwada mutane da aka kwantar a asibiti kaɗai za ta sami kashi mafi yawa na masu gwajin da za a gwada idan aka kwatanta da ƙasar da ke gwada dukan mazaunanta, ko suna da alamun cutar ko a'a, idan aka yi la'akari da sauran abubuwan.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, tsari ne na tsabtace hannu don cire datti, mai, microorganisms ko wasu abubuwa marasa kyau.
Wanke hannuwanka da sabulu a wasu "lokutan da ake bukata" a rana yana hana yaduwar cututtuka da yawa, kamar zawo da kwalara, waɗanda ke yaduwa ta hanyar bakin.
Mutane za su iya kamuwa da cututtukan numfashi kamar mura ko sanyi, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hancinsu ko bakinsu (watau mucous membranes).
Sa'o'i biyar na musamman a rana da wanke hannu da sabulu yake da muhimmanci sun haɗa da: kafin da bayan yin fitsari, bayan tsabtace bayan jariri ko canja diapers, kafin ciyar da jariri, kafin cin abinci, kafin da bayan shirya abinci ko kuma sha'anin nama ko kifi ko kaza.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka.
Kafin a shirya abinci, a lokacin da ake yinsa, da kuma bayan an gama.
Kafin kula da marar lafiya da kuma bayan haka.
Bayan an canja wa yaro diaper ko kuma bayan an tsabtace shi bayan ya je bayan gida.
Bayan ka share hancinka, ko tari, ko fitsari.
Bayan an taɓa dabbobi, ko abincin su, ko ƙazantarsu.
Tsabtace hannu na likita yana nufin tsabtace jiki da ke da nasaba da aikin likita.
Wanke hannu kafin a ba da magani ko kuma a ba da taimako zai iya hana ko kuma rage yaduwar cutar.
Babban manufar wanke hannu ta hanyar likita shine tsabtace hannaye daga masu cutarwa (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da muhimmanci musamman ga waɗanda suke aiki a fannin abinci ko kuma aikin likita, amma kuma yana da muhimmanci ga mutane.
Wanke hannu yana da fa'idodi da yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus, da sauran cututtuka masu yaduwa, hana cututtukan cututtukan da ke haifar da gudawa, rage kamuwa da cututtukan numfashi, da kuma rage yawan masu kamuwa da cutar.
Kuma rage yawan mutuwar jarirai a gida.
Wani bincike da aka yi a 2013 ya nuna cewa ingantaccen wanke hannu na iya haifar da ɗan ci gaba a cikin tsayin yara a cikin yara 'yan ƙasa da shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara daga cututtukan numfashi da gudawa ta hanyar yin wasu canje-canje a halayensu, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage mutuwar waɗannan cututtuka da kusan kashi hamsin cikin ɗari.
Matakan da ke ƙarfafa wanke hannu za su iya rage yawan zazzaɓin ciki da kusan kashi ɗaya cikin uku, kamar yadda ake samun ruwa mai tsafta a yankunan da ba su da kuɗi sosai.
Ana iya danganta raguwar kamuwa da zawo da kashi 48 cikin ɗari da wanke hannu da sabulu. Wanke hannu da sabulu ita ce hanya mafi inganci da rahusa don hana zawo da cututtukan cututtukan numfashi (ARE) lokacin da ake aiwatar da aikin kai tsaye a gidaje, makarantu da al'ummomi a duniya.
Ciwon huhu, wanda shi ne babban ciwon numfashi, shi ne sanadin mutuwa mafi yawa a cikin yara 'yan kasa da shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Cutar gudawa da ciwon huhu suna kashe yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan amfani da bayan gida zai iya ceton rayuka fiye da duk wani allurar rigakafi ko maganin likita, rage mutuwar da za a iya samu daga zawo da kusan rabi, da kuma mutuwar cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu da sauran ayyukan tsabtace jiki a cikin tsarin ruwa da tsafta.
Wanke hannu yana kuma kāre mu daga cutar kwalara da ake samu ta hanyar saduwa da mutane.
Wani mummunar sakamako na wanke hannu shi ne cewa wanke hannu sau da yawa zai iya lalata fata saboda bushewa.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu zai iya haifar da wata cuta da ake kira eczema da kuma ciwon hanci, wadda ta fi yawa a tsakanin ma'aikatan kiwon lafiya.
Ana kuma yawan ganin cewa wanke hannu yana nuna alamun OCD.
Akwai muhimman lokuta biyar a rana da wanke hannu da sabulu yake da muhimmanci wajen rage yaduwar cututtuka ta hanyar baki: bayan yin wanka (yin fitsari, fitsari), bayan wanke bayan jariri (canza diapers), kafin ciyar da jariri, kafin cin abinci, kafin / bayan shirya abinci ko sarrafa nama, kifi ko kaza.
Don hana yaduwar cutar, ya kamata a yi wanka da hannu kafin ko bayan an yi wa mutum ciwo, bayan an yi wa mutum fitsari ko tari ko kuma bayan an wanke hanci, bayan an taɓa shara ko kuma bayan an yi amfani da shi, da kuma bayan an taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu yana raguwa.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita kashi 38.7% na gidaje suna wanke hannayensu da sabulu. Wani binciken da aka gudanar a shekarar 2014 ya nuna cewa Saudiyya tana da mafi girman adadin a kimanin kashi 97%, Amurka tana kusa da matsakaici da kashi 77%, kuma China tana da mafi karancin kashi 23%. Yanzu akwai hanyoyin canza dabi'u da yawa don kara amfani da wanke hannu da sabulu a lokutan da suka wajaba.
Shirin Kula da Kiwon Lafiya na Farko da Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na babban matakin da aka dauka don inganta lafiyar yara da iliminsu.
Maganin tsutsotsi sau biyu a shekara, tare da wanke hannaye da sabulu da kuma tsabtace hakora da fluoride a kowace rana, sune ainihin shirin na kasa.
An yi nasarar aiwatar da shi a Indonesia.
Ƙara sabulu ko kuma kayan wankewa a cikin ruwa yana sa a kawar da ƙwayoyin cuta daga fata.
Babban tasirin sabulu da kayan wankewa shine rage hana lalata, da haɓaka narkewa.
Ruwa kadai ba shi da amfani wajen tsabtace fata domin kitse da furotin, abubuwan da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Duk da haka, samun ruwa mai yawa yana taimakawa wajen wankewa.
Sabulu mai tauri, saboda yanayin sake amfani da shi, na iya ɗaukar ƙwayoyin cuta da aka samu daga amfani da baya.
Wasu nazarin da suka lura da yaduwar kwayoyin cuta daga sabulu mai ƙazantawa sun kammala cewa yaduwar ba ta yiwuwa saboda ana wanke kwayoyin cuta da kumfa.
Cibiyar Kula da Cututtuka ta ce: "Ya fi kyau a yi amfani da sabulu mai ruwa daga na'urar da ba ta taɓa sabulu ba".
Ana yin amfani da sabulu mai hana ƙwayoyin cuta sosai don masu amfani da lafiyar jiki.
Har zuwa yanzu, babu wata shaida da ta nuna cewa ana amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta don kawar da ƙwayoyin cuta a cikin yanayi.
Duk da haka, sabulu na antibacterial yana dauke da abubuwa masu amfani da kwayoyin cuta kamar trichlosan, wanda ba ya shafar yawancin kwayoyin halitta.
Saboda haka, idan sabulu na maganin ƙwayoyin cuta ba ya shafar ƙwayoyin cuta masu jurewa, ba zai yi tasiri kamar yadda aka tallata shi ba.
Baya ga mai rage damuwa da kuma mai kare fata, abubuwan da aka haɓaka na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita acidity, benzoic acid mai aiki mai hana ƙwayoyin cuta, da sauran abubuwan ƙoshin fata (caustic, bitamin, menethole, tsire-tsire na tsire-tsire). Binciken da Jami'ar Kiwon Lafiyar Jama'a ta Oregon ta yi ya nuna cewa sabulu na yau da kullun yana da tasiri kamar sabulu mai hana ƙwayoyin cuta na masu amfani da ke ɗauke da triclosan wajen hana cututtuka da cire ƙwayoyin cuta daga hannaye.
Ruwan da ke da zafi don wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin suna girma da sauri a zafin jiki (37 digiri Celsius).
Duk da haka, ruwan dumi da sabulu sun fi ruwan sanyi da sabulu tasiri wajen kawar da man fetur na halitta da ke riƙe ƙura da ƙwayoyin cuta.
Sabanin abin da mutane da yawa suke tsammani, binciken kimiyya ya nuna cewa amfani da ruwan dumi ba ya rage yawan ƙwayoyin cuta a hannaye.
Mai tsabtace hannu ko mai tsabtace hannu abu ne da ba ruwa ba don tsabtace hannu.
A ƙarshen shekarun 1990s da farkon ƙarni na 21, masu tsabtace hannu na giya waɗanda ba su da ruwa kuma suna lalata ta hanyar shafawa (wanda aka fi sani da wanke hannu mai shan giya, wanke hannu mai tsabtace hannu ko masu kashe hannu) sun fara samun karbuwa.
Yawancin su sun dogara ne da isopropyl ko ethanol barasa tare da wani mai kara kuzari kamar carbomer (polymer na acrylic acid) a cikin gel, ko mai laushi kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da rage tasirin bushewa ta barasa.
Ƙara hydrogen peroxide mai ƙarancin ruwa yana ƙara aikin antibacterial. Masu tsabtace hannu waɗanda ke da aƙalla kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta.
Magungunan kashe kwayoyin cuta ta hanyar shafawa suna kashe kwayoyin cuta, kwayoyin cuta masu jurewa da magunguna (goldstaphylin masu jurewa methylsillin da vancomycin masu jurewa), tarin fuka, wasu ƙwayoyin cuta (ciki har da HIV, herpes, respiratory encephalopathy virus, nasal viruses, syphilis, mura, hepatitis), da fungi.
Magungunan kashe kwayoyin cuta masu dauke da barasa 70% ta hanyar shafawa suna kashe kashi 99.97% (ragewar logarithmic na 3.5, kwatankwacin ragewar decibel na 35) na kwayoyin cuta a hannaye bayan dakika 30 da sanya su da kuma kashi 99.99% zuwa 99.999% (ragewar logarithmic na 4 zuwa 5) na kwayoyin cuta a hannaye bayan minti 1 da sanya su. Masu kashe kwayoyin cuta sun fi tasiri akan kwayoyin cuta kuma basu da tasiri akan wasu ƙwayoyin cuta.
Magungunan kashe kwayoyin cutar hannu na barasa kusan ba su da tasiri sosai a kan ƙwayoyin cutar norovirus (ko norwalk), wanda shine mafi yawan cututtukan cututtukan ciki da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A shafa gaba da baya na hannayenka da tsakanin dukkan yatsunsu da iyakarsu na kimanin dakika 30 har sai ruwa, kumfa, ko gel sun bushe.
Hakanan ya kamata a wanke yatsun hannu sosai, kuma a shafa su a duka sassan. Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar wanke hannu da shafawa da maganin kashe ƙwayoyin cuta, musamman idan hannaye suna da datti sosai.
Ana amfani da waɗannan kayan tsabtace hannu saboda sauƙin amfani da saurin aikinsu na kawar da ƙwayoyin cuta; duk da haka, bai kamata su zama madadin wanke hannu da kyau ba sai dai idan babu sabulu da ruwa.
Yin amfani da maganin kashe ƙwayoyin cuta na iya sa fata ta bushe idan ba a saka ruwan sama ko ruwa ko duka biyun ba.
Ana iya rage ko kawar da shan giya da ke sa fata ta bushe ta wajen ƙara glycerin ko wasu abubuwa masu sa ruwan sama ko kuma duka biyun.
Gwaje-gwaje na asibiti sun nuna cewa maganin kashe ƙwayoyin cuta na giya da ke ɗauke da ruwan sama yana sa fata ta zama mai ƙoshin lafiya da bushewa fiye da sabulu ko kayan tsabtace ƙwayoyin cuta.
Ba safai ake samun cututtukan fata na allergic, cututtukan cututtukan fata na allergic, ko kuma rashin lafiyar giya ko kuma abubuwan da ke cikin kayan wanke hannu.
Rage yiwuwar kamuwa da cutar cututtukan fata na irritant ya zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancin kayan wanke hannu da ba na ruwa ba, ba sa wanke hannu daga kwayoyin halitta, amma kawai suna kashe su.
Saboda wannan dalili, maganin kashe cututtuka ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtuka da yawa, saboda cututtukan suna kan hannu.
Amfanin maganin hana shan giya ya dogara da sinadarai da kuma yadda aka yi shi, kuma a tarihi, yana da tasiri sosai fiye da wanda ke ɗauke da barasa wanda ya dogara da shafawa da giya.
Kwanan nan, an nuna cewa abubuwan da ke amfani da benzalkonium chloride suna da tasiri mai mahimmanci da ci gaba da maganin ƙwayoyin cuta bayan amfani, ba kamar barasa ba wanda aka nuna cewa yana da tasiri bayan amfani da shi sau da yawa, watakila saboda halayen fata na gaba.
Mutane da yawa a cikin al'ummomin da ke da kuɗi kaɗan ba za su iya sayen sabulu ba kuma suna amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙura na iya zama mafi tasiri fiye da ruwa shi kaɗai, amma yana iya zama ƙasa da sabulu.
Wani abin damuwa shi ne idan ƙura ko toka ta ƙazantu da ƙwayoyin cuta, za su iya ƙara yaduwar cutar maimakon rage ta.
Ash kuma, kamar sabulu, yana da tsabtace jiki domin yana da alkaline idan ya taɓa ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da toka ko yashi a madadin sabulu idan babu shi.
Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar wanke hannu yadda ya kamata don hana yaduwar cutar.
Ka yi wanka da ruwan sanyi ko mai dumi.
Ana ba da shawarar amfani da ruwa mai gudana domin tafkuna da ke wurin suna iya ƙazantuwa, kuma a lokaci guda, zafin ruwan ba ya da wani bambanci.
Ka yi kumfa a hannunka ka shafa da sabulu mai yawa, ka rufe bayan hannunka, tsakanin yatsun hannu da kuma ƙarƙashin ƙusoshinka.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai idan sun yi amfani da sabulu maimakon ruwa kawai.
Ka shafe shi na akalla dakika 20.
Rubbing yana haifar da ƙwanƙwasawa, yana taimaka wajen kawar da ƙwayoyin cuta daga fata, kuma rubbing na tsawon lokaci yana kawar da ƙarin ƙwayoyin cuta.
Ka wanke sosai a ƙarƙashin ruwan da ke gudana.
Wanke hannu a cikin kwanon wanka zai iya sake gurɓata su.
Ka bushe shi da tawul mai tsabta ko ka bar shi ya bushe a cikin iska.
Hannun da suke da ruwa da rigar suna sake ƙazantar da su cikin sauƙi. Abubuwan da aka fi mantawa da su sune babban yatsa, wuyan hannu, tsakanin yatsunsu, da ƙarƙashin ƙusa.
Ƙwararrun ƙusa da kuma zanen ƙusa da aka fasa suna iya ƙunsar ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana bushewar hannaye, saboda bushewar fata na iya lalata shi wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya samar da zaɓuɓɓuka masu sauƙi don sauƙaƙe wanke hannu a ƙasashe masu tasowa, inda babu ruwan famfo ko sabulu ko duka biyun, kamar zubar da ruwa daga kwanon da aka rataye ko kuma an yi ramuka da shi da kyau da / ko amfani da toka idan ya cancanta. A wuraren da ke da iyakantaccen samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai mafita don daidaita amfani da ruwa, kamar "Tippee tap" da sauran zaɓuɓɓuka masu ƙarancin farashi.
Tap tap wani fasaha ce mai sauƙi da ke amfani da kwalba da aka rataye a kan igiya, da kuma hannu mai sarrafa ƙafa don zuba ruwa kaɗan a hannayenka da sabulu.
Drying hannu da kyau wani muhimmin bangare ne na tsabtace hannu, amma akwai wasu muhawara game da mafi ingancin bushewa a cikin gidan wanka.
Bincike da yawa sun nuna cewa tawul ɗin takarda sun fi na na lantarki tsabtace hannu da ke cikin ɗakunan wanka da yawa.
A shekara ta 2008, Jami'ar Westminster a Landan ta gudanar da bincike, wanda aka shirya ta hanyar taron tattaunawa na masana'antar takarda na Turai, don kwatanta matakan tsabtace jiki da takarda takarda, da na'urar busar hannu da iska mai dumi, da na'urar busar hannu da sabon iska mai iska.
Bayan wanke hannuwanku da bushe su da busar iska mai dumi, an gano cewa yawan kwayoyin cuta a yatsunsu ya karu da kashi 194 cikin dari kuma a tafin hannu da kashi 254 cikin dari.
Drying da jet air dryer ya kara yawan kwayoyin cuta a yatsunsu da kashi 42 cikin dari da kuma a tafin hannu da kashi 15 cikin dari.
Bayan wanke hannu da bushe su da tawul na takarda, yawan kwayoyin cuta a kan yatsunsu ya ragu da kashi 76% kuma a kan tafin hannu ya ragu da kashi 77%. Masana kimiyya sun gudanar da gwaje-gwaje don sanin ko akwai yiwuwar kamuwa da cuta ga sauran masu amfani da gidan wanka da kuma yanayin gidan wanka sakamakon kowane nau'in bushewa.
Jirgin iska mai bushewa, wanda ke fitar da iska daga cikin na'urar a cikin saurin da zai iya kaiwa 180 m / s (650 km / h; 400 mph), yana iya busa ƙwayoyin cuta daga hannaye da na'urar, kuma ƙila yana iya watsa kamuwa da cuta ga sauran masu amfani da gidan wanka da kuma yanayin gidan wanka a nesa da mita 2.
Yin amfani da na'urar busar iska mai dumi yana yada ƙwayoyin cuta a nisan mita 0.25 daga na'urar busar.
A shekara ta 2005, wani bincike da TÜV Produkt und Umwelt ya yi ya kimanta hanyoyin bushe hannu dabam-dabam.
An lura da waɗannan canje-canje a cikin ƙwayoyin cuta bayan bushe hannayen:
Akwai masu yin busasshen hannu da yawa, kuma sun haɗa busasshen hannu da busasshen takarda.
Wanke hannu da tawul ɗin kashe ƙwayoyin cuta na hannu wani zaɓi ne yayin tafiya saboda babu sabulu da ruwa.
Ya kamata maganin kashe ƙwayoyin cuta na hannu ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu ya zama wajibi na likita na dogon lokaci bayan likitan Hungary Agnats Semmelweis ya gano ingancinsa (a 1846) don hana cututtuka a cikin asibiti.
Akwai na'urorin lantarki da ke ba da bayanin kula don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa amfani da su ya rage yawan kamuwa da cutar.
Wanke hannu na likita ya kamata ya kasance na akalla dakika 15, ta amfani da sabulu da ruwa ko gel mai yawa don yin kumfa da shafa kowane ɓangaren hannu.
Dole ne a shafa hannaye tare, yatsunsu a haɗe.
Idan akwai datti a ƙarƙashin ƙusa, za a iya amfani da goga mai gashi don cire shi.
Tun da ƙwayoyin cuta za su iya kasancewa a cikin ruwan da ke hannayenku, yana da muhimmanci ku wanke su sosai kuma ku bushe su da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul na takarda don rufe ruwa (kuma buɗe kofar fita idan ya cancanta).
Wannan yana hana sake gurɓata hannayen daga waɗancan rufin.
Yin wanke hannu a wurin kiwon lafiya yana kawar da ƙwayoyin cuta da ke haifar da cuta da kuma hana su yaduwa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu har yanzu yana da rashin yarda a yawancin wuraren kiwon lafiya, tare da yawancin likitoci suna mantawa da wanke hannayensu a kai a kai kafin su taɓa marasa lafiya, suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi za su iya rage yawan cututtukan jini da ke tattare da maganin cath. da kashi 66 cikin ɗari. Ƙungiyar Lafiya ta Duniya ta wallafa wata takarda da ta nuna yadda ake wanke hannu da kuma shafawa a wuraren kiwon lafiya.
Ana kuma iya samun tsarin jagorar tsabtace hannu da ƙungiyar ta bayar a shafinta don jama'a su yi sharhi a kai.
Whitby da wasu sun yi bincike game da wannan.
Masu sayar da kayayyaki za su iya auna tsabtace hannu idan ya zama dole su tabbatar da cewa an bi ƙa'idodin.
Hukumar Lafiya ta Duniya tana da "Lokaci biyar" don wanke hannu:
Bayan an yi amfani da jini/ruwan jiki
Kafin aikin kashe kwayoyin cutar,
Bayan kula da marasa lafiya. Ƙara sinadarai masu tsabtace sabulu ("likita" ko "antibacterial") yana ƙara wani abu mai kashewa a kan mai wanke hannu.
Wannan kayan aikin kashewa na iya zama mai kyau kafin tiyata ko a wuraren da kwayoyin cuta masu jurewa maganin rigakafi ke yaduwa sosai. Lokacin da mutum ya "rub" hannunsa don tiyata, ana buƙatar samar da famfo wanda za'a iya kunnawa da kashewa ba tare da taɓa hannayen ba, wasu chlorhexidine ko iodine washer, tawul ɗin da aka bushe don bushe hannayen bayan wanka, goga mai tsabta don shafawa, da kuma wani kayan aikin tsabtace tsabta don tsabtace ƙusa.
Dole ne a cire duk kayan ado.
Wannan aikin yana bukatar wanke hannu da hannuwan hannu har zuwa gwiwar hannu, yawanci na minti 2 zuwa 6.
Ba lallai ba ne a shafe tsawon minti 10 ana shafawa.
Idan ana wanke hannu, kada ruwa ya koma daga hannu zuwa hannu.
Bayan an gama wanke hannuwan, sai a bushe hannuwan da zane mai tsabta kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, zai fi kyau a wanke hannu ko kuma a yi amfani da maganin wanke hannu kafin a kula da marar lafiya da kuma bayan an kula da shi.
Don magance kamuwa da ƙwayoyin cuta a asibitoci, an gano cewa amfanin da aka samu daga wanke hannu ya fi yawa a kashi 20 na wanke hannu, kuma an samu ƙarin amfani kaɗan idan aka ƙara yawan wanke hannu zuwa fiye da kashi 35 cikin ɗari.
Wankewa da sabulu na yau da kullun yana haifar da fiye da sau uku na cututtukan cututtukan ƙwayoyin cuta da ke wucewa ta hanyar abinci idan aka kwatanta da wankewa da sabulu na antibacterial. Idan aka kwatanta da shafa hannuwan da maganin barasa tare da wanke hannuwan da sabulu na antibacterial na dakika 30 a matsakaita, an gano cewa shafa barasa yana rage gurɓatar ƙwayoyin cuta da kashi 26% fiye da sabulu na antibacterial.
Amma ruwa da sabulu sun fi maganin wanke hannu na barasa tasiri wajen rage cutar H1N1 da kuma cututtukan cututtukan hannu. Matakan da za a iya ɗauka don inganta tsabtace hannu a wuraren kiwon lafiya na iya haɗawa da ilimantar da ma'aikata game da wanke hannu, ƙara wadatar maganin wanke hannu, da kuma rubutaccen saƙon tunatarwa ga ma'aikata.
Ana bukatar ƙarin bincike don sanin ko waɗanne daga cikin waɗannan matakan ne suka fi tasiri a wurare daban-daban na kiwon lafiya.
A ƙasashe masu tasowa, an yarda cewa wanke hannu da sabulu kayan aiki ne mai araha don samun lafiya mai kyau, da kuma abinci mai gina jiki.
Duk da haka, rashin ingantaccen ruwa, sabulu, ko wuraren wanke hannu a gidaje, makarantu, da wuraren aiki yana sa samun dabi'un wanke hannu ya zama da wahala.
Alal misali, a yawancin yankunan karkara na Afirka, ba a yawan samun famfunan wanke hannu kusa da kowane gidan wanka na jama'a ko na masu zaman kansu, duk da cewa akwai wasu hanyoyin da za a iya yin wanke hannu.
Amma, rashin wanke hannu yana iya zama sakamakon al'ada maimakon rashin sabulu ko ruwa.
Tallafawa da kuma ba da shawara ga wanke hannu da sabulu zai iya shafar yanke shawara na siyasa, ƙara wayar da kan jama'a game da amfanin wanke hannu, da kuma haifar da canjin halayyar jama'a a cikin dogon lokaci.
Don wannan ya yi aiki yadda ya kamata, dole ne a lura da kuma kimantawa.
Binciken tsarin nazarin nazarin 70 ya gano cewa hanyoyin al'umma suna da tasiri wajen kara wanke hannu a cikin ƙasashe masu karamin karfi da matsakaitan kuɗi, yayin da kamfen ɗin tallatawa na zamantakewa ba shi da tasiri sosai. Misali ɗaya na inganta wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" da UNICEF ta tsara don ƙarfafa makarantu su ɗauki matakai masu sauƙi da araha don tabbatar da ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran buƙatun kiwon lafiya.
Idan aka cika ƙa'idodin, makarantun za su iya ci gaba daga tauraro ɗaya zuwa uku.
Gina tashoshin wanke hannu zai iya zama wani ɓangare na kamfen ɗin tallata wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke ƙoƙarin kawo canjin halaye. Saboda annobar cutar coronavirus ta 2019-20, UNICEF ta ƙarfafa yin amfani da alamar nuna hannu.
Wasu nazarin da aka yi sun bincika yadda yawan kuɗin wanke hannu a ƙasashe masu tasowa ke da alaƙa da shekarun da aka daidaita don nakasa.
Duk da haka, wani bincike ya nuna cewa wanke hannu da sabulu ya fi sauran hanyoyin tsabtace ruwa da kuma najasa.
An fara gane muhimmancin wanke hannu ga lafiyar mutum - musamman ga mutanen da ke fuskantar mawuyacin yanayi kamar uwaye da aka haifa ko sojoji da aka ji rauni a asibitoci - a tsakiyar karni na 19 daga majagaba biyu na tsabtace hannu: likitan Hungary Agnats Semmelweis wanda ke aiki a Vienna, Austria, da Ingilishi Florence Nightingale "wanda ya kafa aikin jinya na zamani".
A lokacin, mutane da yawa suna tunanin cewa kamuwa da cuta ta samo asali ne daga ƙamshi mai ƙyama da ake kira miasma.
A cikin shekarun 1980, cututtukan da ke tattare da abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta inganta tsabtace hannu sosai a matsayin muhimmiyar hanyar hana yaduwar kamuwa da cuta.
Cutar mura ta alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa mutane da yawa a ƙasashe da yawa sun san muhimmancin wanke hannaye da sabulu don kare kansu daga waɗannan cututtukan.
Alal misali, an saka alamun da ke ɗauke da kalmomin nan "daidai hanyoyin wanke hannu" kusa da wuraren wanke hannu a bayan gida a Jamus da kuma bayan gida a ofisoshin gwamnati da kuma filayen jirgin sama.
Wannan furcin "wanke hannuwanku daga" wani abu yana nufin sanarwar cewa mutum baya son ɗaukar alhakin wani abu ko shiga cikin haɗin kai.
Wannan kalmar ta samo asali ne daga ayar Littafi Mai Tsarki a cikin Matta inda Bilatus Ba-Bunti ya wanke hannayensa daga hukuncin gicciye Yesu Kristi, amma ya zama magana da aka yi amfani da ita sosai a wasu al'ummomin Ingilishi.
A cikin wasan Shakespeare na Macbeth, Lady Macbeth ta fara wanke hannayenta da yawa don ƙoƙarin wanke wani wuri na tunanin da ke wakiltar laifin da ta yi da laifin da mijinta ya yi.
An kuma gano cewa mutane, bayan sun nuna ko kuma sun yi tunanin yin abin da bai dace ba, suna yawan wanke hannayensu fiye da wasu, kuma suna daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ƙyale su su wanke hannuwansu bayan wannan binciken ba su da damar shiga wasu ayyukan "tsabtace" kamar aikin sa kai.
Addinai suna bayyana wanke hannu don dalilai na kiwon lafiya da na alama. Yin wanke hannu na alama, ta amfani da ruwa ba tare da sabulu don wanke hannu ba, wani ɓangare ne na al'adar wanke hannu da ta bayyana a addinai da yawa, gami da koyarwar Baha'i, Hindu, Tevilah, wanke hannu a Yahudanci, wanke hannu a Kiristanci, da Haske a Musulunci. Addinai ma suna buƙatar wanke hannu mai tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun bukaci a wanke hannu bayan an je bayan gida.
Addinin Hindu, Buddha, Sikh, Yahudanci, da Musulunci sun bukaci a wanke hannu kafin da kuma bayan kowane abinci.
Kula da haɗarin COVID-19 a wurin aiki
Kula da haɗarin COVID-19 a wurin aiki shine aiwatar da hanyoyin kula da haɗarin lafiya da lafiya don hana cutar coronavirus 2019 (COVID-19).
Kulawa da haɗarin aiki na aiki ya dogara da wurin aiki da aikin aiki, bisa la'akari da haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da abubuwan haɗari ga ma'aikata waɗanda ke iya fuskantar haɗarin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗarin haɗari suna ƙarancin hulɗa da jama'a da sauran abokan aiki, yanayin da aka ba da shawarar yin amfani da matakan hana kamuwa da cuta, gami da wanke hannu da ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kiyaye ɗagawa da hancin ɗagawa, da kiyaye al'adun tsabtace aiki da tsabtace yanayin aiki.
Ayyukan da ke da haɗarin haɗari sun haɗa da waɗanda ke buƙatar hulɗa da mutane da ba a san su da cutar ko kuma waɗanda ake zargi da cutar COVID-19 ba, amma suna iya kamuwa da cutar ta hanyar ci gaba da yaduwar cutar a cikin al'umma ko tafiya ta duniya.
Wannan ya haɗa da ma'aikata waɗanda ke hulɗa da jama'a kamar a makarantu, wuraren aiki masu yawan aiki, da kuma wasu manyan wuraren sayar da kayayyaki.
Kula da haɗari ga wannan rukunin, ban da matakan hana kamuwa da cuta, sun haɗa da iska mai ƙarfi, shinge na hancin, da kuma amfani da kayan kariya na mutum idan kun yi hulɗa da mutumin da ke da COVID-19.
Hukumar Kula da Lafiya da Lafiya ta yi la'akari da ma'aikatan kiwon lafiya da masu kula da gawawwaki waɗanda ke fuskantar haɗarin haɗari ga wanda aka sani ko ake zargi da cutar COVID-19 a matsayin masu haɗari sosai, wanda ke ƙara haɗarin haɗari sosai idan ma'aikata suna aiwatar da ayyukan samar da iska, ko tattara ko sarrafa samfuran daga wanda aka sani ko ake zargi da cutar COVID-19.
Kulawa da ya dace don sarrafa haɗarin waɗannan ma'aikata ya haɗa da kulawar injiniya kamar ɗakunan iska mai matsin lamba, da kayan aikin kariya na mutum wanda ya dace da aikin aiki.
Cutar COVID-19 tana iya haifar da sakamako da yawa a wurin aiki.
Ma'aikata suna iya yin rashin aiki domin rashin lafiya, kula da wasu, ko kuma tsoron haɗari.
Hanyoyin kasuwanci na iya canjawa, ta hanyar ingancin kayayyaki da ake so da kuma hanyoyin samun su (misali cin kasuwa a waje da lokacin aiki ko ta hanyar sabis na kai ko cin kasuwa ba tare da barin mota ba).
A ƙarshe, ana iya dakatar da jigilar kaya daga yankunan da COVID-19 ya fi shafa. Za a iya amfani da shirin shirye-shiryen cututtuka da amsawa don jagorantar matakan kariya.
Shirye-shiryen suna magance haɗarin haɗari da ke tattare da wurare daban-daban na aiki da kuma ayyuka na aiki, ciki har da tushen haɗari, abubuwan haɗari daga gida da wuraren jama'a, da abubuwan haɗari ga ma'aikata na mutum kamar tsufa ko yanayin rashin lafiya.
Ƙari ga haka, ya bayyana yadda za a bi da waɗannan haɗarin da kuma yadda za a magance yanayin da zai iya tasowa idan cutar ta ɓarke.
Shirye-shiryen shirye-shirye da kuma amsawa ga cututtuka masu yaduwa na iya zama ƙarƙashin shawarwarin ƙasa da ƙasa.
Manufofin amsawa ga barkewar cutar sun haɗa da rage yaduwar kamuwa da cuta tsakanin ma'aikata, kare mutanen da ke cikin haɗarin haɗarin rashin lafiya, kiyaye ayyukan kasuwanci, da rage tasirin tasirin tasirin wasu abubuwa a cikin sarkar samar da su.
Ƙari ga haka, idan mutum yana da ciwo mai tsanani, zai iya yin aiki a wani wuri.
Tsarin matsayi na kula da haɗari shine tsarin da aka yi amfani dashi a cikin aikin lafiya da lafiya don rarraba kula da haɗari ta hanyar tasiri.
Saboda ba za a iya kawar da haɗarin COVID-19 ba, iko mafi inganci shine sarrafa injiniya, sannan sarrafawa, kuma a ƙarshe kayan kariya na mutum.
Kulawa na injiniya ya haɗa da ƙuntata ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba, kuma yana iya zama mafita mafi inganci dangane da farashin aiwatarwa.
Dokar gudanarwa ta shafi canje-canje a tsarin aiki da kuma ayyuka da ke bukatar ma'aikaci ko mai aiki ya yi.
Kayan aikin kare kai (PBE) ba su da tasiri sosai kamar sarrafa aikin injiniya da sarrafawa, amma suna iya taimakawa wajen hana wasu wuraren kamuwa da cutar.
Dukkanin nau'ikan kayan kariya na mutum dole ne a zaba bisa ga haɗarin da ma'aikaci ke fuskanta, dacewa daidai kamar yadda ake buƙata (kamar na'urorin numfashi), sakawa koyaushe da yadda ya kamata, bincika, kiyayewa da sauyawa a kai a kai, kamar yadda ya cancanta, cirewa, tsaftacewa, adanawa, ko zubar da su yadda ya kamata don kauce wa gurɓataccen yanayi.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amirka, ayyuka da ba su da haɗari suna bukatar a riƙa tattaunawa da mutane da kuma abokan aiki.
Abubuwan da aka ba da shawarar don hana kamuwa da cuta a duk wuraren aiki sun haɗa da wanke hannaye sau da yawa da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kiyaye ɗorawa da hancin ɗorawa ciki har da rufe baki da hanci lokacin tari da hancin, samar da tawul da kwandon shara, shirye-shiryen yin aiki daga nesa ko tsara ayyukan aiki a jere idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da kiyaye tsaftacewa da tsabtace yanayin aiki.
Gano mutane da ke da yiwuwar kamuwa da cutar da kuma ware su da wuri mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi, da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) sun ba da shawarar cewa ma'aikata da ke fama da alamun cututtukan numfashi masu tsanani su kasance a gida har sai zazzabi, alamun zazzabi da sauran alamun sun tafi aƙalla awanni 24 ba tare da amfani da maganin zazzabi ko wasu magunguna masu sauƙaƙe alamun ba, kuma manufofin izinin rashin lafiya su kasance masu sassauƙa, suna ba ma'aikata damar zama a gida don kula da wani dangin da ke rashin lafiya, kuma ma'aikata suna sane da waɗannan manufofin.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki, ayyukan haɗari na matsakaici sun haɗa da waɗanda ke buƙatar hulɗa sau da yawa ko kusa da ƙafa shida (1.8 m) daga mutanen da ba a san su da cutar COVID-19 ba ko kuma waɗanda ake zargi da cutar, amma suna iya kamuwa da SARS-CoV-2 saboda ci gaba da yaduwar kamuwa da cuta a cikin al'ummar da ke kewaye da wurin aiki, ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa wurin da yaduwar kamuwa da cutar COVID-19 ke yaduwa.
Waɗannan sun haɗa da ma'aikata da ke hulɗa da jama'a kamar a makarantu, yanayin aiki mai ƙarfi, da wasu manyan wuraren sayar da kaya. Kulawa na injiniya don haka da ƙungiyoyi masu haɗari sun haɗa da shigar da matattarar iska mai inganci, ƙara yawan iska, shigar da shingayen zahiri kamar su filastik mai haske, da shigar da tagogi don hidimar abokan ciniki waɗanda ke siyayya ba tare da barin motar ba. Kulawa na gudanarwa da ƙungiyoyi masu haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, samun tarurruka zuwa wurare da wuraren da ake tsammani, ƙirƙirar canje-canje na yau da kullun, yin amfani da mafi ƙarancin yanayin aiki wanda zai iya haifar da haɗari, da samar da kayan aiki masu mahimmanci, da samar da kayan aiki masu mahimmanci, da samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki masu mahimmanci, da kuma samar da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kuma wasu abubuwa masu mahimmanci.
Ma'aikata da ke cikin wannan rukunin haɗari ba sa yawan yin amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan kariya masu dacewa don kare ma'aikata da sauran fasinjoji sun haɗa da nisantar da fasinjojin da ke fama da rashin lafiya daga wasu a tazarar ƙafa 6, sanya memba ɗaya na ƙungiyar jirgin sama don kula da mutumin da ke fama da rashin lafiya, ba mutumin da ke fama da rashin lafiya abin rufe fuska ko kuma buƙatar mutumin da ke fama da rashin lafiya ya rufe bakinsa da hancinsa da tawul lokacin da yake tari ko hancinsa.
Ma'aikatan jirgin dole ne su sa safar hannu da za a iya zubar da su idan sun taɓa matafiyi mai ciwo ko kuma sun taɓa ruwa ko farfajiyar da ta ƙazantu, kuma wataƙila su yi amfani da ƙarin kayan kariya idan matafiyin da ke ciwo yana da zazzabi, tari ko kuma wahalar numfashi.
Ya kamata a zubar da safofin hannu da sauran abubuwa masu yarwa a cikin jakar rigakafin haɗarin halittu, kuma ya kamata a tsabtace da kuma kashe ƙwayoyin cuta bayan haka. Ga jigilar kayayyaki, gami da jiragen ruwa na yawon shakatawa da sauran jiragen fasinja, kulawar haɗarin ya haɗa da jinkirta tafiya idan suna rashin lafiya, keɓe kai da sanar da cibiyar likitancin jirgin nan da nan idan wani ya kamu da zazzabi ko wasu alamomi yayin cikin jirgin.
A cikin yanayi mafi kyau, ya kamata a bi da likita a cikin ɗakin mutum. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko tsabtace idan mutum mai kamuwa da cuta yana cikin ginin makarantar ba tare da la'akari da yaduwar jama'a ba.
Lokacin da akwai iyakantaccen matsakaiciyar yaduwar kamuwa da cuta a cikin al'umma, ana iya aiwatar da dabarun nisantar da jama'a kamar soke tafiye-tafiye, tarurruka, da sauran manyan tarurruka kamar darussan ilimin motsa jiki ko darussan ƙungiyar mawaƙa ko cin abinci a kantin, ƙara tazara tsakanin ofisoshi, tsara lokutan zuwa da fita, rage baƙi marasa mahimmanci, da amfani da ofishi na kiwon lafiya daban don yara masu alamun cutar mura.
Idan akwai yaduwar kamuwa da cuta a cikin al'umma, ban da dabarun nisantar jama'a, ana iya yin la'akari da tsawaita lokutan barin makaranta. Ga ma'aikatan tilasta yin doka da ke yin ayyukan yau da kullun, Cibiyar Kula da Cututtuka ta ɗauki haɗarin kiwon lafiya kai tsaye da ƙarancin.
Ana ba jami'an tilasta yin doka da ke da alaƙa da mutanen da aka tabbatar ko ake zargi da cutar COVID-19 shawara su bi ƙa'idodin da likitocin gaggawa ke bi, har da kayan kariya na mutum.
Idan an yi hulɗa kai tsaye a lokacin tsare, ma'aikata ya kamata su tsabtace bel da kayan aiki da kuma tsabtace su kafin sake amfani da su tare da fesawa ko tsabtace gida, bi tsarin aiki na yau da kullum don magance gurɓataccen yanayi, zubar da kayan aikin kare kai da aka yi amfani da su, tattara tufafi da wanke su.
Hukumar Kula da Lafiya da Lafiya ta yi la'akari da cewa wasu ma'aikatan kiwon lafiya da masu ajiye gawawwaki suna cikin waɗanda suke da haɗari sosai.
Ayyukan da ke da haɗari sun haɗa da masu ba da sabis na kiwon lafiya, masu tallafawa, dakunan gwaje-gwaje, da masu jigilar magunguna waɗanda ke fuskantar masu cutar COVID-19 da aka sani ko ake zargi.
Wannan yana da haɗari sosai idan ma'aikata suna yin aikin samar da iska, da kuma tattara samfurori daga marasa lafiya da aka tabbatar ko waɗanda ake zargi da cutar COVID-19 ko kuma suna hulɗa da su.
Hanyoyin samar da iska sun haɗa da bututun ruwa, hanyoyin hana tari, gwajin ƙwayoyin cuta, wasu hanyoyin da gwaje-gwaje na likitan hakori, ko kuma tattara samfurori na cutar.
Ayyukan ajiyar gawawwakin da ke da haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin mutanen da aka tabbatar ko ake zargin suna da COVID-19 a lokacin mutuwarsu; waɗannan suna da haɗari sosai idan sun yi nazarin gawa. Ƙarin sarrafawa na injiniya don waɗannan rukunin haɗari sun haɗa da ɗakunan keɓewa don marasa lafiya da aka sani ko ake zargin suna da COVID-19, gami da lokacin aiwatar da hanyoyin samar da iska.
Ana iya yin amfani da iska mai ƙarancin iska a wasu wuraren kiwon lafiya da kuma ajiyar gawawwaki.
Dole ne a bi da samfurori tare da matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar keɓe marasa lafiya masu zuwa a wuraren jira daban-daban dangane da ko ana zargin suna da COVID-19. Baya ga sauran kayan kariya na mutum, Hukumar Kula da Lafiya da Kiwan lafiya ta ba da shawarar yin amfani da na'urorin numfashi ga waɗanda ke aiki a nesa da ƙafa 6 daga mutanen da aka sani ko ake zargin suna da SARS-CoV-2, da waɗanda ke yin hanyoyin samar da iska.
A Amurka, dole ne a yi amfani da kayan numfashi tare da N95 mai tacewa, wanda aka amince da shi daga Cibiyar Kula da Lafiya da Lafiya ta Kasa, ko mafi kyawun kayan aiki, a cikin tsarin tsarin kula da numfashi na gaba ɗaya, wanda ya haɗa da gwaji da dacewa, horo, da gwajin likita.
Sauran nau'ikan na'urorin numfashi na iya samar da ƙarin kariya da inganta yanayin jin daɗin ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar yin amfani da na'urorin numfashi ba, saboda COVID-19 cuta ce ta numfashi maimakon ta hanyar ruwa na jiki.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa ma'aikatan asibiti su riƙa amfani da abin rufe fuska a wuraren da ake shiga.
Ga waɗanda suke karɓar samfurori na numfashi daga marasa lafiya na COVID-19, kula da su, ko motsa su ba tare da yin aikin samar da iska ba, WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata, tabarau masu kariya, ko kariya ta fuska, sirap da safar hannu.
Idan an yi aikin samar da iska, ana maye gurbin abin rufe fuska da abin rufe fuska na N95 ko FFP2.
Ganin cewa samar da kayan kariya na mutum a duniya bai isa ba, WHO ta ba da shawarar rage buƙatar kayan kariya ta sirri ta hanyar kula da nesa, da shinge na zahiri kamar windows mai haske, ba da izinin kawai waɗanda ke cikin kulawa ta kai tsaye su shiga ɗakin da ke da mai cutar COVID-19, ta amfani da kayan kariya na mutum kawai don takamaiman aikin, ci gaba da amfani da abin rufe fuska guda ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa da ke da cutar iri ɗaya da kuma sa ido da daidaita sarkar samar da kayan kariya na mutum, yayin amfani da abin rufe fuska ga mutanen da ba su da alamomi.
Daga: Catherine Maher, Shugabar Wikimedia Foundation
Ga: Duk ma'aikatan Wikimedia Foundation
Labari: [COVID 19] Sauƙaƙa Nauyin da Shirye-shiryen Nan Gaba
Ranar da aka watsa: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙoƙin haƙƙin mallaka
Mun sami kanmu cikin yanayi na musamman a wannan watan.
Cutar COVID-19 ta zama abin da ke nuna haɗin kan ɗan adam na duniya da kuma nauyin da muke da shi ga wasu.
Tarihinmu bai taɓa fuskantar irin wannan ƙalubalen ba, amma mun san cewa mafi kyawun amsa ya dogara ne da wasu nau'ikan jinƙai na duniya, haɗin kai da gina al'umma, waɗanda sune abubuwan da ke cikin zuciyar wannan ƙungiyar.
Ƙaunar da muke nunawa da kuma kulawar da muke nunawa tsakanin abokan aikinmu ta hanyar imel, kira da kuma tattaunawa, tabbaci ne mai kyau na yadda muke yin aiki da mutane.
Ina matuƙar godiya da kuma alfahari da ku abokan aiki na gaskiya.
A makon da ya gabata, wani ya aiko min da wasiƙa don nuna godiya ga aikinmu.
Sun tunatar da ni muhimmancin da duniya ke da shi wajen samun damar shiga Wikipedia a wannan lokaci, da kuma alamar da ke nuna cewa wannan muhimmin kayan aiki yana kan layi kuma yana da kyau ga kowa.
Kokarinku ya sa hakan ya yiwu, ko ta hanyar ci gaba da aiki da shafukanmu, ko samun albashi ga abokan aikinmu, ko kuma samar da tsaro ga al'ummominmu.
Duniya tana bukatar bayanan da ke cikin Wikipedia fiye da dā.
Lokaci ne da muke tasiri a duniya ba kawai ta hanyar ƙoƙarinmu ba, amma kuma ta hanyar da muke yi.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, za mu yi wasu canje-canje a yadda muke aiki tare daga mako mai zuwa.
Canje-canje a tsarin aiki da jadawalin aiki
Kamar yadda Robin ya ambata a baya, ƙungiyar C ta haɗu jiya don tattauna yadda za mu yi da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun duba abin da muke ganin zai iya zama amsa mai dacewa ga abin da muke fuskanta, da kuma hanya mafi kyau don ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba a wannan lokacin.
Mun yi marmarin kawar da damuwa da damuwa, kuma muna son mu ci gaba da aikinmu.
Idan kuna son rage nauyi da ayyuka, to, ba laifi.
Ga dukan ma'aikata, 'yan kwangila da ma'aikatan kwangila:
Lokacin aiki na yau da kullum yana da awa 4 a rana ko kuma awa 20 a mako har sai an ba da sanarwa.
Ba za mu ba da hutu ba, idan za ka iya yin aiki fiye da yadda kake yi, za ka iya ƙara ƙoƙari.
Duk da haka, yanayin duniya ya zama abin da ba za a iya tsammani ba, kuma ko kana son kula da ƙaunatattunka ko sayen kaya daga kantin sayar da kaya ko zuwa wurin likita, lafiyarka ita ce fifiko.
Ba mu san lokacinka ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata a fahimci cewa ba za mu faɗi ba, amma mun faɗi hakan.
Ba ka bukatar hutu na rashin lafiya ko hutu da ake biya. Ka gaya wa shugabanka kuma ka taimaka wa ƙungiyarka su duba kalandarku da jadawalin aiki don su tabbata cewa an rufe manyan fannonin aiki.
(Idan likitanka ya tabbatar da cewa kana da COVID-19, ka gaya wa Brian a Sashen Ilimi da Takaddun shaida don Sashen Ilimi da Takaddun shaida su taimaka wajen ba da taimako da kuma tabbatar da cewa kana samun kulawar da ta dace daga Sashen).
Ana biyan ma'aikatan da suke aiki a kan sa'a ɗaya cikakken albashi.
Mun riga mun ambata hakan, kuma mun sake tabbatar da wannan alkawarin da kuma alkawuranmu ga abokan aikinmu da kuma abokan aikinmu na sa'a.
Kowane ma'aikaci zai sami albashi bisa ga yawan lokutan aiki.
Wannan ya haɗa da ko ma'aikaci yana rashin lafiya ko kuma ba ya iya aiki.
Idan kana son aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aikinsu don su shawo kan matsi da ke faruwa a duniya.
Abin da za mu iya yi zai kawo sakamako mai kyau, musamman a lokacin wahala kamar wannan.
Kuma, wannan batun kula da mutum ne.
Abin da kawai za mu ce shi ne ka tuntuɓi shugabanka don ya san abin da za ka yi tsammani kuma ya daidaita yadda kake bi da yanayin.
Wasu ayyuka suna da muhimmanci.
Akwai kuma wasu abubuwa da dole ne mu ci gaba da su.
Ƙungiyoyin injiniya na amincin shafin, ayyukan HR, amincewa, gaskiya, tara kuɗi (da sauransu) suna yin aiki mai mahimmanci, wanda zai buƙaci ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan gwamnati don tantance manufofinmu na yanzu da kuma mayar da hankalinmu kan tallafawa abubuwan da suka wajaba don cimma aikinmu.
Akwai aiki da yawa da ya kamata mu yi, kuma za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Da a ce na ɗan rage gudu yanzu, hakan ba zai cutar da mu ba.
Ba mu shirya "ninka lokacin aiki don dawo da abin da ya ɓace" bayan annobar ta ƙare.
Ba a bukatar mu yi aiki na tsawon lokaci don mu cika wa'adin da ba za mu iya cikawa ba.
Mun yarda da cewa waɗannan yanayi sun canza, kuma za mu yi aiki don kafa sababbin manufofi da jadawalin lokacin da ya dace.
Menene ke faruwa a cikin shirin shekara-shekara?
Don daidaitawa da sabon gaskiyar da kuma tsammanin lokutan aiki na yau da kullun, muna da niyyar daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Muna shirin ba da shawarar tsawaita shirinmu na 2019-2020 don ba da ƙarin lokaci don tsara kasafin kuɗi don ba ma'aikata damar fifita mahimman ayyuka, kula da kansu da kula da ƙaunatattun su yayin daidaita yanayin waɗanda ke buƙatar aiki a cikin jadawalin rage sa'o'i ko so, a cikin 'yan makonni masu zuwa.
Wannan ƙarin lokaci yana rage nauyin aikin tsarawa da kuma matsin lamba a cikin dukan ƙungiyar.
Za mu gabatar da shawarwarinmu ga kwamitin a mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi game da matakan da za a bi nan gaba da zarar an tabbatar da hakan.
Muna godiya ga ƙungiyar tsara shekara-shekara don rawar da suka taka a wannan.
Yanayin ofishin, nunawa, tsaftacewa
A makon da ya gabata mun sami labarin cewa wani abokin aikinmu a San Francisco na iya kamuwa da cutar COVID-19.
Duk da haka, saboda taka tsantsan da kuma taka tsantsan, mun ɗauki ƙungiyar tsabtace ƙwayoyin cuta don tsabtace dukkan farfajiyoyi a ofishinmu na San Francisco.
Ƙungiyar ta yi amfani da maganin rigakafin ƙwayoyin cuta na asibiti don tsabtace dukkan farfajiyoyi, da kuma harabar da kuma ɗaga-hawan da ke kaiwa zuwa bene.
Ginin ya bi ƙa'idodin kula da shi ta wajen yin amfani da kayayyakin da ke taimaka wa masu haya su kasance da aminci.
Muna farin ciki cewa an shirya ofishin sosai har lokacin da muka koma aiki.
Ofishinmu a Washington, D.C. yana cikin wani gini na WeWork, wanda ya raba mana ƙa'idodin COVID-19 da kuma duk membobin ƙungiyarmu a hedkwatarmu a Washington, D.C.
Tun makon da ya gabata, ofishinmu a Washington, D.C., ya koma wani wuri mai nisa, bisa ga shawarar da muka tsai da tare da ofishinmu a San Francisco.
Kamar yadda wasu abokan aikinmu a hedkwatarmu a birnin New York suka sani, mun tattauna batun hayar wani wuri a Brooklyn.
Har yanzu ana ci gaba da tattaunawar amma za ta iya jinkirta na wani lokaci.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki a nesa sun san cewa zai iya zama gyara, kuma suna so su ba ku wasu shawarwari:
Ya kamata a ƙayyade lokacin taron aƙalla awa ɗaya ko kuma a ƙara zuwa awa biyu.
Idan ana bukatar a yi taro na tsawon lokaci, ya kamata a yi tunani a kan yadda za a raba su cikin kwanaki da yawa.
Ya kamata a tsara taron da kyau, a shirya jadawalin ayyuka, kuma a aika da littattafan da za a karanta a gaba.
Ya kamata a sanya bidiyo a matsayin mafita ta asali, kuma a yi amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da sadarwa kai tsaye.
Ya kamata a ɗauki mataki don sauƙaƙe kowane taro, tare da wani yana lura da tattaunawar don neman tambayoyi da kuma bin jerin masu magana, kuma wani don taimakawa wajen yin rubutu (ko aiwatar da aiwatar da bayanin kula na haɗin gwiwa).
Idan kana bukatar lasifikan kai mai kyau, sai ka aika da imel zuwa sashen taimakon fasaha.
Za a iya amfani da shirin biyan diyya na lafiya da lafiya don samun kuɗin abincin dare.
Za ka iya shiga tashar #remoties a Slack don tattaunawa da abokan aiki game da aikin da aka rarraba
Ƙungiyar ayyukan HR tana neman jagora don abubuwan da ke da amfani ga mai amfani bisa ga taron kan layi, don tallafawa karuwar aikin da aka rarraba a cikin ƙungiyarmu.
A makon da ya gabata, mun nemi duk masu karɓar tallafin al'umma da su soke duk abubuwan da Wikimedia ke tallafawa, kamar taron editan yanar gizo na Editathon har sai WHO ta ayyana ƙarshen annobar.
Mun gaya musu cewa mun fahimci cewa buƙatarmu ta sokewa da sauran ƙuntatawa na iya sa kammala ayyukan tallafin da aka amince da su ba zai yiwu ba, kuma ba za a ci tarar kowa ba saboda jinkirin ko gyara waɗannan manufofin.
Za mu fitar da ƙarin jagororin da za a bi a mako mai zuwa game da Wikimedia da sauran taron yanki da na al'umma.
Jin daɗin da ke cikin al'ummar duniya ya kasance tsakanin baƙin ciki saboda rikice-rikice, jin daɗin bayyanawa da kuma iya mai da hankali ga al'ummomin su, Wikimedia da sauransu.
Don ci gaba da waɗannan ayyukan, ƙungiyar amsawar rikice-rikice tana aiki kan tsara shafi a MetaWiki don samar da sarari ga al'umma don lura da tasirin da kuma bin duk hulɗa da shi.
Kasancewa cikin sanarwa game da batutuwan da suka shafi COVID-19
Za mu aika da gayyatar zuwa kalandarku ranar Alhamis mai zuwa, karfe 14:00 UTC, 07:00 Pacific Time don taron ƙungiyar ma'aikata.
Za mu yi amfani da wannan lokacin don raba ƙarin labarai, amsa tambayoyi da kuma ba da lokaci don sadarwa tare da juna.
Muna cikin wannan yanayin tare kuma a shirye muke mu taimaka.
A wannan lokacin, za mu iya ci gaba da samun bayanai daga wannan imel ɗin, da duk wasu bayanai masu mahimmanci game da COVID-19 da ke cikin WikiOffice.
Ƙungiyarmu za ta ci gaba da ba da bayanai a kan waɗannan shafuka kuma za su riƙa kasancewa a wuri ɗaya.
Muna kuma ci gaba da tuntuɓar ma'aikatan da ke zaune a ƙasashen da abin ya shafa sosai.
Idan kana da wasu tambayoyi game da tafiye-tafiye, abubuwan da suka faru, manyan fannoni na aiki, ƙalubalen ɗaukar hoto ko wani abu da kake buƙatar taimako, don Allah kada ka yi jinkirin sanar da mu kuma ka haɗa kai da ƙungiyarmu ta ba da amsa ta rikici.
A koyaushe muna shirye mu ba da taimako da kuma sadarwa idan ya cancanta.
Idan kana da wata tambaya ta sirri ko kuma mai daɗi, ka aika da imel zuwa Brian Goodman, Manajan Ayyuka na Ƙasa da Ƙasa na Ƙasa na Ƙasa.
Ba za a ɗauki canje-canjen da aka yi a matsayin ƙin aikinmu ko kuma alkawuranmu ba.
Maimakon haka, yana da fahimtar cewa a wannan lokacin, aikinmu da kuma alkawuranmu suna bukatar su daidaita da yanayin yadda ba mu taɓa yi ba a baya.
Mun yi imanin cewa waɗannan matakai suna da muhimmanci don tallafa wa juna, don mu ci gaba da aiki, don samar wa ma'aikatanmu goyon bayan da suke bukata, da kuma ba duniya sabis ɗin da suke dogara da shi.
Ayyukan da muka shirya za su kasance a jiranmu idan lokacin aikinsu ya yi.
Yanzu lokaci ya yi da kowa zai taimaki juna kuma ya samar da sarari don aiki mai muhimmanci da zai zo a makonni da watanni masu zuwa.
Muna bukatar ku duka ku tabbatar da hakan, don haka muna bukatar ku duka ku kula da kanku da iyalanku don ku kasance cikin mafi kyawun yanayinku lokacin da kuke buƙatar ƙoƙarinku.
Yanzu, ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, darektan tawagar amsa rikicin (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jimmy V, Joel L, Lynette L, Ryan M, da Tony S), da sauran mambobin ƙungiyar jagoranci (Grant I, Heather W, Jimmy V, Jane Y, Lisa S, Robin A, Ryan M, da Toby N).
ACE2 yana ɗaurewa da ƙwayoyin ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, koda, da kuma hanji.
Angiotensin-converting enzyme 2 yana hana aikin angiotensin-converting enzyme (ACE) ta hanyar rage adadin angiotensin 2 da ƙara angiotensin (1-7); yana mai da shi magani mai ban sha'awa a cikin maganin cututtukan zuciya da jijiyoyin jini. Hakanan yana da hanyar shiga wasu nau'ikan ƙwayoyin cuta zuwa cikin sel.
Ana kiran kwayar halitta ta mutum da hACE2.
An san shi da angiotensin-converting enzyme 2 a matsayin sinadarin zinc wanda yake kan farfajiyar kwayoyin ciki da sauran kwayoyin.
Furotin mai canza enzyme na angiotensin 2 yana da nau'in peptidase M2 wanda yake da amino acid, kuma jerin jerin kwayoyin cuta na karboxylic wanda ke dauke da amino acid.
Angiotensin-converting enzyme 2 shine nau'in furotin na membrane na nau'in 1, wanda ke da masu karɓar enzymes masu aiki waɗanda ke kan farfajiyar ƙwayoyin huhu da sauran kyallen takarda.
An cire wani abu a waje da tantanin halitta wanda ke canza angiotensin 2 daga cikin tantanin halitta ta hanyar wani enzyme da ake kira shidases, wanda ke haifar da furotin mai narkewa a cikin jini kuma daga bisani ya fita cikin fitsari.
Ana samun enzyme mai canza angiotensin 2 a yawancin gabobin jiki: yana haɗuwa da membrane na sel na kwayar cuta ta 2 a cikin huhu, a cikin ƙwayoyin hanji na ƙananan hanji, da ƙwayoyin ƙwayoyin jijiyoyi da jijiyoyi, da kuma ƙwayoyin tsoka masu laushi a cikin bangon arteries a yawancin gabobin.
RNA mai aikawa da enzyme mai canza angiotensin 2 yana cikin ƙwayar cuta, da kuma cikin ƙwayar cuta, da kuma cikin ƙwayar cuta.
Babban aikin angiotensin-2 shi ne daidaita aikin angiotensin.
Enzyme mai canza angiotensin yana motsa jujjuyawar hormone angiotensin 1 zuwa angiotensin 2 mai riƙe da jijiyoyin jini.
A akasin wannan, enzyme mai canzawa na angiotensin 2 ya raba ƙarshen carboxyl mai ɗauke da amino acid phenylalanine daga angiotensin 2 (aspartate-arginine-valine-tyrosine-isoleucine-histidine-brolin-phenylalanine) kuma ya canza shi zuwa angiotensin (1-7), (histidine-aspartate-arginine-phenylalanine-tyrosine-isoleucine-histidine-brolin-phenylalanine).
Anenzyme mai canzawa na Angiotensin 2 ya rabu zuwa wasu peptides da suka hada da [des-arginine9] - bradykinin, aplin, neurotensin, dinorphine A, da gerlin.
Hakanan enzyme mai canzawa na angiotensin 2 yana tsara zirga-zirgar membrane na mai jigilar amino acid mai tsaka tsaki SLC6A19, kuma yana da rawar gani a cikin cututtukan Heartburn.
Angiotensin-converting enzyme 2, a matsayin furotin mai wucewa ta membrane, shine babban hanyar shiga cikin sel na wasu coronaviruses, wanda ya haɗa da kwayar cutar coronavirus ta NL63, SARS-CoV (kwayar cutar da ke haifar da SARS), da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV-2 tare da ƙwayar enzyme na angiotensin 2 a kan farfajiyar tantanin halitta yana haifar da ƙwayoyin halitta da kuma ƙwayar cuta da ƙwayar cuta zuwa cikin kwayoyin halitta.
Wannan aikin shigarwa yana buƙatar gina S-protein ta hanyar ƙwayar cuta ta membrane, Serin2 na mai watsa shiri, wanda har yanzu ana gwada shi a matsayin magani mai yiwuwa. Wannan ya sa wasu sun yi tunanin cewa rage matakan enzyme mai canza angiotensin 2 a cikin sel na iya taimakawa wajen magance kamuwa da cuta.
Duk da haka, ƙungiyoyi da yawa da ke kula da kansu sun ba da shawarar ci gaba da amfani da maganin hana ƙwayar cuta na angiotensin da kuma masu hana karɓar angiotensin a matsayin magani.
Wani bincike na tsari da bincike na yau da kullun da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa "amfani da masu hana enzymes na angiotensin-converting enzyme yana da alaƙa da raguwar haɗarin cutar huhu da kashi 34% idan aka kwatanta da ƙungiyar ma'auni".
Bugu da ƙari, "Rashin ciwon huhu ya ragu tsakanin waɗanda aka ba su maganin hanawa na angiotensin-T, waɗanda ke da haɗarin ciwon huhu, musamman waɗanda ke fama da bugun jini ko rashin ƙarfi.
Yin amfani da magungunan hana jini ya rage yawan mutuwar cututtukan huhu, ko da yake sakamakon bai yi daidai da haɗarin kamuwa da cutar huhu ba".
An yi imanin cewa anjin angioutensin-2 mai canzawa na mutum (rhACE2) zai zama sabon magani don mummunan rauni na huhu. An gano cewa yana inganta yaduwar jini na huhu, da kuma wadatar oxygen a cikin aladu da ke fama da cututtukan numfashi mai tsanani wanda ya haifar da mai mai yawa.
Anjiotensin 2 yana da rabin rayuwa na kimanin sa'o'i 10, yayin da yake fara aiki bayan minti 30, kuma yana ci gaba da aiki (lokaci) har zuwa sa'o'i 24.
Akwai alamun da yawa da ke nuna cewa angiotensin-containing 2-transferase enzyme na iya zama kyakkyawan magani ga waɗanda ke fama da rashin haƙuri ga masu hana tsarin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin
Aikace-aikacen COVID-19 aikace-aikacen software ne na na'urorin hannu waɗanda aka tsara musamman don taimakawa wajen bin diddigin mutanen da suka kamu da cutar a cikin amsar cutar coronavirus ta 2019-20, ma'ana gano mutanen da ("masu kamuwa") waɗanda za su iya haɗuwa da mutumin da ke da cutar.
An tsara aikace-aikace da yawa ko kuma an ba da shawarar tare da tallafin gwamnati a wasu yankuna da kuma yankuna.
An kafa tsarin aiki da yawa don tsara aikace-aikacen bin diddigin lamba.
Mutane da yawa sun nuna damuwa game da sirrin sirri, musamman game da tsarin da ke dogara da bin diddigin wurin masu amfani da aikace-aikacen.
Sauran hanyoyin da ba su da matsala sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci da mai amfani da sauran wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar cewa za su haɗa aikin da ke tallafawa waɗannan aikace-aikacen da ke amfani da Bluetooth, kai tsaye a cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin tare da Alipay sun kaddamar da wata manhaja da ke ba 'yan ƙasa damar bincika ko sun taɓa saduwa da mutanen da ke da cutar COVID-19.
Wannan wata manhaja ce da mutane ke amfani da ita a birane sama da 200 na kasar Sin. A Singapore, mutane suna amfani da wata manhaja da ake kira TraceTogether.
Wata kungiyar fasahar kere-kere ta kasa ta dauki nauyin tsara manhajar, ta fitar da ita a matsayin manhajar budewa kuma za a mika ta ga gwamnati. Arewacin Macedonia ta kaddamar da manhajar "StopKorona", manhajar da ke amfani da Bluetooth don bin diddigin kamuwa da mutane masu dauke da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha ta yi aiki tare da Ma'aikatar Lafiya don tsara manhajar.
A ranar 14 ga Afrilu, 2020, har yanzu ana jiran aikace-aikacen don karɓar Google Play Store da App Store daga Apple.
A ranar 12 ga Afrilu, gwamnati ta ba da rahoton cewa aikace-aikacen bin diddigin lamba yana cikin ci gaba, kuma yana iya kasancewa don rarrabawa a cikin makonni. Ireland da Faransa suna shirin ƙaddamar da irin wannan aikace-aikacen, wato ("StopCovid").
Australia da New Zealand suna tunanin yin aikace-aikacen da suka danganci TraceTogether na Singapore, da kuma yarjejeniyar BlueTres.Then Rasha tana shirin ƙaddamar da aikace-aikacen da ke amfani da yanayin yanayin ƙasa na marasa lafiya waɗanda likitoci suka gano suna da COVID-19 daga mazaunan Moscow, wanda aka tsara don tabbatar da cewa ba su bar gida.
Ross Anderson, farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya ambaci wasu matsaloli masu amfani da ke tattare da tsarin aikace-aikacen, gami da rashin sakamako mai kyau da kuma yiwuwar rashin tasiri idan amfani da aikace-aikacen ya iyakance ga ƙananan ɓangaren jama'a.
Don magance damuwa game da yaduwar ɓatarwa ko aikace-aikacen cutar coronavirus, Apple ya sanya ƙuntatawa kan nau'ikan ƙungiyoyi waɗanda za su iya ƙara aikace-aikacen da ke da alaƙa da cutar coronavirus zuwa shagon aikace-aikacen su; ta iyakance ga "ainihin" ko wasu ƙungiyoyi masu martaba kawai.
Google da Amazon sun kafa irin wannan dokar.
Masu ba da shawara game da sirri sun nuna damuwa game da tasirin sa ido na tarin yawa da ke haifar da amfani da aikace-aikacen coronavirus, musamman game da ko tsarin sa ido da aka tsara don magance cutar coronavirus zai tafi da zarar barazanar ta ƙare.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
Kungiyoyin sun kuma bayyana sharudda takwas ga ayyukan gwamnati:
Dole ne sa ido ya zama "doka, dole, kuma daidai gwargwado";
Za a yi amfani da wannan tsari don tabbatar da cewa ana iya yin amfani da shi a cikin gida.
Ya kamata a iyakance amfani da bayanan ga dalilai masu alaƙa da COVID-19.
Dole ne a kare tsaro da sirrin bayanan masu mallakar su kuma a tabbatar da kariya bisa ga shaida;
Dole ne kulawar dijital ta guji ƙara nuna bambanci da ɓoyewa;
Ya kamata a ƙayyade duk wani rabawa na bayanai tare da wasu ɓangarorin waje a cikin doka;
Ya kamata a samar da kayan kariya daga amfani da kuma kare hakkokin 'yan kasa don magance amfani da su;
Ana buƙatar samar da "haɗin kai mai tasiri" daga duk "masu ruwa da tsaki", gami da masana kiwon lafiyar jama'a da ƙungiyoyin da ba a kula da su ba. Jamusanci Chaos Computer Club (CCC) da Reporters Without Borders (RSF) suma sun fitar da jerin abubuwan bita.
Shirin da aka gabatar na Google / Apple yana nufin magance matsalar sa ido ta yau da kullun ta hanyar cire bin diddigin daga tsarin aiki na na'urori da zarar an daina buƙatarsa.
Wasu ƙasashe sun yi amfani da bin hanyar sadarwa maimakon amfani da aikace-aikace, wanda ke kawar da buƙatar saukar da aikace-aikacen kuma yana ba da damar kauce wa bin sawu.
A Isra'ila, jami'ai sun yi amfani da hanyar sadarwa.
Amma hanyoyin sadarwa da ke da damar samun bayanan asali na wuraren da ke da manyan matsalolin sirri.
Koyaya, ba duk tsarin da ke da sabar uwar garke ke buƙatar samun damar bayanan wurin mutum ba; an ƙirƙiri wasu tsarin tsare sirri waɗanda ke amfani da sabar uwar garke don sadarwa tsakanin juna kawai (duba sashe na gaba a ƙasa).
A Koriya ta Kudu, jami'ai sun yi amfani da tsarin da ba na aikace-aikace ba don bin diddigin masu tuntuɓar.
Maimakon amfani da wata manhaja, tsarin yana tattara bayanan bin diddigin daga tushe daban-daban, ciki har da bayanan bin diddigin na'urorin hannu da bayanan ma'amala na katin, kuma yana haɗa waɗannan bayanan don aika sanarwar saƙon rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu haɗari, gwamnati ta ba da damar samun bayanan wurin a fili, wanda ya ba da izinin saboda canje-canje masu yawa a dokokin sirrin bayanai bayan barkewar cutar coronavirus ta Gabas ta Tsakiya.
Ana samun wannan bayanin a cikin aikace-aikace da shafukan yanar gizo da yawa. Ƙasashe kamar Jamus sun yi la'akari da amfani da tsarin tsare sirri da kuma tsarin tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a ba da cikakken bayani game da wannan ba.
Kulawa da masu hulɗa da sirri wata ma'ana ce mai amfani da nasara kuma ana tallafawa ta hanyar rubuce-rubuce masu ƙarfi waɗanda suka fara aƙalla 2013. A ranar 7 ga Afrilu, 2020, sama da ƙungiyoyi da yawa na masana sun yi aiki don samun damar hanyoyin magance sirrin sirri, kamar Bluetooth mai ƙarancin ƙarfi (PLE) don yin rajistar kusanci da mai amfani da sauran wayoyin hannu.
Duk da haka, BBB-PT ya kasance aiki ne na haɗin gwiwa wanda ya ƙunshi duka hanyoyin tsakiya da na rarraba, ba yarjejeniya ta mutum ba. Waɗannan sun haɗa da ladabi na tushen rarraba bayanai na kiyaye sirri (DPBT/DPT-3T), lambobin kira na wucin gadi (TCN, da aka sani da lambobin taron kira, CNE), ladabi masu mahimmanci, hanyoyin bin diddigin masu cutar ta hanyar na'urorin hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan da ke nuna mutum ba ya barin na'urar, kuma duk abubuwan da suka dace suna faruwa akan na'urar.
Kungiyar sirrin sirri a MIT Media Lab tana aiki kan haɓaka SafePaths, dandamali don amfani da fasahohin tsare sirri lokacin tattara bayanan wuri ko hanyar wucewa da amfani da su don bin diddigin yaduwar COVID-19.
Yana dogara ne akan bincike da aka samu daga rahoton "Animal Face of Apps: Tsare Sirrin Mutum a ƙarƙashin Cutar" wanda aka fitar a watan Maris na 2020.
SafeTrace yana amfani da fasahar na'urori masu aminci don ba masu amfani damar raba bayanan wuri da lafiyar lafiya tare da masu amfani da sauran masu kula ba tare da lalata sirrin bayanai ba.
A ranar 5 ga Afrilu, 2020, ƙungiyar Tracking Global Contact Numbers ta kafa ta ƙungiyoyi masu sha'awar abin da aka ɗauka a matsayin irin wannan tsarin da kuma ladabi masu yawa, da nufin rage rikice-rikice da ba da damar musayar duniya tsakanin aikace-aikacen sa ido da faɗakarwa, babban alama don cimma amfani da yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTree, wanda aikace-aikacen gwamnati na hukuma ke amfani da shi.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa tsarin aiki na na'urorin hannu na Android da iOS, sun ba da sanarwar shirin bin diddigin masu tuntuɓar; inda suka yi iƙirarin cewa za su kiyaye sirrin sirri ta hanyar dogaro da haɗin fasahar Bluetooth mai ƙarancin makamashi da ɓoye sirrin sirri.
Sun kuma buga takamaiman fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, makasudin shine a gabatar da tsarin a matakai uku, wato:
Samar da kayan aiki don baiwa gwamnatoci damar gina aikace-aikacen hukuma masu tsare sirri don bin diddigin cutar coronavirus.
Haɗa wannan aikin kai tsaye cikin Android da iOS kamar yadda Google da Apple ke shirin magance matsalolin amfani da kulawa ta yau da kullun ta hanyar rarraba tsarin da farko ta hanyar sabunta tsarin aiki sannan kuma ta hanyar cire su ta hanyar da ta dace da zarar barazanar ta ƙare.
Sake amfani da magani (wanda aka fi sani da sake amfani, sake amfani, sake amfani da shi ko sake amfani da magani) shine sake amfani da magani wanda aka amince da shi don magance wata cuta ko yanayin kiwon lafiya daban da abin da aka tsara shi don magance shi.
Wannan wata hanyar bincike ce da masu bincike ke bi yanzu don samar da lafiya da kuma maganin COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma watsa jini. Kwayar cutar SARS-CoV-2 tana da kusan furotin 66 masu magani, kowane furotin yana da wurare masu ɗaurewa da yawa.
Binciken waɗannan rukunin yanar gizon yana ba da kyakkyawan tsari don haɓaka ingantaccen maganin rigakafin cutar da ke kashe furotin na COVID-19.
Daga cikin mahimman sunadarai masu mahimmanci na SARS-CoV-2 sune protease na gaba, RNA-da ke dogara da RNA-da ke dogara da RNA, helix, S-protein, da adenosine diphosphate ribophosphate.
Hussain A. A., da sauransu sun yi nazarin yawancin abubuwan da aka yi amfani da su wanda aka inganta da kuma nazarin su don kamanceceniya da tsarin su tare da magungunan da aka amince da su tare da mafi girman kama da wannan don hanzarta haɓaka magungunan SARS-CoV-2 mai ƙarfi a cikin binciken sa na farko don ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na zazzabin cizon sauro wanda likitoci ke amfani da shi wajen magance wasu cututtuka na autoimmune.
A ranar 18 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chloroquine da hydroxychloroquine da ke da alaƙa da shi na iya kasancewa cikin magunguna huɗu da ake nazari a matsayin ɓangare na gwajin haɗin kai na asibiti.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chloroquine da hydroxychloroquine na iya farawa a ranar 24 ga Maris. A ranar 28 ga Maris, Hukumar Abinci da Magunguna ta ba da izinin amfani da hydroxychloroquine sulfate da chlorine phosphate a ƙarƙashin lasisin Amfani da Gaggawa (EUA).
Ba a amince da maganin ba ta hanyar gwajin gwaji na FDA kuma an ba da izini a ƙarƙashin lasisin gaggawa kawai a matsayin magani na gwaji don amfani da gaggawa don kula da marasa lafiya da aka kwantar amma ba za su iya samun magani a gwajin asibiti ba.
CDC ta sanar da cewa har yanzu ba ta tantance "amfani da hydroxychloroquine don rigakafin kamuwa da SARS-CoV-2, maganin sa, allurai ko lokacin sa ba".
Likitoci sun ce suna amfani da miyagun ƙwayoyi ne kawai idan "ba su da wani zaɓi".
Wata ƙungiyar bincike ta Turkiya a Istanbul tana gudanar da wani ƙaramin bincike a kan amfani da chlorine da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da bincike mai zurfi a jami'ar Duke da Oxford.
Makarantar Likitancin Langoon a Jami'ar New York tana gudanar da gwaji kan lafiyar da ingancin amfani da hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin cewa favifirvir ya kasance "mai tasiri sosai".
Daga cikin marasa lafiya 35 a Shenzhen, sakamakon gwajin ya kasance mara kyau a matsakaita na kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kai kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A wani bincike da aka yi a birnin Wuhan, an yi wa marasa lafiya 240 da ke fama da ciwon huhu, rabin su an ba su maganin FAVIFIRAVIR, sauran kuma an ba su maganin omyfinovir.
Hukumar Kula da Magunguna ta Italiya ta faɗakar da mutane cewa hujjojin da ke goyan bayan maganin ba su da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar cewa za ta sayi maganin daga Japan don sanya shi a cikin ajiyar ta, kuma sojojin za su yi amfani da shi don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar jaridar China Morning Post, Shinzo Abe ya tattauna da gwamnatin Trump game da sayan maganin. Da alama maganin ba zai yi tasiri sosai wajen magance cututtuka masu tsanani ba inda cutar ta riga ta ninka.
Ba shi da lafiya ga mata masu ciki ko mata masu son yin ciki.
Wani bincike da ya yi amfani da maganin lupinavir/ritonavir (CALITRA), wato maganin rigakafin cutar da aka hada da lupinavir da ritonavir, ya ce sakamakon "ba shi da amfani".
An tsara magungunan ne don hana kwayar cutar HIV ta sake haifuwa ta hanyar ɗaure ta da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magunguna don isa ga wani fili wanda ke da alaƙa da SARS-CoV-2 protease. Al'umma ta kimiyya tana fuskantar ƙalubalen da ke tattare da tura albarkatu don sake fasalin abubuwan da ake amfani da su na magunguna da aka tsara musamman don maganin HIV / AIDS.
Hukumar Lafiya ta Duniya ta ƙara Lupinavir/Ritonavir a gwajin haɗin kai na duniya.
Gilead Sciences ta haɓaka maganin Remdesivir don maganin cutar Ebola da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafin kwayar cuta a cikin dakin gwaje-gwaje akan yawancin ƙwayoyin cuta, ƙwayoyin cuta, da coronaviruses.
Wata matsala da ke tattare da maganin rigakafin cutar ita ce, ta hanyar canji, cutar tana iya zama mai jurewa, kuma hakan na iya haifar da cututtuka masu tsanani.
Wasu nazarin farko na farko sun nuna cewa remdesivir na iya nuna babban shinge na asali zuwa juriya. Akwai gwaji da yawa na yau da kullun, gami da gwaji biyu da Asibitocin Jami'ar Cleveland ke gudanarwa; ɗayan yana kan marasa lafiya masu matsakaiciyar cuta, ɗayan kuma yana kan marasa lafiya masu cutar mai tsanani.
Akwai gwaji uku na asibiti akan maganin rigakafin cutar kwayar cutar Vitamin C akan marasa lafiya da ke cikin asibiti da ke fama da mummunan rashin lafiya saboda COVID-19, da kuma gwaji biyu da aka sarrafa ta amfani da maganin (China, Kanada) da gwaji mara sarrafawa (Italiya).
Jihar New York ta fara gwaji kan tasirin maganin Azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kiwon Lafiyar Jama'a da Magunguna ta Japan (NCGM) na shirin gudanar da gwajin asibiti game da amfani da Alvisco (cichlisonide) wanda Teijin ke samarwa, corticosteroid mai shan iska don maganin asma, don kula da marasa lafiya da ke da sabon coronavirus kafin bayyanar cututtuka.
A halin yanzu ana gudanar da gwaji na biyu ta amfani da wani nau'in enzyme mai canza angiotensin 2 akan marasa lafiya 200 da ake buƙatar shiga cikin gwaji daga masu fama da cutar mai tsanani da aka kwantar a Denmark, Jamus, da Austria don ƙayyade tasirin maganin.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke fama da alamun cutar COVID-19.
Binciken, mai suna Colcorona, ya haɗa da manya 6,000 masu shekaru 40 zuwa sama waɗanda likitoci suka gano suna da COVID-19 kuma sun sami alamun rashin lafiya ba tare da buƙatar asibiti ba.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba su da maganin hana ɗaukar ciki ba su cancanci yin hakan ba.
Ana kuma gwada magungunan hana yaduwar jini a Italiya.
A halin yanzu ana amfani da ƙananan kwayoyin halittar heparin don kula da marasa lafiya, wanda ke buƙatar Hukumar Magunguna ta Italiya ta buga jagororin amfani da shi.
An sanar da wani bincike na cibiyoyi da yawa a Italiya akan marasa lafiya 300 don bincika amfani da sodium enoxabarin a allurai na rigakafi da na magani a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga sake amfani da magungunan rigakafin ƙwayoyin cuta da aka tsara don magance ɓarkewar cutar kamar Mars, SARS, da West Nile.
Ribavirin: Masana sun bada shawarar amfani da ribavirin don maganin COVID-19 bisa ga fitowar 7 ta jagororin kasar Sin.
Omefenovir: Masana sun bada shawarar amfani da Omefenovir don maganin COVID-19 bisa ga fitowar 7 ta umarnin kasar Sin.
Wasu magungunan rigakafin da masana suka gano cewa za a iya sake amfani da su a matsayin magungunan COVID-19 sun haɗa da:
Tosilisumab (mai karɓar mai karɓar interleukin-6): An amince da shi daga China.
An yi gwaji a Italiya da China ma. Ka duba tosisilzumab #COVID-19.
Allurar rigakafin COVID-19 allurar rigakafi ce da ake tsammani don cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu alluran rigakafi da aka kammala don gwajin asibiti, akwai ƙoƙari da yawa da ake yi don haɓaka wannan allurar.
A ƙarshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
Akwai alluran rigakafi biyar da aka yi a farkon gwajin lafiyarsu a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
A shekara ta 2020, wata babbar annobar ta ɓarke a faɗin duniya, wanda ya haifar da saka hannun jari da kuma ayyukan bincike don samar da allurar rigakafi.
Kungiyoyi da dama suna amfani da bayanan da aka buga don samar da alluran rigakafi da za su iya magance SARS-CoV-2.
Abubuwan da ake buƙata na shirin Coalition for Epidemic Preparedness Innovations don samar da alluran rigakafi, wanda aka sanar a watan Afrilu, shine sauri, ƙarfin masana'antu, yaduwa da isa ga duniya.
A watan Afrilu, masana kimiyya na Kungiyar kirkire-kirkire na shirye-shiryen annoba sun ba da rahoton cewa an yi bincike da ci gaba a kan dandamali na fasaha daban-daban 10 a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Babban manufofin dandamali wanda ya ci gaba zuwa matakin farko na nazarin aminci sun haɗa da:
DNA (Ribonucleic acid da RNA) (mai haɓaka mataki na farko da allurar rigakafi: Moderna, da mRNA-1273)
Mai ɗaukar hoto (mai haɓaka mataki na farko da allurar rigakafi: Moderna, mai ɗaukar hoto na gland virus na nau'in 5)
A cewar masana kimiyya na Alliance for Epidemic Preparedness Innovations a watan Afrilu, akwai takarar allurar rigakafi 115 a farkon matakan ci gaba, tare da tabbatar da ayyukan 78 (79, a cewar Cibiyar Milkin), kuma an sanar da wasu ayyukan 37, amma tare da ɗan bayani na jama'a (wanda ake zaton yana cikin shirin ko ana tsara shi).
Gwajin lokaci na farko da na biyu shine gwajin farko na aminci da rashin amfani, yawanci bazuwar, sarrafawa ta mutum, a wurare da yawa, tare da ƙayyade mafi inganci da inganci.
Gwaje-gwaje na mataki na uku yawanci sun haɗa da mahalarta da yawa, gami da ƙungiyar ma'auni, da gwajin ingancin allurar rigakafin don hana cutar, tare da lura da tasirin tasirin mafi kyawun sashi.
Daga cikin alluran rigakafi 79 da ke cikin ci gaba (an tabbatar da su a farkon Afrilu 2020), 74 ba su kasance a cikin kimantawar ɗan adam ba (har yanzu suna cikin binciken "preclinical").
A ranar 24 ga Janairun 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar yin allurar rigakafin kwayar halitta wanda zai gyara sunadarai na kwayar cutar ta hanyar kwayoyin halitta don haifar da amsawar rigakafi.
A ranar 24 ga Janairun 2020 a Kanada, Cibiyar allurar rigakafin ƙasa da ƙasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi, da nufin fara gwajin ɗan adam a 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka ta China a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, kamfanonin harhada magunguna na Janssen, karkashin jagorancin Hanneke Schweitzer, sun sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen tana haɓaka allurar rigakafin baka tare da abokin aikinta na fasahar kere-kere, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairun 2020, OncoGen Lab a Romania ya buga wani bincike game da ƙirar allurar rigakafi tare da fasahar kama da wacce ake amfani da ita don maganin cutar kansa tare da sabon allurar rigakafi.
A ranar 25 ga watan Maris shugaban cibiyar bincike ya sanar da cewa sun kammala samar da allurar rigakafin kuma sun fara gwajin.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani reshen kamfanin Generex, ya sanar da cewa ya fara aikin allurar rigakafi don ƙirƙirar allurar II-Key peptide akan COVID-19.
Sun so su samar da rigakafin da za a iya gwadawa a cikin mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Sojojin Amurka na Binciken Likitoci da Kayan aiki a Fort Derek da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka biyu a yammacin Maryland, sun sanar da cewa suna aiki kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
A cikin ci gaba da kuma samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da shirye-shiryen gwajin farko da gwaji na farko na farko a watan Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar cewa tana aiki da mutane 11 da aka ware, kuma ko da aikin ya yi sauri, zai ɗauki aƙalla shekara ɗaya da rabi zuwa kusan shekaru biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere-kere a Quebec City, Quebec, ya ba da rahoton cewa yana haɓaka kwayar cutar da ta yi kama da kwayar cutar coronavirus tare da tallafin kuɗi daga Cibiyar Nazarin Kiwon Lafiyar Kanada.
Ana gudanar da bincike a dakin gwaje-gwaje, tare da shirin gwajin mutum a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba CureVac "kuɗaɗe masu yawa" don samun damar yin allurar COVID-19, wanda gwamnatin Jamus ta yi hamayya da shi.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don shiga cikin haɓaka allurar rigakafi bisa tushen RNA mai aikawa.
A halin yanzu ana gudanar da gwajin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigaka
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar halittu na Italiya, ya ba da sanarwar cewa za ta sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za a iya fara gwajin gwajin mutum a ƙarshen kaka.
A Faransa a ranar 19 ga Maris, 2020, Ƙungiyar Innovation don Shirye-shiryen Cutar Cutar (CEPA) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike na allurar rigakafin COVID-19 wanda ya haɗa da Cibiyar Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na Alliance for Epidemic Preparedness Innovations a cikin haɓaka allurar COVID-19 zuwa dala miliyan 29.
Abokan hulɗa na Coalition for Epidemic Preparedness Innovations don haɓaka allurar COVID-19 sune Moderna, Curevac, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na alluran rigakafi shida daban-daban.
Masu bincike a Kwalejin Imperial ta Landan sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin rigakafin rigakafin COVID-19 mai haɓaka kansa.
An samar da allurar rigakafin a cikin kwanaki 14 bayan an samu jerin sunayen daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da tallafin CAD$275 miliyan don ayyukan bincike 96 kan matakan likita na COVID-19, gami da alluran rigakafi da yawa da aka gabatar a kamfanonin Kanada da jami'o'i, kamar Medicago Initiative da Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 na Kanada musamman don haɓaka allurar rigakafin COVID-19, tare da shirye-shiryen kafa "Bankin allurar rigakafi" na ƙasa na sabbin alluran rigakafi da za a iya amfani da su idan akwai wani barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwaje-gwaje na PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, inda suka ba da rahoton cewa "Sars-CoV-2 subunit S1 alluran rigakafin da aka ba da su ta hanyar allura ta hanyar microscopy sun haifar da martani mai ƙarfi ga ƙwayoyin cuta na musamman na antigen [a cikin beraye] waɗanda suka bayyana tun daga makonni 2 bayan allurar".
A Kanada a ranar 16 ga Afrilu, 2020, Makarantar Pharmacy a Jami'ar Waterloo ta sanar da ƙirar allurar rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin
Ta amfani da maganin kashe ƙwayoyin cuta, ƙwayar RNA mai ƙarancin oxygen za ta iya tsara kwayoyin cuta don sake haifuwa a cikin kwayoyin cutar don samar da ƙwayoyin cuta marasa lahani kamar na SARS-CoV-2, wanda zai iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta ga SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗu da albarkatu don samun damar manyan kwamfutoci daga IBM, tare da albarkatun girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako dabam, kuma ana kiransu sakamako marar iyaka.
Wannan yana nufin cewa za su iya kawo amfanin da ya wuce cutar da kuke fama da ita.
Wani gwaji da aka yi a Ostareliya ya nemi a yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Ana iya samun alluran rigakafin da ba su da lafiya ko tasiri.
Binciken farko don kimanta ingancin allurar ta amfani da takamaiman samfurin dabba don COVID-19, kamar beraye waɗanda aka canza su da angiotensin 2, da sauran dabbobin gwaji, da kuma masu ba da shawara ba na ɗan adam ba, suna nuna buƙatar matakan haɗarin haɗarin haɗari na 3 don magance ƙwayoyin cuta masu rai, da haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitattun hanyoyin aminci.
An gwada alluran rigakafin SARS da ciwon numfashi na Gabas ta Tsakiya a kan dabbobi da ba mutane ba.
A shekara ta 2020, babu magani ko allurar rigakafin SARS da aka tabbatar da cewa yana da lafiya da tasiri a cikin mutane.
Dangane da takardun bincike da aka buga a cikin 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya. Hakanan babu wani allurar rigakafin da aka amince da ita akan cututtukan numfashi na Gabas ta Tsakiya.
Lokacin da cutar Mars ta bazu, an yi imani cewa binciken da aka yi game da SARS zai iya samar da samfurin da zai iya taimakawa wajen samar da alluran rigakafi da magunguna don kamuwa da cutar Mars-CoV.
A watan Maris na 2020, akwai allurar rigakafi guda ɗaya don ciwon numfashi na Gabas ta Tsakiya (wanda ya dogara da DNA mai hana oxygen) wanda ya kammala gwajin gwaji na mutum, kuma wasu allurai uku suna cikin ci gaba, dukansu alluran rigakafi ne na kwayar cutar, alluran rigakafin cutar glandvirus (ChAdOx1-MERS, BVRS-GamVac), da kuma allurar rigakafin MVA (MVA-MERS-S).
Shafukan sada zumunta sun tayar da wata ka'idar makirci da ke cewa an san kwayar cutar da ke haifar da COVID-19 kuma riga-kafin ya riga ya kasance.
Patents da aka ambata a cikin kafofin watsa labarun da yawa suna nufin haƙƙin mallaka na asali na jerin kwayoyin halitta da alluran rigakafi don sauran ƙwayoyin cuta na coronavirus kamar SARS.
Cutar kwayar cutar coronavirus ta 2019 (COVID-19) ta kamu ne daga kwayar cutar coronavirus ta 2 da ke da alaƙa da mummunan cututtukan numfashi (SARS-CoV-2).
Alamomin da aka saba gani sun haɗa da zazzabi, tari, da kuma numfashi a hankali.
Sauran alamun cututtuka sun haɗa da gajiya, ciwon tsoka, zawo, kumburi, rashin jin ƙamshi, da ciwon ciki.
Yawancin lokaci, lokaci tsakanin kamuwa da cutar da bayyanar cututtuka yana da kwana biyar, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin cututtuka suna nuna alamun rashin lafiya, wasu suna ci gaba zuwa cutar huhu da rashin aiki na gabobin jiki.
A ranar 17 ga Afrilu, 2020, an bayar da rahoton kamuwa da mutane sama da miliyan 2.24 a cikin ƙasashe 210 da yankuna, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar ne tsakanin mutane yayin haɗuwa, galibi ta hanyar fesawa lokacin tari, hancin, ko magana.
Sa'ad da aka yayyafa ruwan a lokacin da ake yin wannan aikin, yakan faɗi ƙasa ko kuma a kan rufi maimakon ya yi nisa.
Mutane kuma suna iya kamuwa da cutar idan sun taɓa gurbataccen abu sannan suka taɓa idanunsu, hancinsu, ko bakinsu.
Kwayar cutar na iya rayuwa a saman farfajiya har tsawon sa'o'i 72.
Ana kamuwa da cutar a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakai na ƙarshe na cutar. Hanyar daidaitaccen ganewar asali ita ce ta hanyar amsawa ta hanyar polymerase reverse transcriptase (RT-PCR) ta hanyar zane-zane na hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da kamuwa da cutar da kuma masu kula da su.
Shawarar da aka bayar game da yin amfani da abin rufe fuska ya bambanta. Wasu hukumomi sun ce kada a yi amfani da shi, wasu kuma sun ce a'a, wasu kuma sun ce dole ne a yi amfani da shi.
A halin yanzu, babu wani rigakafi ko maganin rigakafin cutar COVID-19 na musamman.
An bayar da rahoton yaduwar cutar a cikin gida a yawancin ƙasashe a duk yankuna shida na WHO.
Waɗanda ke da kwayar cutar ba za su iya nuna alamun cutar ba ko kuma su nuna alamun cutar kamar mura kamar zazzabi, tari, gajiya da kuma numfashi mai wuya.
Ana ba da shawarar neman taimakon likita nan da nan idan ka ga alamun gaggawa kamar numfashi mai wuya, ciwo ko matsi a kirji, damuwa, wahalar farkawa, launin shuɗi a fuska ko lebe.
A wasu lokatai, za ka iya samun wasu cututtuka na sama kamar yin fitsari, ɓoyewa ko kuma kumburi.
An lura da alamun cututtukan na hanji kamar tashin zuciya, amai da gudawa a cikin nau'i daban-daban.
Da farko, wasu mutane a China suna fama da ciwon kirji da bugun zuciya.
A wasu, cutar na iya zama ciwon huhu, rashin aiki da gabobin jiki da kuma mutuwa.
Ana kiran wannan lokacin kula da yara.
Yawanci, lokacin kamuwa da COVID-19 yana tsakanin kwanaki biyar zuwa shida amma zai iya zama daga kwana biyu zuwa 14.
97.5% na waɗanda ke nuna alamun cutar za su yi hakan a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda ke da cutar ba za su iya nuna alamun cutar ba.
Har yanzu ba a fahimci cikakken rawar da masu dauke da cutar ba tare da nuna alamun cutar ba ke takawa wajen yada cutar ba; duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yada cutar.
A halin yanzu ba a san adadin mutanen da ke fama da cutar ba tare da alamun cutar ba kuma ana nazarin su. Cibiyar Kula da Cututtuka ta Koriya ta Kudu (KCDC) ta ba da rahoton cewa kashi 20 cikin dari na yawan mutanen da aka tabbatar da cutar ba su da alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara lissafin marasa alamun cutar a cikin adadin yau da kullun a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar a wannan ranar, akwai 130 (78%) daga cikin waɗannan marasa alamun cutar da aka gwada.
Ƙura da kuma kayan wasa suna iya ɗauke da ƙwayoyin cutar sosai.
Yana da kyau idan ka yi magana da babbar murya fiye da yadda kake yi idan ka yi magana da sauƙi.
Wani bincike a Singapore ya nuna cewa tari ba tare da rufe baki ba zai iya haifar da fesawa zuwa tazarar mita 4.5 (ƙafa 15).
Ko da yake cutar ba ta yawan yaduwa ta iska, Cibiyar Nazarin Kimiyya ta Kasa ta nuna cewa ana iya yaduwa ta hanyar iska mai iska, kuma gwajin samfurori daga ɗakin iska a cikin ɗakin da ke waje da ɗakunan mutane ya haifar da sakamako mai kyau na cutar RNA.
Wasu hanyoyin magani kamar su CPR da CPR suna iya sa a fitar da ƙwayoyin cuta daga cikin numfashi a matsayin fesawa, kuma daga nan cutar ta yadu ta iska.
Ko da yake akwai damuwa cewa za a iya yada shi ta hanyar ƙura, ana ganin cewa wannan haɗarin yana da iyaka. Kwayar cutar tana da saurin kamuwa da cuta lokacin da mutane ke da alamomi; kuma yayin da za ta iya yaduwa kafin bayyanar cututtuka, haɗarin ba shi da yawa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce duk da rashin tabbas game da yadda cutar ke yaduwa, mutum ɗaya zai iya cutar da mutane biyu zuwa uku gaba ɗaya. Kwayar cutar tana ci gaba da makale a saman rufi daga awanni zuwa kwanaki.
Musamman, an gano cewa kwayar cutar tana rayuwa har kwana ɗaya a kan kwali, har kwana uku a kan filastik (polypropylene), ƙarfe mai ƙarfe (AISI 304), har zuwa awa huɗu a kan jan ƙarfe 99%.
Amma, hakan ya dangana ga yanayin zafi da kuma danshi.
Sabulu da magungunan wankewa suna da tasiri idan aka yi amfani da su yadda ya kamata. Sabulu yana narkar da fat membrane da ke kare kwayar cutar kuma yana hana ta aiki, ban da kawar da fata da sauran farfajiyoyi daga ciki.
Akwai wasu magunguna, kamar su benzalkonium chloride da chlorhexidine gluconate (mai tsabtace cututtuka), waɗanda ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an ɗauki samfurin ƙura bayan kwana biyu da zuwa asibiti.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna mafi girman ƙwayar cuta, kuma a rana ta biyu na gwajin, mai haƙuri na shida ya nuna mafi girman ƙwayar cuta.
Cutar coronavirus 2 mai haɗari da cututtukan numfashi mai tsanani (SARS-CoV-2) sabuwar cuta ce da ke haɗari da cututtukan numfashi mai tsanani, an fara ware ta daga mutane uku da ke fama da cutar huhu a cikin rukunin cututtukan cututtukan numfashi mai tsanani a Wuhan.
Sabon SARS-CoV-2 yana da halaye iri ɗaya da na coronaviruses masu alaƙa da ke cikin yanayi.
A waje da jiki, sabulu na gida yana kashe kwayar cutar, yana lalata membrane na kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Cutar ta fi shafar huhu saboda cutar tana shiga cikin ƙwayoyin cuta ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin cuta na II a cikin huhu.
Kwayar cutar tana amfani da wani sinadarin sukari na musamman da ake kira spike don haɗuwa da ACE2 kuma ya shiga cikin tantanin halitta.
Kashi 12 cikin 100 na mutanen da aka kwantar a asibiti a birnin Wuhan na kasar Sin sun kamu da ciwon zuciya, kuma hakan ya fi yawa a cikin masu ciwon zuciya.
Yawan cututtukan da ke tattare da zuciya da jijiyoyin jini suna da yawa, saboda amsawar kumburi da rikicewar tsarin garkuwar jiki yayin ci gaban cutar, amma mummunan rauni na jijiyoyin zuciya na iya haɗuwa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ƙwayar AC2 suna da muhimmiyar rawa a cikin zuciya kuma suna da hannu wajen yin ayyukanta.
Yawan bugun jini (31%) da bugun jini (25%) sun karu a cikin marasa lafiya a cikin ICU tare da COVID-19 wanda zai iya kasancewa da alaƙa da rashin tsinkayar abin da zai faru. An gano a cikin gawawwakin mutanen da suka mutu saboda COVID-19 lalacewar jijiyoyin jini (DAD), da kuma ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Duk da cewa SARS-CoV-2 yana kaiwa ga ƙwayoyin EC2 a cikin tsarin numfashi, marasa lafiya masu cutar COVID-19 suna da alamun cutar hyperinflammatory.
Musamman, an nuna cewa ƙwayoyin T da ke samar da GM-CSF masu haifar da cututtuka suna da alaƙa da kawo ƙwayoyin interleukin 6 masu haifar da ƙonewa da cututtukan huhu a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton cewa akwai ƙwayar ƙwayar cuta a cikin autopsy.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwajin da aka saba amfani da ita ita ce RRT-PCR.
Ana yin gwajin ne da yawanci ana amfani da samfurin numfashi da aka karɓa daga allurar ƙwayoyin cuta ta hanci; duk da haka, ana iya amfani da allurar ƙwayoyin cuta ta hanci ko samfurin ƙwayoyin cuta.
Ana samun sakamako a cikin sa'o'i biyu zuwa kwana biyu.
Ana iya yin gwajin jini, amma hakan na bukatar a ɗauki jini sau biyu a mako biyu kuma sakamakon yana da muhimmanci sosai.
Masana kimiyya na kasar Sin sun iya ware kwayar cutar coronavirus da kuma yada tsarin kwayoyin halitta don dakunan gwaje-gwaje a duniya su iya samar da gwajin PCR da kansu don gano cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin antibody (wanda zai iya gano kamuwa da cuta da kuma ko mutum ya kamu da cutar a baya ko a'a) amma ba a yi amfani da shi sosai ba.
Gwajin da aka yi a China ya nuna cewa gwajin ya kasance daidai tsakanin kashi 60 zuwa 70 cikin dari.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin farko na asibiti a ranar 21 ga Maris, 2020 don amfani da shi a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halayen asibiti da haɗarin annoba.
Ƙarƙashin gilashin gilashi yana da ƙananan ƙananan wurare masu yawa tare da yaduwar wurare dabam dabam da kuma baya.
Ƙananan ƙananan ƙwayoyin cuta na iya bayyana tare da ci gaban cutar.
Akwai bayanai kaɗan game da cututtukan ƙwayar cuta da ilimin lissafi na COVID-19.
Babban binciken da aka yi daga binciken da aka yi a kan gawawwakin:
Binciken microscope: cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Akwai nau'i huɗu na cutar sankarar bargo mai saurin yaduwa:
Ƙaramin ciwon huhu: ƙwayoyin huhu, ƙwayoyin ƙwayar cuta, ƙwayoyin sink mai girma, ƙwayoyin ƙwayoyin cuta tare da ƙwayar cuta da kuma samar da kwayoyin halitta masu yawa
Cutar huhu mai tsanani: Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Cutar ta haifar da ciwon numfashi mai tsanani da kuma rashin iskar oxygen.
Maganin ciwon huhu: sarrafa fitarwa a cikin rami na sinus da kuma cutar huhu
Jini: DIC, hawan jini na ƙwayoyin jini
Matakan kariya don rage yiwuwar kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wuraren da jama'a ke taruwa, wanke hannuwanka da sabulu da ruwa sau da yawa na aƙalla dakika 20, yin tsabtace numfashi, da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
Cibiyar CDC ta ba da shawarar rufe baki da hanci da tawul lokacin da kake tari ko hancinsa, kuma ana ba da shawarar amfani da cikin kayan aiki idan ba a sami tawul ba.
Ana ba da shawarar wanke hannuwanka sosai bayan tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, wani ɓangare don rage yaduwar kamuwa da cuta daga waɗanda ba su nuna alamomi. Dabarun nisantar jama'a suna nufin rage haɗuwa da masu kamuwa da cuta a cikin manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata balaguro da soke manyan taron jama'a.
Shawarwarin nisantawa sun kuma haɗa da cewa mutane su kasance aƙalla ƙafa 6 (1.8 m) nesa da juna.
Babu wani magani da aka sani da tasiri wajen hana COVID-19. Kuma tunda ba a tsammanin za a sami allurar rigakafi har zuwa 2021 ba, babban ɓangaren sarrafa COVID-19 shine ƙoƙarin rage ƙimar cutar, wanda aka sani da "lanƙwasa lanƙwasa".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa aƙalla na dakika 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun ƙazantu sosai, kafin su ci abinci, bayan sun share hanci, sun tari ko kuma sun yi fitsari.
Hakanan yana ba da shawarar amfani da maganin kashe ƙwayoyin cuta wanda ya ƙunshi aƙalla kashi 60% na barasa, lokacin da sabulu da ruwa kawai ba su da samuwa. Ga yankunan da ba a samun kayan tsabtace hannu na kasuwanci, WHO tana ba da girke-girke biyu na gida.
Ayyukan antibacterial a cikin waɗannan abubuwa biyu suna fitowa daga ethanol ko isopropanol.
Ana amfani da sinadarin hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin barasa; "ba mai tsabtace hannu ba ne".
Ana ƙara glycerol a matsayin mai laushi.
Mutane suna samun taimako, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma taimakon wasu gabobin da suka kamu.
Cibiyar CDC ta ba da shawarar cewa duk wanda ke da cutar ya sa takunkumin rufe fuska.
Ana amfani da ECMO wajen magance rashin numfashi, amma har yanzu ana nazarin amfaninta.
Ana ba da shawarar tsabtace jiki da kuma rayuwa mai kyau da kuma cin abinci mai kyau don inganta rigakafi.
Magungunan tallafi na iya taimakawa waɗanda ke da alamun rashin lafiya a farkon lokacin kamuwa da cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari don kula da waɗanda aka kwantar da su a asibiti saboda COVID-19.
Masana kiwon lafiya na musamman da kuma likitocin huhu a Amirka sun tattara shawarwarin magani daga wasu hukumomi a cikin wani littafi mai sauƙi, wato littafin kula da cututtuka masu tsanani da ke kan layi.
Ya zuwa watan Afrilun 2020, babu wani magani na musamman don COVID-19.
Don bayyanar cututtuka, wasu likitoci sun ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen a matsayin magani na farko.
Ya kamata a ɗauki matakan kariya don rage haɗarin yaduwar cutar zuwa mafi ƙarancin, musamman a wuraren kiwon lafiya lokacin da ake aiwatar da ayyukan da zasu iya haifar da fesawa, kamar bututu ko numfashi na hannu.
Ga masu kula da lafiya da ke kula da mutanen da ke da cutar COVID-19, CDC ta ba da shawarar sanya mutum a cikin ɗakin keɓewa daga kamuwa da cutar ta iska (AIR) tare da amfani da matakan kariya na yau da kullun, haɗuwa da haɗuwa da kariya daga cututtukan iska. CDC ta bayyana jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Abubuwan da aka ba da shawarar: Kayan aikin kariya na mutum, kayan numfashi ko abin rufe fuska, masu kariya na ido, da safar hannu.
An amince da kayan numfashi na N95 don masana'antu, amma Hukumar Abinci da Magunguna ta ba da izinin amfani da abin rufe fuska a ƙarƙashin lasisin Amfani da Gaggawa (EUA).
An tsara su don karewa daga kwayoyin da ke cikin iska kamar ƙura, amma ba a tabbatar da ingancinsu a kan takamaiman kwayar halitta ba idan ana amfani da su don wasu dalilai da ba a bayyana ba.
Idan babu abin rufe fuska, CDC ta ba da shawarar amfani da abin rufe fuska, ko abin rufe fuska na gida a matsayin mafita ta ƙarshe.
Yawancin masu kamuwa da COVID-19 ba su da ciwo sosai da zai sa a yi musu allurar numfashi ko kuma a yi musu allurar maye gurbin cutar, amma akwai wasu da suke bukatar hakan.
Ana nazarin irin taimakon numfashi da ake bayarwa ga masu fama da rashin numfashi da ke da alaƙa da COVID-19 a asibitoci, tare da wasu shaidu game da yiwuwar kauce wa tube ta hanyar amfani da bututun hanci mai gudana ko matsin lamba mai kyau na iska.
Ba a san ko waɗannan zaɓuɓɓukan biyu suna da amfani ga waɗanda suke da ciwo mai tsanani ba.
Wasu likitoci sun fi son ci gaba da yin amfani da numfashi na iska lokacin da ake da shi saboda wannan fasaha tana rage yaduwar ƙwayoyin iska idan aka kwatanta da hanyar hanci mai zurfi. Abubuwan da ke faruwa a cikin tsofaffi (wanda ya wuce shekaru 60, musamman ma wanda ya wuce shekaru 80).
Kasashe masu tasowa da yawa ba su da isassun gadajen asibiti don yawan jama'a, wanda ke iyakance ikon tsarin kiwon lafiya don magance hauhawar kwatsam na masu cutar COVID-19 masu haɗari da ke buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5 cikin 100 na masu cutar sun shiga cibiyoyin kulawa, kashi 2.3 cikin 100 na bukatar taimakon numfashi, kuma kashi 1.4 cikin 100 na mutanen sun mutu.
A China, kusan kashi 30 cikin dari na waɗanda aka kwantar a asibiti saboda COVID-19 sun shiga sashen kula da marasa lafiya.
Numfashi na wucin gadi yana da rikitarwa yayin da cutar ta COVID-19 ta ci gaba da ci gaba da ciwon ciwon numfashi mai tsanani (ARDS) kuma samar da iskar oxygen ya zama da wahala.
Ana buƙatar na'urorin numfashi su sami yanayin sarrafa matsin lamba da matsin lamba mai kyau don ƙara isar da iskar oxygen zuwa iyakar yayin rage haɗarin cutar huhu da ke tattare da na'urar numfashi da hutawa ta kirji zuwa mafi ƙarancin.
Ƙarfin jini mai ƙarfi ba zai kasance a cikin tsofaffin na'urorin numfashi ba.
Binciken yiwuwar magani ya fara a watan Janairun 2020, kuma yawancin magungunan rigakafin cutar suna cikin gwajin asibiti.
Da alama cewa Remdesivir ne mafi kyau.
Ko da yake sababbin magunguna na iya ɗaukar har zuwa 2021 don ci gaba, yawancin magungunan da ake gwadawa sun riga sun sami izini don wasu amfani ko kuma suna cikin matakan gwaji.
Za a iya gwada maganin rigakafin cutar a kan waɗanda suke da wata cuta mai tsanani.
Hukumar Lafiya ta Duniya ta ba da shawarar masu sa kai su shiga cikin gwaji game da inganci da amincin magunguna. Hukumar Abinci da Magunguna ta ba da izinin ɗan lokaci don amfani da jini mai tsafta a matsayin magani na gwaji a cikin yanayin da rayuwar mutum ke cikin haɗari ko na nan take.
Ba a yi nazarin asibiti ba don tabbatar da cewa yana da lafiya da tasiri a kan cutar.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar salula don magance cutar.
Ana bukatar masu amfani su shigar da sunansu da kuma lambarsu ta ID.
Aikace-aikacen yana iya gano masu shiga ta amfani da bayanan sa ido kuma don haka haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba halin wasu masu amfani uku.
Idan an gano wata barazana, app din ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da jami'an kiwon lafiya na gida. Ana amfani da nazarin bayanai masu yawa na wayar hannu, fasahar gane fuska, bin wayar hannu, da hankali na wucin gadi don bin diddigin waɗanda ke da cutar da waɗanda suka kamu da ita a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da izinin tsaro su bi bayanan wayar hannu na waɗanda ake zargi da kamuwa da cutar coronavirus.
An dauki matakin ne domin sanya dokar killacewa da kare wadanda za su iya saduwa da mutanen da suka kamu da cutar.
Har ila yau, a cikin Maris 2020, Deutsche Telekom ta raba bayanan wuraren wayar da aka tattara tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don dalilai na bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya, Mista Giulio Galera ya bayyana cewa kamfanonin wayar salula sun gaya masa cewa "kashi 40 cikin 100 na mutane har yanzu suna motsi ko'ina".
Gwamnatin Jamus ta gudanar da wani taron hawan keke na tsawon sa'o'i 48 a karshen mako, inda mutane fiye da 42,000 suka halarci taron.
Shugabar Estonia, Kirsty Kalliolaide ta kuma gabatar da gayyatar duniya don samar da sabbin hanyoyin magance yaduwar cutar coronavirus.
Mutane suna iya jin tsoro saboda keɓewa, ƙuntatawa na tafiya, sakamako na magani ko tsoron kamuwa da cutar kanta.
BBC ta wallafa wani labari daga Rory O'Connor: "Ƙaruwar warewar jama'a, kaɗaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki suna daɗaɗa lafiyar mutane da kuma lafiyarsu".
Cutar na iya zama mai sauƙi tare da alamun rashin lafiya ko kuma ba tare da alamun cutar ba, kamar sauran cututtukan numfashi na sama kamar sanyi.
Sau da yawa, marasa lafiya suna murmurewa cikin mako biyu, amma masu ciwo mai tsanani suna murmurewa cikin makonni uku zuwa shida.
Mata masu ciki na iya zama masu saurin kamuwa da COVID-19 bisa ga bayanan wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma har yanzu akwai ƙarancin bayanai game da COVID-19. COVID-19 na iya shafar huhu a wasu mutane yana haifar da ciwon huhu.
A cikin waɗanda suka fi kamuwa da cutar, COVID-19 zai iya saurin zama ciwon numfashi mai tsanani (ARDS) wanda zai haifar da rashin numfashi, rauni mai saurin kamuwa da cuta ko rashin aiki na gabobin jiki.
Abubuwan da ke tattare da COVID-19 sune kamuwa da cuta, ƙwanƙwasawar jini, da lalacewar zuciya, koda da hanta.
An gano cewa kashi 6 cikin ɗari na mutanen da ke da cutar COVID-19 da aka kwantar a asibiti suna da cutar ƙwayoyin jini, musamman ƙaruwa a lokacin prothrombin, yayin da kashi 4 cikin ɗari ke da cutar koda.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 sun sami ƙaruwa a matakan enzyme na hanta (aminotransmitters).
A cewar wannan rahoton, matsakaicin lokacin da ya wuce tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 10, daga cikinsu kwana biyar a asibiti.
Amma, matsakaicin lokacin da ya wuce tsakanin shigar da su asibiti da mutuwa a cikin waɗanda aka kai sashen kula da marasa lafiya na kwana bakwai.
A cikin binciken da aka yi na farkon lokuta, matsakaicin lokacin bayyanar cututtuka na farko zuwa mutuwa ya kasance kwanaki 14, kuma yawan lokuta ya kasance daga kwanaki shida zuwa kwanaki 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta gudanar, mace-mace sun mutu kashi 1.7 cikin dari, maza kuma kashi 2.8 cikin dari.
Binciken kwayoyin halitta na ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
An lura da canjin cutar ta kwayar cutar a cikin ƙwayoyin cuta.
Hoton na numfashi yana nuna ciwon numfashi mai tsanani (ARDS).
An lura da lalacewar zuciya saboda yawan matakan troponin ko bugun zuciya a cikin kashi 11.8 cikin ɗari na mutuwar da Hukumar Lafiya ta Kasa ta bayar a China.
A cewar bayanan da aka fitar daga Amurka a watan Maris, kashi 89% na waɗanda aka kwantar da su a asibiti suna da wasu cututtuka da suka gabata. Samun albarkatun likita da yanayin tattalin arzikin yankin na iya shafar mutuwar.
Ƙididdigar mutuwar da ke haifar da wannan cuta ta bambanta saboda waɗannan bambance-bambance tsakanin yankuna, amma kuma saboda matsalolin tsarin.
Rage ƙarancin ƙananan cututtuka na iya sa ƙididdigar yawan mutuwar ta fi gaskiya.
Amma, gaskiyar cewa ciwo da aka yi a dā yana kashe mutane yana iya nuna cewa yawan mutanen da suke mutuwa yanzu bai kai yadda yake ba.
Masu shan sigari sun fi saurin kamuwa da cututtukan COVID-19 sau 1.4, suna buƙatar kulawa mai tsanani sau 2.4, kuma suna da saurin mutuwa sau 2.4 fiye da waɗanda ba masu shan sigari ba. An kuma nuna damuwa game da rikitarwa na dogon lokaci.
Asibitin Hong Kong ya nuna raguwar yawan huhu da kashi 20 zuwa 30 cikin dari a wasu masu warkewa daga cutar, kuma gwajin huhu ya nuna lalacewar su.
Hakan zai iya sa mutum ya soma ciwon da ake kira post-concussion syndrome.
A watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata tana ba masu murmurewa daga cutar rigakafi mai tasiri da na dogon lokaci ba.
Ana ganin cewa zai yiwu a samu rigakafi, bisa ga halayyar sauran coronaviruses, amma an bayyana cewa akwai wasu mutane da suka warke daga COVID-19 kuma daga baya suka sake kamuwa da cutar.
Ya yi imanin cewa waɗannan cututtukan suna daɗa muni idan kamuwa da cuta ta ci gaba fiye da lokacin da ta sake faruwa.
Ya yi imanin cewa kwayar cutar ta kasance ta dabbobi ne, saboda yawan kamuwa da cutar.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na 2019, kamuwa da cutar ya kasance sakamakon kamuwa da cutar daga mutum zuwa mutum.
Wani bincike da aka yi a kan mutane 41 da suka kamu da cutar COVID-19, wanda aka buga a cikin The Lancet a watan Janairun 2020, ya nuna cewa ranar 1 ga Disamba, 2019 ita ce ranar farko da za a fara bayyanar cututtuka.
Rahotanni na hukuma daga Hukumar Lafiya ta Duniya sun ba da rahoton cewa ranar 8 ga Disamba, 2019 ita ce ranar farko da alamun cutar suka fara bayyana.
Ana yawan yin abubuwa da yawa don sanin yawan mutanen da suka mutu.
Waɗannan lambobi sun bambanta dangane da yanki da kuma lokaci, kuma suna shafar yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma yanayin yawan jama'a kamar shekaru, jinsi, da kuma lafiyar jama'a.
A ƙarshen 2019, Hukumar Lafiya ta Duniya a cikin bita na 10 na Classification of Diseases ta ba da lambar gaggawa U 07.1 don mutuwar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje da lambar U 07.2 don mutuwar COVID-19 da aka gano tare da SARS-CoV-2 a cikin asibiti ko annobar cutar ba tare da tabbatar da cutar cutar ba.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar kamuwa da cutar a duniya ya kai kashi 6.9% (153,822/2,240,191) tun daga 17 ga Afrilu 2020.
Ƙididdiga ta bambanta daga yanki zuwa yanki. Sauran ma'auni sun haɗa da yawan mutuwar mutane (CFR), wanda kashi ne na waɗanda aka gano suna da cutar kuma suka mutu daga cuta, da kuma yawan mutuwar mutane (IFR), wanda kashi ne na waɗanda ke da cutar (waɗanda aka gano da waɗanda ba a gano su ba) da kuma waɗanda suka mutu daga cuta.
Waɗannan ƙididdigar ba su da lokaci, kuma suna bin ƙayyadaddun alƙaluma daga kamuwa da cutar zuwa ƙaddarar yanayin.
Ko da yake ba dukan mutane ba ne suke samar da ƙwayoyin cuta, amma idan suna nan, za su iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A cikin cibiyar annobar a Italiya, Castilloni d'Adda, wani ƙaramin ƙauye mai yawan mutane 4,600, mutane 80 (1.7%) sun riga sun mutu.
A Janglet, cutar ta bazu ne saboda bukukuwan Carnival, kuma ta koma ga matasa, wanda ya haifar da ƙananan mutuwar, kuma wataƙila ba duk mutuwar COVID-19 aka lasafta ta a matsayin sakamakon ba.
Ƙari ga haka, ba a gajiyar da tsarin kiwon lafiya na Jamus ba.
A ƙasar Holland, kashi uku cikin ɗari na masu ba da jini suna da ƙwayoyin rigakafi.
An tabbatar da mutuwar mutane 69 (0.004% na yawan jama'a) daga COVID-19.
Sakamakon annobar da kuma yawan mace-mace ya bambanta tsakanin maza da mata.
Matattu sun fi yawa a cikin maza a binciken da aka yi a China da Italiya.
Matsayin da ya fi haɗari ga maza shi ne a shekara 50, inda bambancin tsakanin maza da mata ya ƙare a shekara 90.
A ƙasar Sin, yawan mace-macen ya kai kashi 2.8 cikin ɗari ga maza da kuma kashi 1.7 cikin ɗari ga mata.
Ba a san ainihin dalilin da ya sa waɗannan bambance-bambance na jinsi ba, amma ƙwayoyin halitta da halayyar mutum na iya zama sanadi.
Wataƙila bambance-bambance a cikin tsarin rigakafi bisa jinsi, rashin shan taba a tsakanin mata da kuma samun cututtuka na yau da kullum kamar hawan jini a cikin mata da suka fi ƙanƙantawa sun taimaka wajen ƙaruwa a mutuwar maza.
A Turai, kashi 57 cikin ɗari na waɗanda suka kamu da cutar maza ne kuma kashi 72 cikin ɗari na waɗanda suka mutu daga COVID-19 maza ne.
Tun daga watan Afrilu na 2020, gwamnatin Amurka ba ta bin diddigin bayanan jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura da SARS suna shafar maza da mata dabam.
Ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne da yawa kuma suna da haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan hukuma na cutar shine "COVID-19".
Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom Ghebreyesus, ya bayyana cewa, ko a takaice yana nufin cutar korona, kuma a takaice yana nufin cutar, kuma 19 yana nufin shekarar da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa yin magana game da takamaiman wuri (kamar China), nau'in dabba ko ƙungiyar mutane, daidai da shawarwarin lakabi na duniya waɗanda aka yi niyyar hana lalata. Ana kiran kwayar cutar da ke haifar da COVID-19 coronavirus 2 wanda ke da alaƙa da mummunan cututtukan numfashi (SARS-CoV-2).
Bugu da ƙari, WHO tana amfani da kalmomin "Covid-19" da "Covid-19 virus" a cikin bayanan jama'a.
Ana kiran cutar da kwayar cutar da "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira cutar da cutar da "Covid-19" da kuma "Covid-19 Wuhan".
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar amfani da sunayen Novel Coronavirus-2019 da Novel Coronavirus-related acute respiratory illness-2019 a matsayin sunaye na wucin gadi na kwayar cutar da cutar daidai da jagororin 2015 waɗanda ke hana amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen hukuma guda biyu COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin sarkar samar da daidaitattun kayayyaki, kamfanonin masana'antu na dijital suna fitar da kayan kiwon lafiya kamar su binciken hanci da sassan na'urar numfashi.
Misali ɗaya, lokacin da asibiti a Italiya yake bukatar bawul na numfashi, kuma mai ba da kayan aikin bai iya kawo su a kan lokaci ba, wata ƙaramar kamfani a cikin gida ta sake tsara shi kuma ta samar da bawul 100 da ake buƙata cikin dare ɗaya.
Bayan barkewar COVID-19 ta farko, ra'ayoyin maƙarƙashiya da rashin fahimta da ɓatarwa game da asalin cutar, girmanta, rigakafi, magani da sauran fannoni sun bayyana kuma sun bazu cikin sauri akan Intanet.
Da alama mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken bai sami wata shaida ba cewa kwayar cutar ta yadu a aladu, ducks, da kaji.
Babu magani ko allurar riga-kafi da aka amince da su don magance cutar.
Cibiyoyin gwamnati, kungiyoyin ilimi da masana'antu masu bincike suna gudanar da bincike na duniya kan alluran rigakafi da magunguna na COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da gwajin hadin kai don tantance tasirin maganin maganin cutar ta hanyar maganin cutar guda huɗu da ke da kyakkyawan fata.
Babu riga-kafi, amma kungiyoyi daban-daban suna aiki sosai wajen samar da riga-kafin.
Suna amfani da binciken da aka yi a baya game da SARS-CoV saboda yana kama da SARS-CoV-2 wajen amfani da masu karɓar ACE2 don shiga cikin ƙwayoyin mutum.
Ana nazarin dabarun yin amfani da kwayoyin halitta guda uku.
Da farko, masu bincike suna son samar da cikakkiyar allurar rigakafin cutar.
Amfani da irin wannan kwayar cutar, ko ba ta aiki ko ta mutu, yana nufin haifar da amsawar rigakafi nan take a jikin mutum game da sabon kamuwa da cutar COVID-19.
Dabara ta biyu, rigakafin ƙananan kwayoyin, tana nufin ƙirƙirar allurar rigakafi da ke sa tsarin garkuwar jiki ya zama mai saurin kamuwa da wasu ƙananan ƙwayoyin cutar.
A cikin SARS-CoV-2, wannan bincike ya mai da hankali ne kan furotin SpikeS wanda ke taimaka wa kwayar cutar ta shiga cikin masu karɓar enzyme na ACE2.
Dabara ta uku ita ce allurar rigakafin DNA (allurar rigakafin DNA mai launin ruwan kasa ko ribose DNA, sabuwar fasaha ce ta ƙirƙirar allurar rigakafi).
Dole ne a gwada alluran rigakafin gwaji da aka samar daga kowane ɗayan waɗannan dabarun don tabbatar da amincinsu da ingancinsu. A ranar 16 ga Maris, 2020, gwajin farko na asibiti na allurar rigakafi ya fara akan masu sa kai huɗu a Seattle.
Wannan allurar tana dauke da kwafin kwayar halitta mara lahani daga kwayar cutar da ke haifar da cutar. An nuna cewa karfafawar kwayar cutar ta hanyar maganin rigakafi wata matsala ce da ke fuskantar samar da allurar SARS-CoV-2, amma wannan abu ne mai rikitarwa.
Akwai gwaji sama da 300 da ake gudanarwa tun daga watan Afrilun 2020.
An yi gwaji bakwai na maganin zazzabin cizon sauro, daga cikinsu akwai hudu da suka shafi hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar da aka gabatar don sake amfani da su don magance sabuwar cutar sune mafi yawan binciken kasar Sin, ta hanyar gwaji na uku na Remdesivir a cikin kasashe da yawa kuma za a ba da rahoton sakamakon su a ƙarshen Afrilu.
An gudanar da nazarin ci gaban asibiti na alluran rigakafi da magungunan COVID-19 masu yuwuwa daga Afrilu 2020. Ana kimanta magungunan rigakafin cutar da yawa da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine, hydroxychloroquine, lopinavir/ritonavir, da lopinavir/itonavir a hade tare da interferon beta.
Akwai shaidar farko game da tasirin Remdesivir, tun daga Maris 2020.
An lura da ingantaccen yanayin asibiti a cikin marasa lafiya waɗanda aka kula da su da maganin Remdesivir don amfani da mahaifa.
Ana gudanar da gwaji na asibiti na mataki na uku a Amurka, China da Italiya. An fara nazarin chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, a China a watan Fabrairun 2020, kuma yana da sakamako na farko.
Duk da haka, akwai kira don nazarin bincike.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chlorokine.
Duk da haka, Cibiyar Bincike ta Wuhan ta nuna cewa duk da shawarar da aka bayar na gram daya, rage yawan maganin yana da haɗari kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, Hukumar Abinci da Magunguna ta bayar da izinin amfani da gaggawa ga hydroxychloroquine da chloroquine bisa ga shawarar likitocin da ke kula da mutanen da ke fama da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar allurai masu yawa na ribavirin don hana SARS-CoV-2 a cikin dakin gwaje-gwaje.
An ba da shawarar ƙarin nazarin tasirin nitasoxanide akan kwayoyin bayan an tabbatar da hana shi don ƙananan ƙididdigar SARS-CoV-2. Nazarin ya nuna cewa farkon tsari na furotin na ƙwanƙwasa ta hanyar protease 2 na serine na membrane (TMBRSS2) ya zama dole don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da azithromycin ko ba tare da shi ba ya ƙunshi manyan rashi waɗanda suka hana ƙungiyar likitoci karɓar waɗannan magungunan ba tare da ƙarin nazari ba. Oceltaphamvir ba ya hana SARS-CoV-2 a cikin dakin gwaje-gwaje kuma ba shi da sanannen rawar a cikin maganin COVID-19.
Guguwar cytokine na iya zama wata matsala a ƙarshen COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-tsunami na cytokine. Hukumar Lafiya ta Kasa ta kasar Sin ta kara tosillizumab zuwa jagororin magani bayan kammala karamin bincike.
Ana yin gwajin lokaci na biyu a Italiya bayan an gwada shi a kan mutanen da ke fama da ciwo mai tsanani.
Baya ga yin amfani da shi wajen gwada viratin a cikin jini don gano guguwar cytokine, an yi niyyar magance irin wannan ci gaban, wanda ake tsammanin shine dalilin mutuwar wasu masu cutar.
Hukumar kula da magungunan abinci da magunguna ta FDA ta amince da maganin karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar
Har zuwa yanzu, babu wata tabbatacciyar shaida da ta nuna cewa tosisilzumab magani ne mai tasiri ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Hanyar da aka samar da rigakafi mai tsabta da kuma mai ƙarfi wanda tsarin rigakafin COVID-19 ya samar ga waɗanda suke buƙatar shi ana nazarin shi azaman hanyar rigakafin rigakafin rigakafi.
An gwada wannan dabarar a kan SARS kuma sakamakon ba shi da kyau.
Halin da ake ciki na cutar yana wakiltar tsarin aikin da ake tsammani wanda maganin antibody mai illa zai iya aiki a matsayin matsakaiciyar kariya ga SARS-CoV-2.
Amma, wataƙila za a iya yin amfani da wasu hanyoyin kamar su antibody-based cellular toxicity ko ingestion ko duka biyun.
Akwai wasu hanyoyin maganin rigakafi, kamar amfani da rigakafi na halitta guda ɗaya, da ake ci gaba.
Za a iya ƙara samar da ƙwayar ƙwayar cuta, wadda ta ƙunshi jini na marasa lafiya da suka warke kuma tana ɗauke da ƙwayoyin cuta na wannan ƙwayar cuta don ta yaɗu da sauri.
Cutar Corona, tarin cututtuka masu alaƙa.
Li Wen Liang, likita a babban asibitin Wuhan, ya kamu da cutar COVID-19 kuma ya mutu bayan ya jawo hankali kan yaduwar cutar.
